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ABSTRACT 
 
Histone H1 phosphorylation is thought to affect chromatin condensation and function, but 
few details are known about the impact of H1 variant-specific phosphorylation in higher 
eukaryotes.  Using novel proteomic approaches, we directly demonstrate that specific 
sites in the two dominant H1 variants of HeLa S3 cells are phosphorylated either 
exclusively during mitosis or during both interphase and mitosis.  Interphase H1 
phosphorylation in HeLa S3 cells is abundant and remarkably hierarchical, contrary to 
evidence that sites are used fortuitously during the cell cycle.  Analyses with antisera to 
individual H1.2 and H1.4 interphase phosphorylations reveal that they are distributed 
throughout nuclei but appear to be particularly enriched in nucleoli.  Chromatin 
immunoprecipitation analyses reveal that interphase phosphorylated H1.4 is enriched at 
active rDNA promoters and is rapidly induced at steroid hormone response elements by 
hormone treatment.  Our results imply that site-specific interphase H1 phosphorylation 
facilitates transcription by RNA polymerases I and II, and has an unanticipated function 
in ribosome biogenesis and the control of cell growth.  In contrast to histone 
modifications enriched at gene regulatory regions, site-specific interphase H1 
phosphorylation is enriched within the body and the regulatory elements of transcribed 
genes.  Our data suggest CDK8 and CDK9, kinases with known association with the 
transcriptional machinery, as candidates that could account for this distribution of 
interphase H1 phosphorylation.  Comparative analyses of H1 variant expression and 
phosphorylation in different human cell lines reveal that H1.3 is significantly less 
phosphorylated during interphase relative to other H1 variants in the cell lines tested.  
Analyses of the phosphorylation of site-specific H1 mutants ectopically expressed in 
human cells identified features of H1.3 that lead to its underphosphorylation.  Together 
these results suggest that differences in interphase phosphorylation may contribute to the 
functional diversity of H1 variants.   
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CHAPTER 1 
INTRODUCTION 
1.1  Nucleosome 
Eukaryotic cells are faced with the challenge of packing their genomic DNA, more than a 
meter long in the case of humans, into nuclei with average diameters of only a few 
microns.  The association of DNA with histones in nucleosomes and the higher order 
folding of nucleosomal filaments in chromatin provides the degree of compaction 
necessary to achieve this and constitutes the basis by which portions of the genome are 
selectively made accessible for transcription and other DNA-templated processes.  The 
nucleosome is composed of 146 bp DNA wrapped in 1.7 left-handed superhelical turns 
around an octamer formed by two histone H2A-H2B heterodimers and one H3-H4 
tetramer.  A molecule of histone H1, also termed as linker histone, binds DNA on the 
outer surface of the nucleosome at the point where the entering and exiting strands meet.  
The binding of H1 is thought to both “seal” the nucleosome and to enable the reversible 
folding of extended 10 nm or “beads-on-a-string”, transcriptionally active chromatin 
fibers into the 30 nm, transcriptionally inactive chromatin fibers that comprise the bulk 
form of chromatin in interphase nuclei (Khorasanizadeh, 2004; Oudet et al., 1975).   
 
Members of the H1 family in higher eukaryotic cells, including extreme variants such as 
H5 found in avian erythrocytes, possess a tripartite structure with a globular domain 
flanked by less structured N- and C-terminal tails.  In particular, the vey long C-terminal 
tail comprising almost half of the protein is highly basic with abundant lysines and 
arginines.  Unlike the conserved core histones, histone H1 is more divergent across 
species.  The putative H1 called Hho1p in s. cerevisiae possesses two globular domains 
whereas H1 in tetrahymena lacks globular domain (Mizzen et al., 1999; Schafer et al., 
2005).  This structure discrepancy leads to the debate that whether there is H1 
counterparts in these two organisms.   
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Several crystal structures of nucleosome core particles have been obtained from 
reconstituted nucleosome containing human α-satellite DNA, which are able to form 
homogenous nucleosome particle (Harp et al., 2000; Luger et al., 1997).  From these 
structure studies, we have learned that the core particles are formed by “handshake 
arrangement” through interaction between histone fold domains, consisting of three helix 
core domains.  Besides the histone fold core, there are disordered N-terminal and 
C-terminal tails for each histone, which protrude beyond the nucleosome disk.  Very 
importantly, these tails are ideal for numerous covalent modifications, also called 
post-translational modification (PTM), such as methylation, acetylation, 
ADP-ribosylation, ubiquitination and phosphorylation.  As pointed out by 
Khorasanizadeh, the PTMs in the histones seem have no effect in the structure of 
nucleosome in higher eukaryotic cells (Khorasanizadeh, 2004).  Interestingly, crystal 
structure of s. cerevisiae nucleosome core particle reveals yeast nucleosomes are likely to 
be subtly destabilized as compared with higher eukaryotic cells since the stabilizing 
interactions between H2A-H2B are absence in the H2A L1 loops area, which is consistent 
with the idea that much of the yeast genome remains open through much of its life cycle 
(White et al., 2001).  It is worth noting that this weaker organization of nucleosomes in 
yeast might require the extra globular domain in putative linker histone for the properly 
compacting of 30 nm fiber.   
 
1.2 30 nm Chromatin Filament 
The 30 nm chromatin fiber is the secondary structure proposed for the hierarchy folding 
into the large scale configuration for the entire chromosome.  Although the 30 nm fiber 
structure has not been seen in the whole nuclei, the facts that it can be assembled in vitro 
and visualized when chromatin is released from the nuclei by MNase (Micrococcal 
nuclease) digestion argue that the 30 nm fiber is a distinct secondary higher-order 
chromatin structure.  Despite several models have been proposed for 30 nm folding, its 
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structure still remains elusive (Robinson and Rhodes, 2006; Staynov, 2008; Tremethick, 
2007).  As discussed by Dorigo et al (Dorigo et al., 2004), these models can be grouped 
into two classes: 1) the one-start helix, with the bent linker DNA connecting consecutive 
nucleosomes arranged in the same helix path, and 2) the two-start helix, based on straight 
linker DNA connecting between two adjacent stacks of helically arranged nucleosomes.  
Solenoid and zigzag are examples for one-start and two-start helix respectively.  In 
solenoid model, six consecutive nucleosomes are arranged in a turn of a helix with a pitch 
of 11 nm (Finch and Klug, 1976).  In zigzag model, histone H1 directs the formation of 
stem-like organization by juxtaposing the entering and exiting linker DNA segments, 
which in turn directs the arrangement of two rows of nucleosomes and the subsequent 
folding into the helix with linker DNA crisscrosses between each stack of nucleosomes 
(Bednar et al., 1998).  In another word, consecutive nucleosomes are physically closer 
to each other in the one-start helix whereas alternative nucleosomes are closer to each 
other in the two-start helix.   
 
To overcome the obstacle of structure determination for 30 nm fiber caused by the 
heterogeneity of native chromatin fiber, Richmond’s lab reconstituted highly regular 
arrays on repeats of DNA sequence having nucleosome-positioning properties and has 
demonstrated two rows of 6 nucleosomes instead of a single stack of 12 nuclesomes were 
obtained from protein-protein crosslinked 12 nucleosome repeats, which supports the 
zigzag model (Dorigo et al., 2004).  In addition, the crystal structure of the 
tetranucleosome they obtained further supports the zigzag conformation and 
demonstrated the axis of two rows of nucleosome stacks are not parallel but rotated by 
-71.3 degrees with each other and only the central linker DNA is straight (Schalch et al., 
2005).  More importantly, the same zigzag conformation was also demonstrated for the 
H1 containing nucleosome arrays by crosslinking and electron microscopy study (Dorigo 
et al., 2004).   However, the diameter of chromatin fiber calculated from the model 
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building by stacking the tetranucleosome crystal structure is about 25 nm, which is 
smaller than expected for the 30 nm fiber.  Rhodes’ Lab has taken different approach to 
determine the structure of 30 nm fiber (Robinson et al., 2006; Routh et al., 2008).  They 
also reconstituted nucleosome arrays on nucleosome-positioning sequence, but, in 
contrast to Richmond’s lab, contained specialized chicken linker histone H5 and used 
different length of linker DNA.  They proposed the interdigitated solenoid model based 
on the tight constraints obtained from the physical dimension and compact ratios 
measured in the EM images of series of arrays having different nucleosomal repeats 
lengths ranging from 177 to 237 bp with 10 bp increment.  Very importantly, they found 
the diameter of folded fiber does not increase linearly with the length of the linker DNA 
as expected from the zigzag model.  Fibers folded from 177-207 bp nucleosomal repeat 
length have diameter of 33-34 nm and compact ration of 11 nucleosomes per 11 nm, 
which are more closer to the native chromatin fiber (Woodcock et al., 1984).  The 
authors suggested the different structure models reported from these two labs are likely 
caused by the presence of the linker histone.  In addition, Staynov pointed out the zigzag 
conformation reported from Richmond lab might represent a special kind of chromatin 
structure originated from the telomeric yeast chromatin (Staynov, 2008).   In summary, 
among several structures proposed for 30 nm chromatin fiber, interdigitated solenoid 
fiber is the only structure constructed so far with addition of histone H1, hence should 
more closely resemble its native structure.   
 
1.3  Roles of Histone H1 in the Organization of 30 nm Chromatin Fiber 
The idea of histone H1 facilitating the folding of 10 nm filament into 30 nm higher order 
structure has been suggested by numerous studies (Allan et al., 1981; Finch and Klug, 
1976; Thoma et al., 1979).  On the contrary, the fact that 30 nm fiber can also be 
achieved without the H1 to form the crystal seems argue against the essential role of H1 
in the 30 nm fiber compaction (Dorigo et al., 2004; Schalch et al., 2005).  However, it 
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has also been clearly demonstrated that inorganic cations and histone H1 are required to 
achieve full stability of condensed nucleosomal arrays (Carruthers et al., 1998).   
 
The position of the H1 on the nucleosome has not been fully determined over the past 
three decades despite numerous efforts.  DNase I footprinting results indicate H1 binds 
directly to the minor grove in the dyad and symmetrically protects the 10 bp linker DNA 
in the entering and exiting strands (Staynov, 2008; Staynov and Crane-Robinson, 1988).  
However this symmetric model proposed by Allan et al. (Allan et al., 1980) has been 
challenged by the crystal structure study of the globular domain of chicken histone H5 
(GH5), which demonstrates globular domain is a three-helix bundle sharing structure 
homology with helix-turn-helix DNA-binding domain and there is only two instead of 
three DNA binding sites one would predict from symmetric model (Ramakrishnan et al., 
1993).  Fluorescence recovery after photobleaching (FRAP) is an invaluable technique 
to dissect the dynamic behavior of chromatin-binding proteins in vivo, the observed 
fluorescence recovery rate is a direct reflection of their chromatin interactions.  
Combined FRAP with systematic mutagenesis, Brown et al. have found globular domain 
of mouse histone H1
0 
interacts with the nucleosomes through two distinct binding sites 
formed by several spatially clustered positively charged residues.  By theoretical 
modeling, they further proposed that one site interacts with the major groove near the 
dyad axis and the second site interacts with the minor groove on the linker DNA (Brown 
et al., 2006).  This slightly off-axis location reconciles the binding of minor grove 
predicted by DNAse I footprinting with binding of major groove in the DNA by 
helix-turn-helix domain.  However, it can not explain the MNase digest experiment.  If 
there are only two DNA binding sites in the globular domain, only one of the 10 bp linker 
DNA is bound and protected by globular domain in H1 while the other 10 bp linker 
should become accessible to the enzyme.  Then why does MNase digestion of native 
chromatin only generate 147 and 168 bp without intermediate size fragment?  The 
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answer might lie in the C-terminal domain (CTD) in H1.  Biophysical analysis with 
series of CTD deletion mutants of mouse H1
0 
using analytical ultracentrifugation has 
identify two specific subdomains in the CTD, which can stabilize the tertiary structure of 
reconstituted 12-nucleosome arrays (Lu and Hansen, 2004).  Interestingly, both 
subdomains encompass one out of three cyclin-dependent kinase (CDK) phosphorylation 
motifs (S/TPXK) within the CTD and such S/TPXK motif can form a β-turn to bind the 
minor DNA groove (Lu and Hansen, 2004).  Similar results have been obtained in vivo 
by FRAP techniques.  The deletion of the entire CTD resulted in severe decrease of 
residence time of human H1.1, which suggests CTD also promotes H1-nucleosome 
binding.  Interestingly, a single substitution of Thr152 (residing in S/TPXK motif) with 
glutamic acid reduced the affinity of H1 to chromatin to the same extent as deletion of all 
70 CTD residues, whereas substitution of Ser183 with glutamic acid (residing in S/TPXK 
motif) elicited less dramatic effect (Hendzel et al., 2004).  This result indicates the 
S/TPXK motifs in different part of molecule contribute differently to the binding of H1.  
Since serine and threonine in the S/TPXK motifs are the phosphorylation sites in H1, it is 
very likely that phosphorylation at different sites can modulate binding of H1 to 
chromatin differently.  Taken these together, Brown et al. proposed a model for H1 
binding in 30 nm fiber (Brown et al., 2006): First, the disordered H1 CTD captures linker 
DNA through efficient but nonspecific binding to linker DNA; second, this binding 
places the globular domain near the nucleosome and, perhaps promotes the stable and 
specific binding through one-dimensional scanning; third, stable globular binding then 
facilitate the acquisition of structure within the CTD, such as adopting an α-helical 
structure (Vila et al., 2001).  However, more work has to be done in order to fully 
understand how H1 promotes the folding of chromatin. 
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1.4 H1 Variants and Potential Specific Roles 
Multiple H1 family members are expressed in diverse organisms. Both human and mouse 
genomes contain up to 11 variants, including five DNA replication-dependent, non-allelic 
variants of H1 (H1.1, H1.2, H1.3, H1.4 and H1.5), together with the DNA 
replication-independent variant (H1
0
, H1x), the testicular specific variants (H1t, H1T2 
and HILS1) and the oocytic H1oo (Brown, 2003; Happel and Doenecke, 2009).  The 
somatic variants of H1 (H1.1-H1.5) from mouse and human have been intensively 
studied.  Among them, H1.1 is only found in thymus, testis, spleen, lymphocytic and 
neuronal cells in human (Parseghian and Hamkalo, 2001).  In a survey for expression of 
variants in several human cell lines, no H1.1 mRNA was detected in most of the cell lines 
except a low level of H1.1 mRNA in human testis whereas H1.2 and H1.4 in all cells are 
expressed at a high level, indicating these two variants might be more important for 
human cells (Meergans et al., 1997).  
 
Despite the heterogeneity of histone H1 in the same species, which mainly resides in the 
tails, the same variant among mammals is surprisingly conserved in both the globular 
domain and the tails.  From evolution point of view, the sequence of H1 variants is 
moderately conserved among animal species with H1.4 possessing the most conserved 
structure (Ponte et al., 1998).  More specifically, sequence comparison by ClustalW 
program finds 94% identity for H1.4 between human and mouse H1.4 compared with 
only 87% identify between H1.2 and H1.4 in human, two closest sequence-related 
variants.  There is some evidence to support the idea that heterogeneity sequence of H1 
variants result in some extent of functional distinction among them.  For example, H1.5 
but not H1.4 can be specifically recruited by interacting with Msx1, a key regulatory 
element of myogenic determination factor MyoD, and cooperate to inhibit muscle 
differentiation by turning off the expression of MyoD gene (Lee et al., 2004).  In 
addition, both H1.5 and Xenopus H1C can repress Xmyf5, XmyoDa, and XmyoDb, 
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which is consistent with previous studies (Steinbach et al., 1997).  Additional evidence 
for H1 variant specific function comes from the finings that H1.2 but not other variant is 
able to serve as cytochrome c-releasing factor which can transmit apoptotic signals 
arising from DNA damage to mitochondria (Konishi et al., 2003).  It is remained 
puzzling that how cells distinguish newly synthesized H1.2 in cytoplasm from H1.2 
leaking from DNA.  One possibility is through the different modification, such as 
methylation, acetylation, ubiqutination and formylation, which has been identified 
through proteomic approach (Wisniewski et al., 2007).   
 
One approach to study how H1 is associated with nucleosomal DNA is to compare the 
mononucleosome/chromatin binding affinity and chromatin compacting ability for 
different H1 variants.  Although significant studies have been dedicated to answer this 
question, the conclusion remained elusive due to the discrepancies among different 
experiment schemes and labs as described below.  First, comparison of various H1 
variants purified from rat liver using gel retardation classified H1 variants into groups of 
high (H1.2, H1.3 and H1.4), intermediate (H1.1) and low (H1.5) binding affinity to 
mononucleosome (Talasz et al., 1998).  Second, another in vitro study estimating the 
relative affinity between H1 variants purified from rat brain and SAR (scaffold-associated 
region) or the chromatin classified them into groups of high affinity (H1.3, H1.4 and H1
0
), 
intermediate affinity (H1.5 and H1.2) and low affinity (H1.1) (Orrego et al., 2007).  
Third, the in vivo binding characteristic of H1 variants by FRAP study classified them 
into three groups of tight binding (H1.4 and H1.5), intermediary binding (H1
0 
and H1.3) 
and weaker binding (H1.1 and H1.2) (Th'ng et al., 2005).  Fourth, the comparison of 
H1-GFP variants (H1
0
, H1.2, H1.3 and H1.5) in untreated and differentiated MEL cells 
demonstrated increase of residence time for all tested variants in differentiated cells and 
the H1.2 is the most weaker binding variants with residence time roughly half of other 
variants whereas no discernable difference been seen among other variants (Yellajoshyula 
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and Brown, 2006).  Fifth and the most recent study of H1-mononucleosome affinity by 
band shift assay distinguishes three subgroups: high affinity variants, H1.5 and H1.4; 
intermediate affinity variants: H1.2, H1.3 and H1
0
; and low affinity variants: H1.1 and 
H1x (Clausell et al., 2009). 
 
In general, H1 variants’ affinity for mononucleosome/chromatin correlates with their 
chromatin compacting properties.  However, some exceptions exist and the difference 
among literature makes the conclusion elusive again.  For example, H1.2 is reported as 
weakly aggregating variant in dinucleosome (Liao and Cole, 1981) and also shown as 
poorer condenser of chromatin compared to H1.1, H1.3, H1.4 and H1.5 (Khadake and 
Rao, 1995).  In contrast, H1.5 was determined as the least whereas H1.1 as the strongest 
condenser for inducing aggregation of polynucleosome reconstituted from MMTV LTR 
promoter (Talasz et al., 1998).  Moreover, the most recent study by atomic force 
microscopy has classified H1 variants as weak condenser (H1.1 and H1.2), intermediate 
condensers (H1.3) and strong condensers (H1
0
, H1.4, H1.5 and H1x), which is more 
consistent with the findings from FRAP study (Clausell et al., 2009).  Despite the 
discrepancies, all studies agree that H1.2 has low or intermediate while H1.4 has 
strongest affinity.  Considering H1.2 and H1.4 are the most ubiquitous expressed forms 
in human cells, it suggests the different H1 variants might play some specific roles based 
in their affinity to chromatin and cells require at least two H1 variants with very different 
affinity to chromatin.  Another approach to decipher the specific roles of H1 variants in 
vivo is to investigate the subnuclear localization of H1 variants (Parseghian et al., 1993).  
However it is impeded by the lack of H1 variant-specific antibodies.  An alternative 
approach using GFP tagging has demonstrated H1
o
, H1.1, H1.2 and H1.3 are commonly 
enriched in euchromatic regions, whereas H1.4 and H1.5 are preferentially localized to 
hetrochromatic regions (Th'ng et al., 2005). 
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1.5 H1 Phosphorylation 
Cell Cycle Regulated H1 Phosphorylation 
Histone H1 phosphorylation has been studied in various model organisms for over 40 
years.  Histone H1 purified from synchronized CHO cells were separated by ion 
exchange column.  Incorporated rate of [
32
P] phosphate / [
3
H] lysine or electrophoresis 
was used to calculate how many phosphate per molecule and it has been determined that 
1 phosphorylation in late G1, 3 phosphorylations in S/G2, and up to 6 phosphorylations 
in M phase (Hohmann et al., 1976).  All of the phosphorylations in H1 are lost to the 
level below detectable level during telophase, thus resetting H1 to an unphosphorylated 
state at the beginning of the next cell cycle (Gurley et al., 1978).  The more recent effort 
to compare the HPLC profile of tryptic phosphopeptides of H1 from synchronized CHO 
cells found three phosphopeptides in G1/S sample.  Since only 1 phosphorylation has 
been observed at this cell cycle stage, it indicates that it is added to any one of the three 
interphase phosphorylation sites seen in S and G2.  Thus, it does not appear to be an 
absolute order for which site is phosphorylated first, second and third during interphase 
(Gurley et al., 1995).  This random phosphorylation is contradictory to the hierarchy of 
H1 phosphorylation discovered from phosphorylation sites mapping in ciliated protozoan 
Tetrahymena thermophila, where phosphorylation in H1 is added in a sequential fashion, 
first at Thr46, then at Ser42, and last at Ser44, (Mizzen et al., 1999).   
 
How H1 phosphorylation progresses through cell cycle has also been investigated in 
HeLa S3 cells by metabolic labeling of synchronized cells with 
32
P-orthophosphate.  
Both the percentage of phosphorylated H1 and the amount of phosphorylation sites 
increase from G1 to M phase.  For major phosphorylation sites in H1.2, it starts from 0 
in G1 phase, increases to 1 in S phase and reaches 3 or 4 in M phase; for major 
phosphorylation sites in H1.4, it starts from 1 in G1, increases to 2 in S and reaches to 5 
or 6 in M (Ajiro et al., 1981a; Ajiro et al., 1981b).  In short, phosphorylation in H1 starts 
 11 
from G1/S boundary, steadily increases over S and G2 and reaches its maximum level 
during M.  Similar to H1 in CHO, random phosphorylation had also been suggested for 
H1 in M phase HeLa cells.  The number of phosphopeptides found in mitosis was more 
than the phosphorylation number achieved in mitosis, which suggests the candidate of H1 
phosphorylation might exceed the phosphorylation number found in mitosis and there is 
no molecules can achieve all the possible candidate sites simultaneously (Ajiro et al., 
1981b).  The association of hyperphosphorylation with metaphase is not limited to 
mammalian cells, H1 in Physarum polycephalum, a slime mold, can obtain 20-24 
phosphates per molecule in metaphase (Mueller et al., 1985).  
 
CDK1 and CDK2 Are H1 Kinase 
Identifying the kinase for H1 phosphorylation is critical for understanding how 
phosphorylations in H1 are regulated.  CDK1 has been implicated as the major M phase 
kinase for H1 based on comparison of phosphopeptide generated from H1 purified from 
mitotic enriched cells with in vitro phosphorylation of H1 by CDK1 (Langan et al., 1989).  
More refined study has demonstrated that all four tested CDK/cyclin complexes are able 
to phosphorylate H1 to the same extent as achieved in mitosis by comparing HPLC 
profile of tryptic phosphopeptides generated from in vitro phosphorylation with those 
from mitotic enriched CHO cells.  These four tested kinases are interphase-specific 
CDK2/cyclin A, the late interphase CDK1/cyclin A, mitotic-specific CDK1/cyclin B, and 
the CDK1/unknown cyclin (Swank et al., 1997).  This result raise another question: why 
are there only 3 phosphorylations in CHO H1 during S phase when the active S-phase 
CDK2/cyclin A can phosphorylate all 6 sites in free H1?  The authors speculate that H1, 
when bound to chromatin, is locked into a structure that allows only limited accessibility 
to such kinases (Swank et al., 1997).  This notion has been further supported by the 
observation that CDK1 isolated from mitotic HeLa cells, capable of phosphorylating H1 
to the maximum extent, does not significantly phosphorylate chromatin-bound H1 in 
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vitro (Jerzmanowski and Cole, 1992).  However, this explanation was proposed before 
the dynamic feature of H1 has been fully appreciated through FRAP studies.  To 
reconcile the fact that chromatin-bound H1 is constantly exchanging with the pool of free 
H1 and the fact that H1 is not fully phosphorylated in interphase, we speculate 
phosphorylation of H1 during interphase might only happen when they are bound with 
chromatin and it requires CDKs being targeted to chromatin to phosphorylate H1 with 
limited accessibility to all candidate sites. 
 
Besides the in vitro data to support CDK1 and CDK2 are the kinases for H1, in vivo 
studies have corroborated these findings.  When CDK1 was inactivated at the 
non-permissive temperature in FT210 cells harboring a temperature sensitive mutation of 
CDK1, cells were blocked in early G2 phase and H1 did not undergo mitosis-related 
phosphorylations, suggesting that H1 is an in vivo substrate for the CDK1 kinase (Guo et 
al., 1995).  The correlation between higher CDK2 activity in the oncogene transformed 
cells and more abundance of H1 interphase phosphorylation suggests CDK2 is H1 kinase 
responsible for the interphase phosphorylation (Chadee et al., 1995; Herrera et al., 1996). 
 
Model for Reconciling the Paradox of H1 Phosphorylation 
Considering that the positively charged lysine-rich N and C-terminal tail domains of H1 
are involved in neutralizing the negative charge associated with DNA phosphates, one 
might predict that H1 phosphorylation should counteract this charge, neutralization and 
promote chromatin decondensation.  Why then, does hyperphosphorylation of H1 at 
mitosis correlate with chromosome condensation?  To reconcile this paradox, Roth and 
Allis have proposed that H1 phosphorylation causes transient decondensation of 
chromatin which in turn allows specific chromosome condensation factors to gain access 
to specific DNA regions and condense the chromatin subsequently (Roth and Allis, 1992).  
However, no such factor has been identified yet, thus this paradox remains elusive. 
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Effect of H1 Phosphorylation on H1-Chromatin Interactions  
Although the function of H1 phosphorylation is not understood, a significant amount of 
progress has been obtained through continuing research.  Determining how H1 
phosphorylation affects its binding to chromatin and its effect in chromatin structure is a 
key step toward deciphering the function of H1 phosphorylation.  The correlation 
between increased H1 phosphorylation and the relaxation of chromatin structure suggests 
phosphorylated H1 binds more loosely to chromatin and in turn causes the chromatin 
become more accessible to MNase digestion (Chadee et al., 1995; Herrera et al., 1996).  
Early reconstitution experiments show that H1 phosphorylation diminishes its ability to 
condense chromatin (Langan and Chambers, 1987).  The chromatography purified 
naturally occurring H1 from early G1, S phase and M phase, representing none-, 
medium- and hyper-phosphorylation respectively, were used to compare how 
phosphorylation affects the ability of H1 to bind mononucleosome or promote the 
aggregation of polynucleosome.  It turns out the ability of H1 to bind mononucleosome 
was not affected by phosphorylation, but the ability to aggregate polynucleosomes was 
reduced when H1 was hyperphosphorylated (Talasz et al., 1998).  This result indicates 
the medium phosphorylation which H1 received in interphase doesn’t change 
H1-chromatin interaction but the hyperphosphorylated H1 in mitosis actually binds 
chromatin more loosely. 
 
Although there is no easy way to tag the phosphorylated H1 with GFP, several FRAP 
experiments were able to provide indirect evidence to infer how phosphorylation 
influences H1-chromaitn interaction in vivo.  Lever et al. showed a kinase inhibitor 
staurosporine can greatly increase the recovery time of mouse GFP-H1.1 (GFP fused with 
N-terminal of H1) in the stable cell line, which suggest phosphorylation decrease the 
H1-chromatin interactions thus recovery time increase once phosphorylation of H1 is 
inhibited.  However, from the same report, no decrease of recovery time was observed 
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in early G1 phase cells when phosphorylation level in H1 is lowest (Lever et al., 2000).  
This discrepancy can be either explained by the indirect effect resulted from wide 
spectrum kinase inhibitory action by staurosporine or the simply fact that H1.1 
phosphorylation is not cell cycle regulated like other H1 variants despite it also possesses 
multiple CDK motifs in the CTD.  Similar to H1.1, no change of recovery time was 
found for stable integrated mouse GFP-H1
o
 (GFP fused with C-terminal of H1) in the 
different cell cycle stages in synchronized embryonic stem cells (Meshorer et al., 2006).  
By contrast, Contreras et al. found the recovery time for human H1.4-GFP (GFP fused 
with C-terminal of H1) were fast, intermediate and slowest for asynchronous, late G1 and 
G0 respectively (Contreras et al., 2003).  Since we don’t know whether and how H1.1 
and H1
0
 phosphorylation change during cell cycle, whereas the dynamic of human H1.4 
phosphorylation has been well documented by Ajiro (Ajiro et al., 1981a), it is likely that 
the discrepancies are just the result of phosphorylation of H1.1 and H1
0
 not cell cycle 
regulated or existing at low abundance that not able to influence the dynamic of H1.  In 
addition, Contreras et al. compared the recovery time of human H1.4-GFP with 
H1.4-M1-5-GFP, five CDK phosphorylation consensus sites mutated from serine or 
threonine residues into alanines, in several cell lines by transient transfection.  Decrease 
of recovery time was observed for mutants, which suggests phosphorylation increase the 
dynamic of H1.  Interestingly, the levels of recovery of the fusion proteins are directly 
correlated with CDK2 activity in three different cell lines.  When CDK2 activity is low, 
moderate, or high, the difference in levels of recovery between H1.4-GFP and 
H1.4-M1-5-GFP is correspondently low, moderate, or high, respectively.  This result not 
only corroborates the effect of H1 phosphorylation in increasing their dynamic but also 
indicates CDK2 is the kinase for H1 (Contreras et al., 2003). 
 
The finding of phosphorylated H1 being more dynamic than unphosphorylated H1 is also 
consistent with earlier immuno-electron microscopy data, which suggests that 
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unphosphorylated H1 is only found on nuclear chromatin/chromosomes, but 
phosphorylated H1 localizes to both nuclear chromatin/chromosomes and the cytoplasm 
in S and M phase cells (Bleher and Martin, 1999).   
 
1.6 Roles of Histone H1 in Transcription 
Is H1 a General or Gene-Specific Transcription Repressor? 
Histone H1 has been shown to be able to repress transcription by all three eukaryotic 
polymerase (reviewed in (Paranjape et al., 1994; Workman and Buchman, 1993)).  
Direct evidence supporting the repression effect of H1 in pol II gene transcription came 
from in vitro chromatin reconstitution experiment, which found transcription from 
chromatin with H1 incorporated reduces dramatically to 1~4% of that with only core 
nucleosomes incorporated (Laybourn and Kadonaga, 1991).  The idea widely accepted 
is that histone H1 is a general transcription repressor and sequence-specific transcription 
factors and/or basal transcription factors are required to displace H1 during transcription 
activation.  However, a couple lines of evidence are against the general repressor model.  
First, all the H1 deletion or overexpression experiments, as will be discussed later, found 
out only small amount of genes are affected in either up- or down-regulation manners.  
Second, the general repressor model predicts a depletion of H1 in the activated gene, 
which has been disproved by multiple ChIP experiments showing H1 only partially rather 
than completely depleted upon transcriptional activation (see review in (Paranjape et al., 
1994; Zlatanova and Van Holde, 1992)).  Third, the more direct approach to address 
whether histone H1 is present in transcriptionally active chromatin has been achieved by 
studying the effect of specific anti-H1 antibodies on in vitro transcription in isolated 
nuclei.  The anti-H1 antibodies significantly and reproducibly inhibited the 
transcriptional activity in isolated nuclei, which indicating that active gene chromatin 
does contain histone H1 (Srebreva and Zlatanova, 1992).  Fourth, H1 was observed to 
localize to both fully extended, actively transcribed genes and repressed 30-nm chromatin 
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fiber in Balbiani ring genes in the salivary glands of Chironomus tentans (Ericsson et al., 
1990).  Similar, H1 was also found in all regions of polytene chromosomes, regardless 
of their transcriptional status (the H1 specific antibody bound to bands, interbands and 
puffs) (Hill et al., 1989).  All these data has clearly demonstrated that complete 
depletion of H1 is not observed for active transcription. 
 
The transcription inhibitory mechanism of H1 has been further reveled by recent studies.  
The in vitro transcription from HTLV-1 reconstituted chromatin demonstrated 
transcription repression effect of H1 relies on the inhibiting the acetyltransferase activity 
of p300.  Interestingly, the inhibitory effect of H1 on p300 acetyltransferase activity is 
alleviated when Tax is present during chromatin assembly, but the activation effect of Tax 
is not achieved by histone H1 displacement (Konesky et al., 2006).  This result actually 
corroborates the finding that H1 acts as a specific repressor of core histone acetylation in 
chromatin, which suggests the repression of PCAF acetyltransferase activity by H1 is 
caused by the steric hindrance of H3 N-terminal tail accessibility from the H1 tails 
(Herrera et al., 2000).  Contradicting previous findings that H1 interferes with 
transcription factor binding to the DNA (Juan et al., 1994),  the repressive effects of H1 
do not result from inhibition CREB or Tax binding to chromatin (Konesky et al., 2006).  
 
The regulation mechanism is not limited to virus gene transcription.  Two recent 
independent studies have identified H1 as a component in a complex that is required to 
repress p53-mediated transcription.  Both PURα and YB1, identified in the H1.2 
complex purified from tagged H1.2, are required for H1.2 to inhibit both the transcription 
from reconstituted chromatin containing p53 regulated promoter and the acetylation of 
core histones by p300 (Kim et al., 2008).  Importantly, knockdown any of these three 
proteins results in the de-repression of p53-dependent gene, which demonstrates that 
histone H1 itself is not enough to repress transcription from specific gene and it requires 
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additional cofactors to achieve the repression.  More intriguingly, the isolated H1.2 
complex also contains cofactors (e.g. CAPERα and nucleolin) that are known to activate 
transcription.  It will be very interesting to investigate further to see whether H1.2 can 
activate transcription when bound with activating cofactor.  Shortly after, Nishiyama et 
al. provided the in vivo evidence that H1-p53-CHD8 complex is necessary for the 
suppression of p53 mediated transcription.  Three different approaches to decrease the 
amount of H1, including triple H1 knockout mouse ES cells, RNAi depletion of all H1 
variants, dominant-negative mutant of histone H1, all results in de-repression of genes as 
indicated by the increase in the abundance of p21 or cell proliferation (Nishiyama et al., 
2009). 
 
Several insights regarding the mechanism of transcription repression effects of H1 can be 
implied from theses studies.  First, how H1 variants can repress a specific genes without 
specific sequence recognition?  It is very likely that H1 variants rely on the sequence 
specific factors to target them to a specific gene.  In the case of p53 targeting H1.2 
together with the repressive cofactors to Bax gene, no comparison of other H1 variants 
has been analyzed but in the Msx1 targeting H1.5 to MyoD gene, some evidences were 
provided that H1.5 is the only variant able to repress the MyoD gene (Lee et al., 2004).  
Second, it shed some light on how H1 represses the transcription by blocking the HAT 
accessibility to core histones.  Third, it is possible that recruitment of Tax might activate 
the transcription by phosphorylating H1 first, which in turn loosen up the chromatin and 
enable the access of H3 by HAT. 
 
Differential effects of histone H1 in transcription are first discovered in the study of 
Xenopus oocyte 5S rRNA gene, a pol III transcribed gene.  The oocyte 5S rRNA genes 
are active in growing oocytes but become progressively repressed after mid-blastula 
transition (MBT) and are repressed in somatic cells.  In contrast, somatic 5s rRNA genes 
 18 
are active in all these stages.  It has been revealed that histone B4, Xenopus oocyte H1 
variant, is replaced by H1 somatic variant H1A during embryogenesis, which results in 
specific repression of Xenopus oocyte 5S rRNA gene (Bouvet et al., 1994; Kandolf, 
1994).  It is believed that H1 in the nucleosome containing H1 blocks TFIIA from 
accessing the oocyte 5S rRNA gene but not the somatic 5S rRNA gene (Howe et al., 1998; 
Sera and Wolffe, 1998).  Mapping of the core particle positioning on oocyte 5S rRNA 
gene found little or no phasing (i.e. was randomly positioned).  With addition of H1, a 
unique phasing was observed to cover all the sequence required for binding of 
transcription factor TFIIA.  In contrast, the chromatosome position (with H1) in the 
somatic 5S rRNA gene does not occlude the critical sequence element for TFIIA binding 
(Sera and Wolffe, 1998).  However, the inhibitory effect of H1 in oocyte 5S rRNA genes 
is not simply the result of transcription factor binding site occlusion.  When the oocyte 
5S rRNA coding sequence was placed at positions 546 bp or 1,237 bp upstream of its 
wild type position, H1 suppression of pol III transcription was lost.  When however one 
5S rRNA was left at wild type position with another sequence inserted at 546 bp, both 
copies are subjected to H1 suppression.  It clearly indicated the large scale chromatin 
reorganization mediated by H1 play some roles in controlling differential inactivation of 
5S rRNA (Tomaszewski and Jerzmanowski, 1997).  The fact that the vast majority of 
genes whose expressions are necessary for Xenopus embryo development are not 
inhibited by H1A also challenges the notion of H1 as general transcription repressor.  
 
Lessons Learned from H1 Deletion in Unicellular Organisms 
It is unexpected that the complete knockout of H1 gene in several unicellular organisms, 
including Tetrahymena thermophila (Shen et al., 1995), Saccharomyces cerevisiae 
(Patterton et al., 1998),  Aspergillus nidulans (Ramon et al., 2000) and Ascobolus 
immerses (Barra et al., 2000), all reveal H1 is not essential for viability or growth.  If H1 
were a general transcription repressor, a global transcription upregulation of transcription 
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would be expected.  However, elimination of H1 does not affect transcription globally in 
Tetrahymena and only causes up- or downregulation of specific genes (Shen and 
Gorovsky, 1996).  Similarly, no derepression of transcription is seen in yeast when H1 is 
removed.  Only 27 genes are downregulated 2-fold or more in the whole genome 
transcription analysis, with less than 0.5% of total genes in this organisms affected 
(Hellauer et al., 2001). 
 
Since H1 in both Tetrahymena and yeast lack the canonical tripartite structure, whether 
what we have learned from deletion in these two organisms can be readily generalized 
has been in debate for a while.  Levy et al. have summarized several evidences to 
support the yeast Hho1p is a true functional homologues to histone H1 in other species, 
including: 1) HHO1 is transcribed during the S phase as seen in mammalian H1; 2) 
Hho1p generates the most similar chromatin immunoprecipitation (ChIP) pattern to the 
four core histones in a high-throughput screen; 3) Hho1p is present in a complex together 
with the core histones in immunoprecipitation (Levy et al., 2008). 
 
Although Hho1p is not essential in yeast, closer examinations reveal roles in fine tuning 
gene transcription or maintaining genome stability.  As an example of fine tuning 
transcription: Hho1p is required for maximal pol I processivity during rDNA 
transcription (Levy et al., 2008).  An example of maintaining genome stability: Hho1p is 
shown to inhibit DNA repair by homologous recombination, thus loss of H1 lead to an 
increase in the propensity to undergo DNA repair and decrease in the life span (Downs et 
al., 2003); Hho1p hinders the de novo establishment of silent chromatin but does not 
affect the stability of preexistent silent chromatin (Yu et al., 2009).  The effect of H1 in 
genome stability is not limited in yeast, removal of H1 in Ascobolus also caused increase 
of accessibility of chromatin to nuclease digestion and shortening of lifespan (Barra et al., 
2000).   
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Lessons Learned from H1 Depletion in Higher Eukaryotes 
Since all of the lower eukaryotes described above each has only one H1 gene, deletion 
and the subsequent interpretation of phenotype is straightforward.  However, the 
multiple H1 variants in animals, up to 11 variants in human and mouse, makes this 
approach very challenging.  
 
The first attempt of knockout was the most divergent of the H1 variants, H1
0
, with a 
rationale of minimum possible compensation effect.  However, H1
0
 knockout mice can 
develop normally (Sirotkin et al., 1995).  Similarly, mice have single (H1.2, H1.3, H1.4) 
knockout or even the combinatory knockout with H1
0
 are all viable with no obvious 
defect (Fan et al., 2001) and mice lacking the testis-specific linker histone H1t has no 
defect in spermatogenesis (Lin et al., 2000).  However the careful examinations have 
identified subtle defects in these knockout mice: it has been demonstrated H1
0
 is required 
for terminal differentiation in dendritic cells (Gabrilovich et al., 2002) and less abundant 
testis-specific H1, H1T2 is critical in spermiogenesis (Martianov et al., 2005; Tanaka et 
al., 2005).  In addition, an interesting analysis of position effect in the single H1 variants 
knockout background demonstrated both positive and negative effects of specific H1 
variants.  Absence of H1.3 or H1.4, but not H1.1, H1.2, or H1
0 
is found to attenuate the 
rate of age-dependent silencing of a multicopy globin transgene.  Similarly, different H1 
variants also have different effects on expressing a variegating YAC transgene.  These 
results strongly suggest that the other variants do not fully compensate for the loss of a 
specific variant in the null mice although compensation effect keeps the H1-to-core ratio 
in null mice similar to the wild type mice (Alami et al., 2003). 
 
Despite no global effects in the single knockout of H1 in mice, a triple knockout of the 
H1c,d,e (H1.2, H1.3 and H1.4) genes in mice results in embryonic lethality, and a 
20~50% reduction in H1-to-core ratio, shorter nucleosome repeat lengths, global 
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alterations in chromatin structure in ES cells recovered from null animals (Fan et al., 
2003).  It is surprisingly similar to deletion experiment in unicellular organisms in a way 
that only small amount of transcription is affected: only 29 genes are significantly altered.  
Interestingly, one third of these are known to be regulated by DNA methylation, 
suggesting links between the function H1 and DNA methylation (Fan et al., 2005). 
 
The recent efforts to deplete a single H1 variant (H1
0
, H1.2, H1.3, H1.4 and H1.5) by 
shRNA in human cell lines have demonstrated different results for different variants and 
some results are cell line specific.  More specifically, only depletion of H1.2 and H1.4 
affects cell survival with depletion of H1.2 causes G1 arrest in T47D and MCF10A breast 
epithelial cell lines and apoptosis in MCF7 cells, whereas depletion of H1.4 causes cell 
death in T47D cells.  The effect of H1.2 depletion in cell cycle arrest is probably the 
results of more than 20 cell cycle regulated genes are significantly downregulated in H1.2 
depletion cells.  Moreover, only small subset of gene is altered with 2.4% of genes 
upregulated and 3.7% of genes downregulated (Clausell et al., 2009).   Very 
interestingly, the three groups classified by ratio of downregulated : upregulated for each 
H1 variant depletion (high: 2.7 for H1.2; intermediate: 2.1 for H1.3 and 1.9 for H1
0
; low: 
1.4 for H1.4 and 1.0 for H1.5) are surprisingly correlative with their ability to condense 
the chromatin as discussed before.  In other word, depletion of a weak condenser like 
H1.2 tends to cause more downregulation of genes, suggesting it is acting as an activator 
in more cases, whereas depletion of a stronger condenser like H1.4 tends to cause less 
downregulation of genes, suggesting it is more so a repressor.  It is worth noting that 
most of the genes are affected by a single H1 variant while a portion of genes are altered 
by more than one H1 variants, which indicate specific roles and some extent of 
redundancy of H1 variants in transcription regulation. 
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Lessons Learned from Overexpression of H1 
Interesting results on the selective effect of histone H1 on transcription of individual 
genes were also obtained using a stably integrated inducible expression system for 
different histone H1 variants in cultured mouse 3T3 cells.  Overproduction of H1
0
, 
which increase H1-to-core ratio from 0.8 to 1.3, exhibits transient inhibition of both G1 
and S phase progression from a quiescent state and a reduced transcription for all genes 
tested.  On the contrary, overproduction of H1.2 to comparable levels of 1.1 H1-to-core 
ratio, has no effect on cell cycle and results in either a negligible effect or dramatic 
increase of some tested genes (Brown et al., 1996).  Moreover, these variant specific 
effects were shown to be due to differences in the structure of the globular domains 
(Brown et al., 1997).  Very surprisingly, overproduction of either H1
0
 or H1.2 result in a 
dramatic increase rather than a repression in basal and hormone-induced expression from 
integrated MMTV promoter (Gunjan and Brown, 1999), which seems to contradict the 
previous observation that decreased amounts of H1 are associated with activated MMTV 
promoter stimulated by hormone (Bresnick et al., 1992).  To reconcile this contradiction, 
it has been postulated that H1 affects nucleosome positioning or other aspects of MMTV 
promoter chromatin architecture to facilitate the binding of liganded nuclear hormone 
receptors, their synergism with transcription factors such as NF1 and AP-1, and the 
recruitment or activation of kinases which phosphorylate and facilitate H1 displacement 
following hormone stimulation (Vicent et al., 2002a).  
 
In summary, all sorts of H1 perturbations result in different effects in different genes, 
which suggest different H1 variants might play different roles in chromatin structure.  
However, what exact roles are still remaining in the shadow. 
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1.7 Evidence That H1 Stoichiometry is Inversely Correlated With Global 
Transcriptional Activity 
The concept of each nucleosome having one H1 has turned out to be oversimplified.  By 
comparing the data from literature, Woodcock found a nice correlation between H1 
stoichiometry and transcription inactivation.  In another word, the ratio of H1-to-core 
increases when cells turn off some transcription during differentiation.   The 
stoichiometry in normal mouse ES cells is only 0.5 (1 H1 in every 2 nucleosomes), but 
increase to 0.8 in 3T3, a mouse embryonic fibroblast cells (Brown et al., 1996; Woodcock 
et al., 2006).  Surprisingly, mouse cells can tolerate as low as 0.25 of H1-to-core 
stoichiometry as seen in H1 triple knockout ES cells mentioned above (Fan et al., 2005).  
Similarly, H1 content also differs among different tissues.  For example, H1 
stoichiometry is 0.79 in liver and 0.83 in thymus, but is as high as 1.3 in chicken 
erythrocyte (0.9 H5 + 0.4 H1) (Fan et al., 2003; Fan et al., 2005; Woodcock et al., 2006).  
It is also worth mentioning the H1 stoichiometry in yeast.  The first estimation of H1 
stoichiometry in S. cerevisiae is very low, only 1 Hho1p per 37 nucleosomes (Freidkin 
and Katcoff, 2001).  More recent study reports the stoichiometry of 0.25 and suggests 
the first study did not measure the abundance of core histones and could therefore have 
underestimated the ratio of Hho1p to nucleosomes (Downs et al., 2003). 
 
1.8 Roles of H1 Phosphorylation in Transcription 
Chromatin immunoprecipitation (ChIP) has become a powerful tool for mapping protein 
interactions along genomic DNA in vivo, and thus has been the most informative assay in 
providing where the specific histone variants or modifications are associated within the 
genome.  However a specific antibody is necessary for every histone variant or specific 
modification to be studied by this approach.  One can circumvent such limitation by 
putting a epitope tag in the interested histone variants and using the available tag antibody, 
however, no similar alternative can be readily applied to histone modification study for 
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now.  A novel non-antibody based technique, aptamer, which is very promising to 
exceed the antibody in both affinity and specificity, will be an excellent alternative for 
modification specific antibody in the near future (Williams et al., 2009).   For now, we 
must rely on phosphor-specific antibody to study the function of H1 phosphorylation and 
the only such antibody is the antisera raised against hyperphosphorylated Tetrahymena 
(Lu et al., 1994).  We will call this antisera pTetH1 hereafter, which has been proven to 
be able to cross-react with phosphorylated H1 from multiple species.  Moreover, it is the 
only available H1 phosphor specific antibody used in most H1 phosphorylation related 
research in the literature. 
 
Despite the distal relationship between metazoan H1 and Tetrahymena H1, what we have 
learned in Tetrahymena might still be able to translate into metazoan and thus it is worth 
mentioning the important works that have been done in this model organism.  With five 
phosphorylation sites in Tetrahymena H1 mapped (Mizzen et al., 1999), two Tetrahymena 
strains were created by gene replacement with alanine or glutamic acid mutations to 
prevent or mimic phosphorylation respectively.  Phosphorylation-mimicking H1 caused 
activating or repressing specific genes in the same manners as H1 deletion.  It leads to 
the first well known working model for H1 phosphorylation: regulating transcription by 
mimicking the partial removal of H1 (Dou et al., 1999).  Improved model claims that 
phosphorylation of H1 is acting by changing the overall charge of a small domain, not by 
phosphate recognition or by creating a site-specific charge, and these charged patches can 
be moved around without losing their phosphorylation mimicking effects (Dou and 
Gorovsky, 2000; Dou and Gorovsky, 2002).  Work from the same lab, further identified 
a positive feedback mechanism between H1 phosphorylation and CDC2 expression and 
an interesting enrichment of dephosphorylated H1 in the CDC2 promoter when gene 
expression is low after starvation.  The authors proposed the localization of 
unphosphorylated H1 in the CDC2 promoter during starvation is achieved by the 
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targeting of the catalytic and/or a regulatory subunit of an H1 phosphatase (Dou et al., 
2005; Song and Gorovsky, 2007). 
 
It has been demonstrated that, in culture cells carrying a stable integration of ~300 copies 
MMTV (Mouse Mammary Tumor Virus) LTR (long terminal repeat) linked to CAT gene, 
enrichment of phosphorylated H1 on the MMTV promoter adjacent to the hormone 
response element (HRE) was lost when transcription from MMTV is inhibited upon 
prolonged hormone treatment by pTetH1 ChIP (Lee and Archer, 1998).  Further 
investigation showed CDK2 specific inhibitor CVT-313 can also inhibit both the 
transcription from MMTV and the enrichment of phosphorylated H1 in the promoter, 
which implies H1 phosphorylation is necessary for MMTV activation (Bhattacharjee et 
al., 2001).  It is known that MMTV promoter exhibits positioned nucleosomes which 
cover the five hormone-responsive elements (HREs) and the binding site for nuclear 
factor 1 (NF1) so that only two of the five HREs can be bound by hormone receptors and 
the binding site for NF1 is not accessible.  The activating process involves a two-step 
synergism. First, the hormone receptor binds to the exposed HREs and triggers a 
chromatin-remodeling event that facilitates the access of NF1.  Second, bound NF1 in 
turn stabilizes an open nucleosomal conformation required for efficient binding of further 
receptor molecules to the hidden HREs and full transactivation (Di Croce et al., 1999).  
Addition of H1 to the chromatin reconstitution system using minichromosomes 
containing MMTV leads to tightening and stabilization of the nucleosome covering the 
regulatory elements of the MMTV promoter, which reduces accessibility for NF1. 
However, incorporation of histone H1 by ~1 H1-to-core stoichiometry leads to a better 
binding of progesterone receptor (PR) and improved synergism between PR and NF1, 
resulting in enhanced transcription initiation.  Moreover, phosphorylated H1 association 
increased while total H1 loading was maintained at the same level over MMTV promoter 
after addition of PR; both phosphorylated H1 and total H1 association greatly reduced 
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after addition of both PR and NF1 (Koop et al., 2003; Vicent et al., 2002b).  Here are a 
couple of interesting conclusions from these studies: 1) PR might be able to recruit or 
activate a kinase to locally phosphorylate H1; 2) H1 phosphorylation is not sufficient to 
activate the transcription in the presence of PR alone; 3) since total H1 loading does not 
change while phosphorylation increase in the presence of PR alone, phosphorylation 
itself might not be enough to induce the displacement of H1; 4) upon full activation of 
transcription initiation in the presence of PR and NF1, the majority of histone H1 leaves 
the promoter (Koop et al., 2003; Vicent et al., 2002b).  It is worth emphasizing that final 
depletion of H1 from promoter after activation might be the result of chromatin 
remodeling but not be the direct consequence of H1 phosphorylation.  It actually has 
been reported that histone H1 can inhibit SWI/SNF chromatin remodeling activity and 
this inhibition can be relieved after H1 is phosphorylated by Cdc2/Cyclin B in chromatin 
reconstitution experiment (Horn et al., 2002). 
 
In vivo assembly experiment using microinjection of different amount of mRNA for 
histone H1 into Xenopus oocyte has found addition of H1 to ~ 1 H1-to-core stoichiometry 
results in maximum effects on enhancing hormone-induced binding of glucocorticoid 
receptor (GR) and stimulating the transcription from MMTV.  A loss of H1 from 
MMTV promoter and the absence of H1-dependent increase of NRL in MMTV promoter 
was observed after hormone induction (Belikov et al., 2007).  These results corroborate 
the mechanism proposed by Beato lab that H1 can enhance the hormone receptor binding 
to the HRE and subsequent activation will displace the H1 from the promoter.  The 
findings described here also shed some light on why overexpression of H1 to 1.2~1.3 
H1-to-core stoichiometry actually increases the induction of MMTV transcription 
(Gunjan and Brown, 1999), possible by increasing the binding affinity with hormone 
receptor. 
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However, opposite effect of histone H1 on transcription activation has also been reported 
in similar experiments scheme with minichromosomes assembled on a synthetic promoter 
consisting of two estrogen-responsive elements (ERE).  In this system, addition of 
histone H1 leads to a dramatic decrease in the activation of transcription induced by 
addition of estrogen receptor α (ERα), which is proved to be caused by the inhibition of 
ERα binding to ERE in the presence of H1 (Cheung et al., 2002).  More research is 
required to clarify such discrepancies, taking into account of the caveats of using a 
synthetic promoter in ER experiment or representing the differential regulatory effects of 
H1 in different genes.  In summary, the effects of H1 in the binding of transcription 
factor can be classified into three groups: no inhibition of the binding as seen in 
Tax/CREB with HTLV-1; enhance of the binding as seen in GR/PR with MMTV, 
inhibition of the binding as seen in ERα with synthetic ERE. 
 
1.9 Histone H1 and Replication 
The cell cycle regulated dynamic of H1 phosphorylation, lowest phosphorylation state in 
G1, increasing amount of phosphorylation during S-phase, reaching a maximum in 
mitosis, has led to the speculation that H1 phosphorylation might play some roles in DNA 
replication (Ajiro et al., 1981a; Ajiro et al., 1981b).  In fact, several lines of evidence 
have suggested the correlation between H1 and replication.  H1 added to X. laevis 
extracts is capable of inhibiting DNA replication in vitro, by limiting the assembly of 
prereplicaiton complex (Lu et al., 1997; Lu et al., 1998).  By contrast, a higher 
replication efficiency for SV40 minichromosomes has been observed for reconstitution 
with S-phase histone H1, which has medium level of phosphorylation, compared with 
G0- or M-phase histone H1 (Halmer and Gruss, 1996).  In addition, artificial 
recruitment of LacI-Cdc 45 to the loci containing lacO/DHFR tandem repeats in CHO 
cells was demonstrated to cause these loci to decondense in association with H1 
phosphorylation by recruitment of Cdk2 by Cdc45 (Alexandrow and Hamlin, 2005).  It 
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has also been reported that genomic DNA in knockdown of H1 in Physarum is more 
rapidly replicated by disruption of the native timing of replication fork firing (Thiriet and 
Hayes, 2009).  In addition, Physarum H1 is transiently lost from replicating chromatin 
facilitated by phosphorylation of H1 (Thiriet and Hayes, 2009). 
 
1.10 Histone H1 and Chromatin Condensation 
Initially, H1 was shown dispensable in chromatin condensation when chromosome can be 
assembled from unreplicated sperm chromatids in CSF-arrested Xenopus egg extract 
without H1(Ohsumi et al., 1993).  Soon this conclusion was put to rest by careful 
examination.  Significant structure defects were detected when replicated chromosome 
were assembled from H1-depleted “cycled” egg extract.  An interesting hypothesis was 
proposed by authors that the reason H1 requires passage through interphase to become 
sufficiently enriched in chromosome is that H1 deposition to chromatin is a DNA 
replication-dependent or assisted process (Maresca et al., 2005).  In addition, H1 
knockout in both Tetrahymena and Physarum exhibit larger nuclear volume, indicating 
that requirement of H1 in chromatin compaction is not limited in Xenopus (Shen et al., 
1995; Thiriet and Hayes, 2009).  More recent study has demonstrated that depletion of 
H1x, a H1 variant accumulating in the nucleolus during interphase and is distributing at 
the chromosome periphery during mitosis, induces aberrant spindle formation, indicating 
H1x is required for chromosome alignment and segregation (Takata et al., 2007). 
 
1.11 H1 and the Histone Code 
The histone code hypothesis predicts that the post-translational modifications (PTM) of 
histones, alone or in combination can function to direct specific and distinct 
DNA-templated programs (Jenuwein and Allis, 2001; Strahl and Allis, 2000).  The tails 
of histones have many sites where covalent chemical modifications can take place, 
including acetylation, phosphorylation and methylation.  For example, the acetylation of 
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key lysine residues of histone H3 and H4 by histone acetyltransferases (HATs) was 
believed to play important roles in transcriptional activation.  In addition, crosstalk 
between two or even three modifications have been reported, for example, 
phosphorylation at ser10 in H3 and acetylation at lys16 in H4 have been shown to 
mediate transcription elongation (Zippo et al., 2009) and preferentially deubiquitination 
of lys119 in H2A in hyperacetylated nucleosomes has been demonstrated to facilitate 
dissociation of H1 by increase of H1 phosphorylation in response to hormone stimulation 
in androgen receptor targeted gene (Zhu et al., 2007).  
 
Izzo et al. proposed that each H1 variant could be considered as an epigenetic mark, since 
each individual H1 variant can regulate a subset of specific genes in either negative or 
positive fashion (Izzo et al., 2008).  Besides transcription, H1 has also been shown to 
play roles in replication, recombination, apoptosis and even senescence (Funayama et al., 
2006).  However, compared with abundant knowledge of core histone and despite the 
significant amount of investigation for deciphering the enigmatic histone H1 code, we 
still do not quite understand even the most abundant modifications of H1, which is 
phosphorylation, no mention several other less abundant forms of modifications 
(Wisniewski et al., 2007).  I hope the study in this thesis can contribute to the 
knowledge of how H1 phosphorylation modulates gene transcription.  
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CHAPTER 2*  
HISTONE H1 PHOSPHORYLATION SITES MAPPING  
AND CELL CYCLE REGULATED DYNAMICS IN HELA S3 CELLS 
 
*: Some material was adapted from manuscript: 
Histone H1 Phosphorylation is Associated with Transcription by RNA Polymerases I and II 
Yupeng Zheng, Sam John, James J. Pesavento, Jennifer R. Schultz-Norton, R. Louis Schiltz, Sonjoon Baek, 
Ann M. Nardulli, Gordon L. Hager, Neil L. Kelleher and Craig A. Mizzen 
 
2.1 Introduction 
Previous investigations have utilized metabolic labeling of synchronized cells with 
32
P-orthophosphate to detect H1 phosphorylation during the cell cycle (Ajiro et al., 
1981a; Ajiro et al., 1981b; Gurley et al., 1995).  This approach provides a measure of 
the net rate of H1 phosphorylation, i.e. the balance between ongoing phosphorylation and 
dephosphorylation over the interval monitored, that may reveal the true abundance of 
different phosphorylated forms.  Generally, it was found that 
32
P incorporation into H1 
was progressive during the cell cycle: it was low or undetectable in G1 phase, increased 
moderately during S and G2 phases, peaked sharply near the G2/M transition to attain a 
maximum during mitosis, and then fell sharply near the end of mitosis.  Several studies 
suggested that interphase phosphorylation occurred preferentially in the C-terminal 
domain of H1.  However, individual sites were not identified and H1 phosphorylation 
sites being used randomly or hierarchically has not been fully resolved. 
 
The mapping of phosphorylation sites in H1 is not only able to clarify the controversy 
between sequential and random phosphorylation discussed in the chapter 1.5.1 but also 
able to greatly benefit the H1 phosphorylation function study.  When this project started, 
the only known H1 phosphorylation sites were obtained from Tetrahymena by 
microsequencing of tryptic phosphopeptides (Mizzen et al., 1999).  However, 
Tetrahymena H1, lacking the globular domain, is very different from mammalian H1 and 
thus is not very useful for the further investigation of the mammalian H1 phosphorylation.  
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In addition, two mapping results for H1 phosphorylation have been published during our 
efforts (Garcia et al., 2004; Wisniewski et al., 2007).  The novel mass spectrometry 
technique we adopted allows us to analyze an intact protein.  Such technique is called 
top-down mass spectrometry (TDMS) compared to the conventional bottom-up approach 
which requires digesting proteins into small peptides before analyzing (Garcia et al., 2007; 
Pesavento et al., 2004).  There are at least there disadvantage of the bottom-up approach: 
first, it cannot always assign the observed phosphopeptides to five conserved H1 
subtypes unambiguously; second, it lost the abundance information of different 
phosphorylated forms; third, it cannot address whether all the phosphorylation sites are 
localized to one molecule simultaneously or not. 
 
2.2 The Expression and Phosphorylation of Histone H1 in HeLa S3 Cells 
We used Top Down Mass Spectrometry (TDMS) to analyze H1 phosphorylation since it 
has been shown previously that this approach can be used to characterize the expression 
and posttranslational modification of histone variants present in mixed samples 
(Pesavento et al., 2008b; Phanstiel et al., 2008; Thomas et al., 2006).  The typical 
broadband mass spectra of crude H1 prepared from asynchronous HeLa cells was shown 
in Figure 2.1 A for three selected charge states.  The relative abundance for each 
component was very similar among different charges.  As shown in Figure 2.1 B, the 
spectra from a single charge state was remarkably simple: a total of eight species with 
distinct molecular weights were readily apparent above background noise.  Four of these 
were clustered between 21200 and 21400 Da (group 1), the other three were clustered 
between 21700 and 22000 Da (group 2).  The last small peak falling between these two 
clusters had higher charge of +26, thus its molecular mass is actually larger than those in 
group 2.  The molecular mass of the smallest component in group 1, 21261 Da, closely 
matched the 21262.7 Da predicted for human H1.2 from Genbank NP_005310, assuming 
the loss of Met residue 1 and acetylation of the newly exposed -amino group of residue 
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2 during protein maturation (Polevoda and Sherman, 2003).  Further analyses confirmed 
that this form is mature H1.2 lacking posttranslational modifications (see below).  The 
next largest component in the group 1, 21291 Da, was approx. 30 Da larger than expected 
for mature H1.2, suggesting either that it was dimethylated (m = + 28 Da) or an allelic 
variant of H1.2 containing one or more amino acid substitutions.  Further analyses 
revealed that this form is a novel A142T substitution allelic variant of H1.2 (H1.2-T142).  
The 21342 Da component closely matched the molecular mass expected for 
monophosphorylated mature H1.2 (21342.7 Da), and we shown below that this 
component is monophosphorylated H1.2 (1p-H1.2-A142).  The 21372 Da component 
was approx. 80 Da larger than expected for unmodified mature H1.2-T142 (21292.7 Da).  
Further analyses confirmed that this component is monophosphorylated H1.2-T142 
(1p-H1.2-T142). 
 
The molecular weights determined for the three components in group 2, 21762 Da, 
217842 Da and 21922 Da, closely matched those predicted from Genbank NP_005312 
for the unmodified, mono- and diphosphorylated forms of mature H1.4 (21763.0 Da, 
21842.9 Da, and 21922.9 Da), respectively.  Further analyses confirmed these 
identifications as shown in Figure 2.1 B.  Relative quantification of the allelic and 
phosphorylated forms of H1.2 in the mass spectrum revealed that monophosphorylation 
of the A142 and T142 allelic forms was proportional to their expression, and that approx. 
28 % of total H1.2 was monophosphorylated in asynchronously growing HeLa S3 cells.  
The extent of H1.4 monophosphorylation was quite similar to that of H1.2, affecting 
approx. 29 % of total H1.4, with diphosphorylation affecting approx. 12 % of total H1.4 
(Table 2.2).   
 
The third H1 variants detected in TDMS was H1.5 with very low abundance and its 
phosphorylation levels was lower than the sensitivity limit of FTMS.  Previous analyses 
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have detected the presence of additional H1 variants including H1
0
, H1.3 and H1.X in 
adherent HeLa cells (Garcia et al., 2004; Happel et al., 2005; Meergans et al., 1997).  
However, given the sensitivity limits of TDMS, our data implies that the levels of these 
proteins are lower than those of H1.2, H1.4 and H1.5, and reveals that H1.2 and H1.4 are 
expressed in markedly greater amounts than other variants in HeLa S3 cells growing in 
suspension.  The relatively minor amounts of H1.5 is further confirmed by 
chromatographic and electrophoretic analyses as shown later, which suggest that H1.5 is 
the third most abundant variant in HeLa cells.  Since fewer than approx. 5 % of the cells 
in asynchronously growing cultures are expected to be in mitosis at a given time, our 
findings that nearly a third of all H1.2/H1.4 is monophosphorylated and roughly a sixth 
of all H1.4 is diphosphorylated under these conditions is consistent with previous 
chromatographic and electrophoretic evidence that interphase H1 phosphorylation is 
moderately abundant in mammalian cells (Ajiro et al., 1981a; Gurley et al., 1975; Lennox 
et al., 1982; Talasz et al., 1996).  
  
2.3 H1 is Progressively Phosphorylated during Interphase  
As discussed in the introduction, H1 phosphorylation levels are cell cycle regulated.  
Our TDMS approach is particularly well suited for analyzing both the expression and 
phosphorylation levels of H1 variants from the crude H1 in a semi-quantitative manner.  
H1 from cells arrested at G1 by butyrate, G1/S by mimosine and M phase by colchicine 
were analyzed [21-23].  As shown in Figure 2.2 A, B, the abundance of 1p-H1.4 was 
barely detectable whereas 1p-H1.2 and 2p-H1.4 fell below the detection limit in the HeLa 
cells arrested in G1 by 20 mM sodium butyrate treatment for 24 hrs.  In addition, H1 
phosphorylation levels were also greatly decreased in cells arrested in G1/S by 0.5 mM 
mimosine treatment for 24 hrs (Krude, 1999).  Theses results suggest H1 
phosphorylation levels are lowest at G1 and start to increase before cells enter S phase.  
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To investigate H1 phosphorylation levels during S phase, we analyzed samples prepared 
at different times after releasing HeLa cells from synchronization at the G1/S boundary 
by double thymidine blocks.  The same seven ion species apparent for samples from 
asynchronous cells were also observed for post-released samples, but their relative 
abundances varied after releasing (Figure 2.3).  2p-H1.4, 1p-H1.4 and 1p-H1.2 were 
increased initially and decreased later in abundance as cells progressed from early S 
phase to G1 phase of the next cell cycle (i.e., from 2 h to 15 h post-release).  
Interestingly, both the increase of 1p-H1.4 when cells progressed toward G2/M and 
decrease of 1p-H1.4 when cells reenter G1 are not as dramatic as seen for 2p-H1.4 and 
1p-H1.2.  This observation of rapid phosphorylation/dephosphorylation versus slower 
phosphorylation/dephosphorylation is also seen in the HIC study described below and 
will be discussed in more details with more frequently sampling data.   
 
For the cells arrested in mitosis by 1 μM colchicine treatment for 18 hrs, maximum of six 
phosphorylations were added to H1.4 and maximum of four were added to H1.2, which 
agrees with early biochemistry analysis (Ajiro et al., 1981a; Ajiro et al., 1981b).  We 
also detected unphosphorylated and intermediate phosphorylated H1 forms.  Among 
them, the presence of 0p- 1p- 2p-H1.4 and 0p-, 1p-H1.2 can be explained by the presence 
of interphase cells (suspension HeLa S3 culture treated with colchicine harvested for this 
analysis had ~20% of cells remaining outside G2/M based on FACS).  It remains 
unresolved whether these 3p-, 4p-, 5p-H1.4 and 2p-, 3p-H1.4 forms are the existing forms 
in cells or just simply the degradation forms of 6p-H1.4 and 4p-H1.2 during sample 
handling.  However, the fact that less intermediate phosphorylation forms were 
observed for the fresh prepared sample analyzed by HIC described later suggests these 
intermediate phosphorylation forms were more likely introduced during sample handling. 
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Although intact H1.2 and H1.4 species were observed when crude H1 was analyzed 
(Figure 2.1), residues 2-5 were missing from most ion species when mild OCAD 
(Collisionally Activated Dissociation) was applied in FTMS to improve the resolution 
(Figure 2.2).  Similar residue loss was more prominent when homogenous individual 
HIC peaks was analyzed using the conditions that maintained the intact H1 forms for 
crude total H1 sample.  Loss of these same residues (typically SETA) in histone H1 
during electrospray ionization has been reported previously (Wang et al., 1997), and 
other proteins are also known to be preferentially fragmented at specific peptide bonds 
during this process (Carroll et al., 2006; Grandori, 2003). 
 
In sum, these TDMS studies of total H1 in HeLa cells have unequivocally determined the 
1p-H1.4, 2p-H1.4 and 1p-H1.2 are present in interphase while 6p-H1.4 and 4p-H1.2 are 
achieved in M phase.  In addition, it also demonstrated that the percentage of mono-/di- 
phosphorylated H1 in interphase starts to increase from G1, keeps progressively 
increasing when cells traverse S phase and reaches the maximum level in G2/M. 
 
2.4 Resolution of Phosphorylated H1 Variants by HIC  
We attempted to directly identify phosphorylation sites in crude H1 using the TDMS 
approach.  However, the fragmentation of phosphorylated H1 achieved by ECD was not 
sufficient enough for phosphorylation sites identification by this approach due to ion 
suppression effect (Ouvry-Patat et al., 2008).  We have employed RP-HPLC to separate 
core histones to individual variants for successful characterizing expression and 
modifications by TDMS in our lab.  Unfortunately, we were unable to resolve H1.2 
from H1.4 by RP-HPLC (see Appendix 6.1). 
 
There is at least three reasons motivated us to develop a chromatography method to 
resolve H1 forms differing in either amino acid sequence or degree of phosphorylations.  
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First, we had trouble to obtain high quality fragments ions by ECD for the MS/MS 
analysis to map the phosphorylation sites from crude H1, which could be very likely 
overcome by just using more homogenous fraction.  Second, chromatography is more 
ideal than TDMS for quantification of single form of modification(s) relative to the total 
pool of that variant and the relative abundance among variants since some ion species 
will be underrepresented in the TDMS due to ion suppression effect (Pesavento et al., 
2006).  Third, the ability to purify naturally occurred phosphorylated H1 forms will 
enable us to do some biophysical studies for H1 phosphorylation in the future, such as 
how specific phosphorylation in H1 could affect its binding with chromatin or the rate of 
transcription from reconstituted chromatin.   
 
Similar to RP-HPLC, hydrophobic interaction chromatography (HIC) separates proteins 
based on surface hydrophobicity.  However selectivity is generally superior to that of 
RP-HPLC for proteins large enough to have significant secondary or tertiary structure.  
Particularly, HIC has greater sensitivity than other chromatography method to the 
location of a modification or residue difference, especially if it involves a nonpolar group.  
Despite this interaction mode does not predict the separation of phosphorylation, we 
successfully resolve H1 heterogeneity due to both non-allelic amino acid sequence 
variation and to phosphorylations.  As shown in Figure 2.4 A, five major components 
for H1 prepared from asynchronously growing HeLa cells was resolved.  Essentially, 
these were the same components observed by TDMS except that the A142 and T142 
allelic forms of H1.2 were not separated from each other by HIC.  Compared to two 
dimensional approaches using RP-HPLC first to resolve non-allelic H1 variants 
irrespective of modification, followed by hydrophilic interaction chromatography (HILIC) 
to resolve phosphorylated forms for each variant fraction individually (Lindner et al., 
1997), the HIC approach simplifies comparison of the expression and phosphorylation of 
H1 variants in different crude samples.   
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2.5 Mapping H1 Phosphorylation Sites by TDMS 
The chromatography purified fraction was desalted, dissolved and then sprayed into the 
source of FT-ICR via direct infusion mode by ESI.  The microdroplets consisting of 
variably-protonated H1 molecules then pass through a heated metal capillary and 
skimmer, become desolvated, multiply charged protein ions in the quadrupole region.  
Specific protein ion charge states can be selected and accumulated before entry into the 
trapped-ion cell by mass filtering of quadrupole.  A typical broadband mass spectrum of 
HIC purified fraction (peak 1) from crude H1 in mid S HeLa cells was shown in Figure 
2.4 B.  Many charges states were observed and those ranging from +32 to +25 were 
shown.  Two species were present in most charge states with +160 Da molecular mass 
shift from either intact mature H1.4 with N-terminal acetylation (purple) or H1.4 losing 
the residue 2 to 4 (-SETA, green), which suggests peak 1 in HIC is a homogenous 
diphosphorylated H1.4.  The quadrupole was used to select the +28 charge state (inset), 
eliminating all others from being sent to the ICR cell.  The mass spectrum of quadrupole 
having the same m/z range as the broadband shown in Figure 2.4 C indicates only little 
amount of ions other than +28 was not eliminated.  After a stored waveform inverse 
Fourier transform (SWIFT) was used to select and accumulate ion specie, all other 
species were ejected out of the ICR cell and the pure 21492 Da ion specie was ready for 
the tandem mass analysis (Figure 2.4 C).  Tandem mass spectrometry (MS/MS), which 
consists of the activation of primary (“precursor”) ions, dissociation or reaction, followed 
by mass analysis of the resulting secondary (“product”) ions, is useful for sequencing 
fragment ions that provide detailed structural analysis of modifications (Marshall et al., 
1998).  Electron capture dissociation (ECD), which is a gentler and more fragment-ion 
rich method for ion dissociation, is used as our main tools for generating fragment ions 
for H1 phosphorylation sites mapping.  The advantage of ECD is that it only break 
precursor ion once, which produce one N-terminal fragment called C ion and one 
C-terminal fragment called Z ion (Cooper et al., 2005).  In addition, Infrared 
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multiphoton dissociation (IRMPD) was used as a supplemental fragmentation method to 
generate B and Y ions.  ECD spectrum of a pure 21492 Da ion specie was shown in 
Figure 2.5 D.  The mass for each fragment ions in the ECD spectrum was manually 
assigned using MIDAS software and compared with the theoretical mass generated for 
H1.4-SETA by ProSightPTM ion predictor software 
(https://prosightptm.scs.uiuc.edu/ionpredictor/) to map two phosphorylation sites 
predicted from +160 Da mass shift.  Series of Z ions, from small to large, can be divided 
into three groups.  First, no mass difference was seen for all the Z ions from Z5 to Z33; 
second, a +80 Da mass difference was present in all the Z ions from Z34 to Z46, which 
indicates one phosphorylation is in position 34 counting from C-terminal (i.e. S187); 
third, a +160 Da mass difference appeared in all the Z ions from Z52, which indicates the 
second phosphorylation is localized within the 6 residue between position 47 to 52 
counting from C-terminal.  The reason that the first phosphorylation can be mapped to a 
single residue whilst the second can only be mapped to a 6 residue stretch is the fragment 
coverage.  However we can take advantage from the fact that phosphorylation only 
occurs in three amino acid residues: serine, threonine and tyrosine.  Since there is only 
one such phosphorylatable residue among the 6 residues stretch, we can unequivocally 
assigned second phosphorylation to S172.  By contrast, all C ions indicated there is no 
modification in the rest part of molecule.  A graphical fragment ions map covered from 
residue 158 (Z ions and Y ions) is depicted to show the backbone cleavages that leads to 
the fragment ions observed in ECD/IRMPD spectra and the phosphorylation sites 
mapped was indicated as circled residue (Figure 2.4 E).  In sum, the phosphorylation 
sites in the diphosphorylated H1.4 was mapped to S172 and S187 (counting methionine 
as the first residue) by MS/MS analysis.  Very importantly, this top down approach 
analysis unequivocally proves that peak 1 is homogeneous of diphosphorylated H1.4 with 
phosphorylation localized to both S172 and S187 but not other sites.   
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2.6 H1 is Phosphorylated at a Specific Subset of Sites during Interphase 
We chose to identify interphase phosphorylation sites in H1 recovered from HIC 
fractions from 4 hour post-release cells (mid-S).  Although phosphorylation levels were 
clearly rising at this time, there was little possibility of contamination by 
hyperphosphorylated H1 from mitotic cells compared to later time points (Figure 2.8 A).  
SDS gel electrophoresis confirmed that peaks 1-3 and peaks 4-5 were essentially 
homogenous fractions of H1.4 and H1.2, respectively, at this time point (Figure 2.8 B).  
We also confirmed that several minor peaks which eluted prior to peak 1 contained H1.5, 
but did not characterize these further. 
 
Mass spectra for HIC peaks 1-5 from the 4 hour post-release sample are shown in Figure 
2.5.  Consistent with the presence of a single band for peak 3 in SDS gels (Figure 2.8 
B), TDMS detected a single major component with molecular mass of 21333.1 Da for 
peak 3.  This closely matched the 21332.8 Da molecular weight predicted for residues 
6-219 of human H1.4 lacking any post-translational modifications.  MS/MS analyses by 
ECD confirmed that it matched unmodified H1.4 missing residues 1-5.  Analysis of HIC 
peak 2 detected a single major component with mass of 21412.3 Da, matching the mass 
predicted for residues 6-219 of H1.4 modified by monophosphorylation (21412.8 Da).  
Strikingly, MS/MS analyses localized this phosphorylation exclusively to serine 187 
located within one of several cyclin-dependent kinase (CDK) substrate consensus motifs 
commonly found in the C-terminal domain of H1 variants of metazoans.  A single major 
component was also detected for HIC peak 1.  This had a molecular mass of 21491.6 
Da, closely matching the 21492.7 Da mass predicted for residues 6-219 of H1.4 modified 
by two phosphorylations.  MS/MS analyses revealed that in this case, phosphorylation 
occurred exclusively on serines 172 and 187, the former residue also occurring within a 
C-terminal domain CDK substrate consensus motif.  Thus, the H1 kinase(s) active 
during interphase appear to generate predominantly just two phosphorylated forms of 
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H1.4: pS187-H1.4 and pS172+pS187-H1.4.  Moreover, the data also suggest that 
interphase phosphorylation of H1.4 proceeds in hierarchical fashion, with preferential 
modification of S187 prior to that of S172 since phosphorylation at S172 alone was not 
detected.  As shown in Figure 2.11, S187 and S172 lie within the most C-terminal and 
second most C-terminal CDK substrate consensus motifs of human H1.4, respectively.  
 
Two major components were detected by TDMS in each of HIC peaks 4 and 5 (Figure 
2.5).  The molecular mass of the smaller component in peak 5, 20832.3 Da, matched 
that predicted for residues 6-213 of H1.2 lacking any modifications (20832.5 Da).  The 
bigger component (20862.2 Da) was 29.9 Da larger and less abundant.  MS/MS 
analyses revealed many peptides in common with H1.2 and localized the +29.9 Da mass 
difference to a fragment spanning H1.2 residues K127-K159 (data not shown).  This 
difference is consistent with one of several amino acid substitutions which results in a 
mass change of approx. +30 Da (G>S, A>T, V>E, Thr>Met, Arg>Trp), and also with 
modifications other than phosphorylation that are common to histones such as 
dimethylation (+28 Da) or oxidation (+16 Da, +32 Da).  However, we were unable to 
determine directly whether specific residues were substituted or modified since ECD did 
not fragment this peptide further under the conditions employed.  Hence, we used 
gene-specific primers to amplify the H1.2 coding region from HeLa S3 cell genomic 
DNA, ligated the products into the pcDNA3.1 vector, and then sequenced plasmids 
recovered from multiple transformants.  This approach detected two polymorphisms in 
the H1.2 gene that have not been described previously.  The first, a T>C substitution at 
nucleotide 108 (TCT > TCC in the codon for Ser36), does not alter the H1.2 amino acid 
sequence and was observed in 30/30 clones analyzed (Figure 2.18).  The second, a G>A 
substitution at nucleotide 424 (GCT > ACT in the codon for Ala142), results in an 
Ala>Thr substitution at residue 142 of the H1.2 protein.  This corresponds to a 30.01 Da 
increase in the predicted molecular weight of the protein, closely matching both the +29.9 
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Da difference between the minor and major components observed for peak 5 and the 
+29.7 Da difference from the 20832.5 Da predicted for unmodified H1.2 residues 6-213 
based on the gene sequence deposited in Genbank (Table 2.1).  This polymorphism was 
observed in 8/30 of the H1.2 clones analyzed, a frequency similar to the relative 
abundances of the 20862.2 Da and 20832.3 Da forms observed by MS for peak 5 (Figure 
2.5) and the corresponding components in the broadband mass spectrum for crude H1 
(Figure 2.1) (i.e. between 1/3 and 1/4).  Thus, HeLa S3 cells can express at least two 
different alleles of H1.2: H1.2-A142 corresponding to Genbank NP_005310, and the 
novel H1.2-T142 allele described here.  Our analyses also suggest that all copies of the 
H1.2 gene expressed in these cells contain the silent T108C nucleotide polymorphism. 
 
Similarly, analyses of HIC peak 4 also revealed two major components (Figure 2.5).  
The smaller more abundant species with molecular mass 20912.1 Da closely matched the 
20912.5 Da predicted for residues 6-213 of H1.2-A142 with one phosphorylation.  The 
larger less abundant species with molecular mass 20941.7 Da closely matched the 
20942.5 Da predicted for residues 6-213 of H1.2-T142 with one phosphorylation.  ECD 
fragmentation and MS/MS analyses localized this phosphorylation exclusively to S173 in 
both forms.  Remarkably, even though H1.2-S173 is homologous with H1.4-S172, the 
second most C-terminal CDK substrate consensus motif in H1.4, the H1.2-S173 CDK is 
the most C-terminal such motif in H1.2 since the H1.4-S187 motif (SPAK) is not 
conserved in H1.2 (SAAK, see Figure 2.11).  Thus, despite the presence of several 
similar motifs elsewhere in these proteins (Figure 2.11), H1.2 and H1.4 are both 
preferentially phosphorylated at their hindmost CDK substrate consensus motifs during 
interphase in HeLa S3 cells. 
 
Our TDMS and HIC analyses of total H1 described above have demonstrated 
phosphorylation in H1 is remarkably simple in HeLa: 1p-H1.2, 1p-H1.4 and 2p-H1.4 in 
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interphase, 4p-H1.2 and 6p-H1.4 in M phase, no other forms of phosphorylation are 
observed.  However, as discussed in chapter 1.5.1, it has been proposed H1 
phosphorylation in interphase (G1, S and G2) is random based on peptide mapping.  
This hypothesis predicts the existence of isoforms for phosphorylated H1.  For example 
the monophosphorylated H1.4 might be the mixture of forms having one phosphorylation 
at any site of T18, S27, T146, T154, S172 and S187 (phosphorylation sites occurred in M 
phase, will be described later) or even any of 16 serines, 10 threonines and 1 tyrosine 
residues in H1.4.  Fortunately, these isoforms can be revealed by MS/MS analysis 
although they are indistinguishable in the broadband spectrum.  During manual 
comparison of observed fragment ions mass against theoretical C/Z ions mass, once the 
80 Da shift appeared in Cn or Zn fragment ion, the observation of any 0 Da shift in Cn+i or 
Zn+i fragment indicates the existence of isoform, otherwise there is no isoforms.  Special 
cautions have been exercised to search for the indication of isoforms and nothing was 
detected in our MS/MS analyses for 1p-H1.2, 1p-H1.4 and 2p-H1.4. 
 
The caveat in our conclusion that interphase H1 phosphorylations occur in the specific 
sites comes from our MS/MS analysis is limited to HIC fractions.  There is a small 
chance that the isoforms of phosphorylated H1 containing other phosphorylation sites 
reported in bottom-up study (Garcia et al., 2004; Wisniewski et al., 2007) are eluted far 
away from peaks we analyzed.  To confirm our conclusion, we tried to establish ion 
exchange chromatograph (IEC) for H1 variants and phosphorylation separation.  We 
theorized that binding of H1 with weak cation exchange column are solely governed by 
charge under the denature condition of 8 M urea and thus isoforms of 1p-H1.2, 1p-H1.4 
and 2p-H1.4 having phosphorylation at different sites will bind column equally since they 
all have the same charge.  As shown in Figure 2.6, five peaks were resolved in IEC and 
the first four peaks have been analyzed by TDMS.  It turns out the elution order was the 
same as predicted by the charge.  Assuming free amino- and carboxyl-termini, assigning 
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+1 for all lysine and arginine residues, -1 for all aspartate and glutamate residues and -1.5 
for one phosphate at pH 7 (pKa for HPO4
2-
 is 7), the predicted net charge at pH 7.0 will 
be 1p-H1.2: +53.5, 0p-H1.2: +56, 2p-H1.4: +55, 1p-H1.4: +57.5 and 0p-H1.4: +59.  The 
MS/MS analysis was performed for 1p-H1.2 and 2p-H1.4 and no isoform was found as 
indicated in the ECD map shown in Figure 2.6 C.  Taken together, the interphase H1 
phosphorylation only occurs in a specific subset of M phase phosphorylation.  However, 
we were unable to rule out the existence of the very low abundant random 
phosphorylation due to limited sensitivity of TDMS. 
 
2.7 H1 Phosphorylation is Reduced during G1 Phase 
The TDMS analyses of crude H1 from different cell cycle stages have found levels of 
phosphorylation in H1 are lowest in G1 phase and highest in M phase cells.  After the 
identity of five major peaks in HIC from H1 in HeLa S3 were revealed by TDMS, we can 
use it to analyze the expression and phosphorylation levels of H1 in different samples.  
First, HIC was utilized to confirm the phosphorylation levels of H1 in HeLa S3 from 
butyrate arrested G1 phase, asynchronous growing and colchicine arrested M phase.  As 
shown in Figure 2.7 A, B, HIC peaks representing 1p-H1.2, 1p-H1.4 and 2p-H1.4 were 
less abundant in H1 prepared from cultures arrested in G1 comparing with H1 prepared 
from asynchronous growing cultures.  More specifically, 1p-H1.2 decreased from 18% 
of total H1 to 4%, 1p- and 2p-H1.4 decreased from 17% and 13% to 8% and undetectable, 
respectively. 
 
In addition, it has also been reported that expression patterns of H1 variants changed 
when HeLa cells were arrested in G1 by butyrate treatment (Happel et al., 2009).  As 
shown in Figure 2.7 A, induction of H1
0
 variants was observed and expression of H1.4 
slightly increased relative to H1.2 in G1 arrested cells (elution order of H1
0
 in HIC will 
be described in chapter 3). 
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2.8 H1 Hyperphosphorylation during M Phase   
In TDMS study, we have already demonstrated the histone H1 are highly phosphorylated 
in the mitotic cells with hexaphosphorylated H1.4 (6p-H1.4) and tetraphosphorylated 
H1.2 (4p-H1.2) as major forms.  Compared with five major peaks in HIC 
chromatograph of H1 from interphase, two additional major peaks were observed and 
labeled as peak 1 and peak 2 (Figure 2.7 A) when crude H1 purified from colchicine 
arrested sample was analyzed by HIC.  Based on the fact that H1.4 is eluted earlier than 
H1.2 and addition of phosphorylation weakens the binding of H1 in the HIC column, 
peak 1 and peak 2 were predicated as 6p-H1.4 and 4p-H1.2. 
 
Using the mapping scheme described before, six phosphorylations in H1.4 were localized 
to T18, S27, T146, T154, S172 and S187 as indicated in ECD map (counting Met as 
residue 1, Figure 2.7 D).  We only analyzed H1.4 losing the first 4 residues by MS/MS 
since it is the major form.  In addition, we also observed intact H1.4 as minor form in 
the broadband spectra of HIC fractions and its mass indicated it is also 
hexaphosphorylated, which excludes the possibility that there is addition phosphorylation 
localized in the first four residues.  Interestingly, five phosphorylatable residues in H1.4, 
except S27, are found in CDK substrate motif.  A sixth phosphorylatable residue, S27, is 
present in an RKS motif resembling that of aurora kinase substrate which is unique to 
H1.4 (Figure 2.11).  Together with immunochemical analyses (chapter 4), our results 
suggest that T18, S27, T146, T154, S172 and S187 of H1.4 are phosphorylated 
exclusively during mitosis, and we refer to them as M sites.  In contrast, we refer to 
H1.4-S172 and H1.4-S187 as I site since it can be phosphorylated during both interphase 
and mitosis (Table 2.3). 
 
Similarly, four phosphorylations in H1.2 were localized to T31, a fragment spanning 
residues A134-A151 (either T146 or S150), T154 and a fragment spanning residues 
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K160-P174 (one of T165, T167 and S173).  Unfortunately, due to ion suppression from 
the presence of H1.4 in HIC fraction, no enough ECD fragments was generated to 
undoubtedly assign the phosphorylation to residues A134-A151 and residues K160-P174.  
Based on the observation that all sites containing CDK substrate motif are 
phosphorylated in H1.4 and the fact that there is only four CDK substrate motifs in H1.2 
(Figure 2.11), we conclude the four phosphorylations in H1.2 were localized to T31, 
T146, T154 and S173 (Table 2.3).  Based on our TDMS and immunochemical analyses, 
we consider T31, T146 and T154 of H1.2 to be M sites whereas S173 is I site (Figure 
2.11).  
 
When the relative abundance of different phosphorylation forms was quantified, it turned 
out the less phosphorylated forms, including 0p-H1.2, 1p-H1.2. 0p-H1.4 and 2p-H1.4, 
were roughly 20% of total H1 (Figure 2.7 B).  Since it was estimated that around 20% 
of cells remaining outside G2/M in our colchicine enriched mitosis HeLa S3 cells (FACS, 
data not shown), this data suggests majority of H1 in mitosis achieve the maximum level 
of phosphorylation (4p-H1.2 and 6p-H1.4). 
 
2.9 I Sites May Differ in Their Phosphorylation Dynamics  
We used HIC to analyze H1 from HeLa cells at different times after release from 
synchronization at the G1/S boundary by double thymidine blocks.  The same five 
major peaks apparent for samples from growing asynchronous cells were also resolved 
for post released samples, but their relative abundance varied at different sampling points 
(Figure 2.8 A).  The proportion of 2p-H1.4 and 1p-H1.2 (HIC peaks 1 and 4) increased 
as cells went from early S phase through G2 and M phases of the cell cycle (1 h to 11 h 
post-release) and then became less abundant as cells entered G1 phase of the next cell 
cycle (11 h to 19 h post-release).  Intriguingly, the abundance of 1p-H1.4 (HIC peak 2) 
changed by only a small amount between 1 and 19 hours post-release compared to 
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2p-H1.4 and 1p-H1.2 (HIC peaks 1 and 4) (Figure 2.8 C).  In addition, the slower 
phosphorylation and dephosphorylation of 1p-H1.4 compared with 2p-H1.4 and 1p-H1.2 
is also observed in the crude H1 analyzed by TDMS (chapter 2.3).  This is consistent 
with the proposal, based on evidence that 
32
P incorporation is disproportionately lower 
than the abundance of phosphorylated H1 in early G1 phase, that some H1 
phosphorylation in G1 phase cells may perdure from the preceding cell cycle (Ajiro et al., 
1981a).  However, why phosphorylation dynamic at Ser187 of H1.4 is different than 
other sites?  The sequence in these interphase phosphorylation sites might offer some 
explanation.  As described in chapter 1.5.2, multiple evidences have indicated CDK2 is 
the kinase for H1 interphase phosphorylation whereas CDK1 is the kinase for H1 mitosis 
phosphorylation.  In fact, all there sites we investigated here all have CDK motif 
(S/TPXK/R) but S187 of H1.4 also has Erk motif (P-X-S/T-P), which raise the possibility 
that less phosphorylation dynamic at Ser187 of H1.4 during cell cycle is the result of 
double kinase actions from cell cycle regulated CDK together with constant active Erk.  
The global analysis of temporal dynamics of phosphopeptides after stimulation of HeLa 
cells with epidermal growth factor (EGF) have identified a slight increase of pS187-H1.4 
peptide but no increase of phosphopeptides representing other sites in H1 (Olsen et al., 
2006).  However, further investigations are required to explore this possibility.  
 
2.10 Hierarchical Phosphorylation of S187 is Not Required for S172 
Phosphorylation in H1.4 
One approach to study the function of phosphorylation is to mimic unphosphorylated or 
phosphorylated forms by introducing alanine or glutamic acid in the position of 
serine/threonine (Dou et al., 1999).  We tried to establish stable cell lines with H1.4 
carrying S187A point mutation fused with FLAG tag in the C-terminus 
(H1.4-S187A-FLAG) driven by CMV promoter in HeLa S3 cells.  The expression level 
of H1.4-S187A-FLAG analyzed by SDS-PAGE of acid extraction of whole histones from 
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isolated nuclei (AEWH) estimated near 1:1 ratio of mutant H1.4 compared to total 
endogenous H1 (H1.2 plus H1.4).  Further quantification indicated H1-to-core ratio 
increased from ~0.8 in HeLa S3 cells to ~1.3 in H1.4-S187A-FLAG stable cell line with 
the endogenous H1.2 plus H1.4 slightly decreased to 0.7 H1-to-core ratio.  Similar 
H1-to-core ratio of 1.3 has been reported in the overproduction of H1
0
 in NIH 3T3 cell 
line under the inducible promoter (Brown et al., 1996).  However, it has been reported 
that overproduction of H1.2 can only reach ~1.1 H1-to-core ration and the importance of 
maintaining overproduction at the low level has been emphasized (Brown et al., 1996).  
This might explain our difficulties in obtaining H1.4-WT-FLAG (wild type) stable cell 
line using the same approach, i.e. cells can tolerate the overproduction of H1.4-S187A 
better than H1.4-WT.  Nonetheless, the toxicity caused by overproduction of 
H1.4-S187A became obvious when cells were continuingly cultured for a month.  The 
phenotype included abnormality of genome copies (FACS, data not shown), change of 
nuclear morphology (IF, data not shown) and loss of H1.4-S187A expression in one 
month (SDS-PAGE, data not shown). 
 
Despite the toxicity problem, it is ideal to test the stringent of the hierarchy of 
phosphorylation in the H1.4 molecule is in these stable cell lines.  As shown in Figure 
2.9 B, the H1.4 molecule having S187A mutation could still be phosphorylated at S172 
based on the result from western blot of pTetH1 antibody, which recognizes pS172-H1.4 
as described in chapter 3.  To further determine the abundance of phosphorylation 
between H1.4 and H1.4-S187A molecules, we use the HILIC established in chapter 3 to 
analyze the crude H1 purified from HeLa S3 cells and stable cell lines respectively.  The 
identity of peaks for crude H1 from HeLa cells in HILIC was labeled as the result 
described in chapter 3 and the appearance of two new peaks were further analyzed by 
TDMS.  Both unphosphorylated H1.4-S187A-FLAG and monophosphorylated 
H1.4-S187A-FLAG were observed in mass spectrum.  The quantification of HILIC 
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chromatography revealed no significant change in abundance of phosphorylation for all 
endogenous H1 variants, namely H1.2, H1.4 and H1.5, was observed in 
H1.4-S187-FLAG stable cell line compared with parental HeLa cells.  The relative 
abundance of monophosphorylation in H1.4-S187A-FLAG, presumably at S172 as 
indicated by pTetH1, was approx 1/3.  Surprisingly, approx 1/3 of H1.2 is 
monophosphorylated and same amount of H1.4 is phosphorylated when both mono- and 
di-phosphorylated forms were counted (Figure 2.9 D).  These results suggested 
phosphorylation of H1 is more stringently regulated at the abundance of phosphorylation 
than how many sites are phosphorylated.  In another perspective, H1.4-S187A is similar 
to H1.2 which is not phosphorylated at the position of S188 (SAAK) due to lack of CDK 
substrate motif (S/TPXK) but still phosphorylated at S173.  The lack of CDK motif at 
both S188 in human H1.2 or S187/S189 in mouse H1.2 might evolve to serve a specific 
purpose (Figure 2.11).  It would be interesting to see whether insertion of a proline to 
restore a CDK substrate motif in this portion of H1.2 will cause phosphorylation in this 
site. 
 
2.11 Sequence Variation at S172 Affects Phosphorylation at S187 and Abundant H1 
Phosphorylation Is Not Critical For Cell Survival 
Among several other mutant stable cell lines we established, H1.4-S172A was very 
interesting in a way that the overproduction of this mutant greatly suppressed the 
expression of endogenous H1.2 and H1.4 to less than 5% (Figure 2.9 E).  Such effect 
has been observed in two different clones, which suggests such high level of 
overproduction is related to some unknown features of this molecule.  Further analysis 
of this mutant protein by TDMS demonstrate it still can obtain monophosphorylation but 
in a surprisingly low abundance.  By contrast, the abundance of mono- and 
di-phosphorylation in endogenous H1.4 in the same spectrum remained the same as that 
those in parental HeLa S3 cells (Figure 2.9 F).  Several implications can be inferred 
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from this interesting result: first, the relative abundant H1 phosphorylation (~30% for 
H1.2 and H1.4) found in HeLa is not critical for cell survival; second, cells have 
mechanism to monitor H1 protein level, very likely through proteosome pathway as 
suggested by (Ryan, 1999); third, phosphorylation at S173 or S187 regions might have 
distinct function; fourth, the most intriguing observation is that the phosphorylation 
pattern of H1.4-S172A resembles to human H1.3, which was phosphorylated at very low 
abundance (described in chapter 3).  The lost of CDK motif in S174 (SAKK) of H1.3 or 
S173 (APKK) of H1.4-S173A resulted in the low abundance of phosphorylation despite 
the next more C-terminal Ser-containing CDK motif is present in both H1.3 and 
H1.4-S173A (S189PAK in H1.3 and S187PAK in H1.4-S173A, Figure 2.11).  However, 
determining the mechanism that sequence variation at S172 affecting the phosphorylation 
at S187 requires further investigation.   
 
2.12 Conclusions and Discussions 
Previous efforts to map the phosphorylation sites in H1 from asynchronous cells did not 
reveal the extent to which the sites identified are phosphorylated in interphase (Garcia et 
al., 2004; Wisniewski et al., 2007).  Earlier analyses of synchronized animal cells 
established that H1 phosphorylation occurs during interphase and changes in abundance 
during cell cycle progression (reviewed in (Gurley LR, 1978), (Ajiro et al., 1981a; Ajiro 
et al., 1981b; Hohmann et al., 1983; Talasz et al., 1996)) but did not identify individual 
sites of phosphorylation.  This has complicated efforts to understand differences in 
interphase phosphorylation between individual H1 variants, whether sites are 
phosphorylated in hierarchical or random fashion during interphase, and whether specific 
functions can be ascribed to any interphase phosphorylations.  The novel data described 
here allows us to clarify some of these issues. 
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All of the interphase phosphorylation we detected in H1.2 is mapped to S173, implying 
that this is the sole site of phosphorylation in this variant outside of mitosis (Figure 2.5 
and Table 2.3).  This finding is further supported by our immunochemical analyses 
(chapter 4), the stoichiometry of interphase phosphorylation reported previously for H1.2 
in several species (Sarg et al., 2005; Talasz et al., 1996; Wang et al., 1997), and much of 
the data reported for the "H1A" (name by the order of elution in chromatography, not the 
nomenclature used formally in the literature, see Table 2.1) fraction resolved by cation 
exchange chromatography for synchronized HeLa cells (Ajiro et al., 1981a; Ajiro et al., 
1981b).  Thus, modulation of H1.2 function via phosphorylation outside of mitosis is 
limited to changing the abundance and distribution of pS173-H1.2 in human cells.  
 
Our combined data on H1.4 suggest it is phosphorylated at a maximum of two sites 
during interphase, consistent with estimates of H1.4 interphase phosphorylation 
stoichiometry reported previously for several species (Sarg et al., 2005; Talasz et al., 
1996; Wang et al., 1997).  Our HIC analyses showing that the relative abundance of 
pS172+pS187-H1.4 increases as cells traverse S and G2 phases (Figure 2.8) also confirm 
previous work (Talasz et al., 1996).  However, our analyses are the first to reveal that 
this phosphorylation occurs hierarchically at S187 followed by S172.  The absence of 
detectable amounts of pS172-H1.4 further suggests that dephosphorylation of 
pS172+pS187-H1.4 follows the reverse hierarchy, or occurs in an "all or none" fashion 
that precludes the accumulation of detectable amounts of the pS172-H1.4 form.   
 
The finding that phosphorylation of S187 precedes that of S172 in H1.4 suggests that 
features of H1.4 or the respective kinase(s) impart a C>N directionality to interphase 
phosphorylation, consistent with previous evidence that interphase phosphorylation 
occurs predominantly at Ser residues in the C-terminal domain, and that N-terminal 
domain sites are generally not phosphorylated until just prior to mitosis (Ajiro et al., 
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1981a; Ajiro et al., 1981b; Gurley LR, 1978).  However recent evidence suggests the 
opposite directionality for H1.5 interphase phosphorylation in human cells, starting at 
S18 in early G1 followed by S172 and S188 (Talasz et al., 2009).  Notably, H1.5 is the 
only somatic variant in humans with a Ser-containing CDK motif in the N-terminal 
domain (Figure 2.11).  Taken together, the available data suggest that interphase H1 
phosphorylation is specific for Ser-containing CDK motifs and proceeds hierarchically in 
variants with multiple SPKK/SPAK motifs, although the C>N directionality of multi-site 
interphase phosphorylation may be variant-specific.  Currently, there is no data to 
exclude the possibility that the accessibility of tails is the determining factor for 
interphase phosphorylation, swapping the Ser-containing I site to the threonine and 
analyzing the phosphorylation pattern of the mutant protein will help to further clarity 
these possibilities. 
 
2.13 Materials and Methods 
HeLa / HeLa S3 Cell Culture  
HeLa S3 cells
 
(ATCC)
 
were grown in suspension in Joklik's modified minimal essential
 
medium supplemented with 10% (v/v) newborn calf serum (NCS) in spinner flask at 
37°C and 2% CO2.  HeLa cells were also obtained from ATCC and maintained as a 
monolayer in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% 
NCS at 37°C and 5% CO2.  Asynchronous cultures were maintained
 
in logarithmically 
growing phase by controlling density under 3 x 10
5
 to 3.5 x 10
5
 cells/ml.   
 
Stable Cell Line Cloning 
Plasmids of Histone H1.4-WT and H1.4-M5 (T18, T146, T154, S172 and S187 all 
mutated to alanine) with FLAG (sequence: DYKDDDDK) fused with the C-terminus 
through six amino acid linker (STDPLP) in pcDNA3.1 hygo(+) were the gift from 
Herrera (Contreras et al., 2003).  Point mutations of S172A and S187A were introduced 
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by site-directed mutagenesis at A(514)GC->GCC and A(559)GC->GCC respectively 
(primer: 5’-GGAGCCAAAAAAGCGAAAGCCCCGAAAAAGGCGAAAGC, 
5’-GGCGCCCAAGGCCCCAGCGAAGGCCAAAG).  For Ser->Glu substitutions, 
underline nucleotides were mutated to GAG.  Dosage of hygromycin B for HeLa S3 
was established at 300 μg/ml, which was the minimum dosage able to kill >95% cells in 
2 weeks.  Cells were transfected with 4.0 μg plasmid with 10 μl lipofectamine 2000 in 
6-well plate format according to manufacture protocol and were subcultured to P100 dish 
with selection of 300 μg/ml hygromycin B at day 3.  Clones appeared after ~3 weeks of 
selection were picked up by localized trypsin digestion under phase-contrast microscope 
using p200 pipette and further cloned by limited serial dilution in a 96-well plate. 
 
Cell Synchronization and FACS 
Cells were synchronized
 
by double thymidine block as described
 
previously (Knehr et al., 
1995). Briefly, cells were blocked in 2 mM thymidine for 16 hrs, released into fresh 
Joklik for 9 hrs, blocked in 2 mM thymidine for another 16 hrs to synchronize in G1/S 
boundary.  Cells at different stages of the cell cycle were obtained by harvesting them at 
different time after releasing from second thymidine block.  Cells were collected by 
centrifugation, quickly washed twice with cold
 
Tris-buffered saline (TBS; 20 mM Tris, 
150 mM
 
NaCl, pH 7.5), and the cell pellets were flash
 
frozen in liquid N2 and stored at 
–80°C prior to nuclei isolation.  The degree of synchrony was assessed by 
Fluorescence-Activated Cell Sorting (FACS) analysis of
 
propidium iodide stained cells 
fixed by 70% ethanol, which was taken hourly after release. 
 
Colchicine-arrested 
samples were also prepared by
 
adding 1 M colchicine to growing asynchronous cultures 
(3 x 10
5
 to 3.5 x 10
5
 cells/ml) for 18 h before harvesting. 
 
 
 
 63 
Histone Extraction 
HeLa S3 nuclei were isolated with NIB buffer (15 mM Tris, 60 mM KCl, 15 mM NaCl, 5 
mM MgCl2, 1 mM CaCl2, 250 mM Sucrose, pH 7.5) containing 0.5 mM 
4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF),
 
5 nM microcystin, 
and 10 mM Na butyrate and extracted with 0.4 N H2SO4.  Crude histone H1 was 
prepared by selective precipitation of other
 
proteins with 5% (w/v final) perchloric acid 
(PCA) from 0.4 N H2SO4 acid extraction.  This fraction was called PCA-Soluble 
(PCAS) and is mostly consisting of histone H1 and the precipitated fraction was called 
PCAI and is mostly consisting of core histones.  H1 remained in PCAS was recovered 
by precipitation with 20% (w/v, final) trichloroacetic acid (TCA).  The precipitation was 
washed with 0.1% HCl acetone once followed with twice wash of acetone. 
 
HPLC (RP, HIC and HILIC) 
Beckman System Gold Programmable Solvent Module 126 and Detector Module 
166/168 were controlled by the 32 karat software.  Absorbance was monitored at 214 
nm. 
Reverse phase high performance
 
liquid chromatography (RP-HPLC): Column used 
included ES industries Chromega MC18 analytical column, 25 cm x 4.6 mm, 1000 Ǻ 
diam. pores, Vydac C4, C8 and C18 column (4.6 mm [inside diameter] by 250 mm). 
Multistep linear gradient from buffer A (0.1% v/v trifluoroacetic acid
 
(TFA)
 
in 5% v/v 
CH3CN) to buffer B (0.094% TFA in 90%
 
CH3CN) with flow rate of 0.8 ml/min was 
used to purify PCA extracted H1. Collected fractions were recovered
 
by Speed-Vacuum.  
Hydrophobic Interaction Chromatography (HIC): PolyPROYL A column (PolyLC Inc., 
4.6 mm [inside diameter] by 100 mm, 3 μm spherical silica with 150 nm diam. pores) 
with a multistep linear gradient from buffer A (2.5 M (NH)2SO4, 50 mM 
ethylenediamine, pH7.0) to buffer B (1.0 M (NH)2SO4, 50 mM ethylenediamine, pH7.0).  
Collected fractions were recovered by RP-HPLC.  Chromatograph was exported as 
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ASCII file from 32 Karat and replot in Excel.  The slop was calculated from the 
beginning to the end of peaks and used to subtract the baseline.   
Hydrophilic Interaction Chromatrography (HILIC): polyCAT A column (PolyLC Inc., 
4.6 mm [inside diameter] by 200 mm, 5 um spherical silica with 100 nm diam. pores) 
with a multistep linear gradient from buffer A (70% CH3CN, 15mM 
triethylamine/H3PO4, pH3.0) to buffer B (70% CH3CN, 0.68M NaClO4, 15mM 
triethylamine/H3PO4, pH3.0). The volatile organic content of fractions was removed by 
Speed-Vacuum and histone H1 was recovered from aqueous parts by 20% TCA 
precipitation.      
 
Mass Spectrometry 
All data were acquired on a custom 8.5 T quadrupole Fourier
 
transform ion cyclotron 
resonance mass spectrometer with an
 
ESI source operated in positive-ion mode as 
described previously(Patrie et al., 2004; Pesavento et al., 2008b).  Desalted HIC/HILIC 
fractions or crude PCAS were dissolved in 50% methanol + 1% formic acid and 
introduced into the mass spectrometer by continuous infusion using a syringe pump or a 
NanoMate 100
 
(Advion) with low-flow nanospray chips.  Targeted ion species were 
externally accumulated in an octopole ion trap, transferred to the ion cyclotron resonance 
(ICR) cell, isolated by Stored Waveform Inverse Fourier Transform (SWIFT), and then 
fragmented by Electron Capture Dissociation (ECD).  Data were collected using the 
modular ICR data acquisition system (MIDAS).  The mass values for individual ion 
fragments were manually determined and compared with theoretical C and Z ion mass 
values.  The mass differences were used to assign the modifications to specific sites.  
ProSight PTM, a Web-based software and database suite, was used
 
to augment the 
manual identification and characterization of
 
histone H1 post-transcriptional 
modifications (https://prosightptm.scs.uiuc.edu).  Masses are reported as neutral, 
monoisotopic species. 
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2.15 Tables and Figures 
Table 2.1 
Histone H1 Nomenclature 
  
I II 
accession 
number 
GenBank  
Official Symbol 
average 
MW 
monoisotopic 
MW 
 MW losing 
1~4 residues  
aa 
h
u
m
a
n
 
hH1.1   NM_005325 HIST1H1A 21710.9  21697.826 21281.635 214 
hH1.2 H1d NM_005319 HIST1H1C 21233.5  21220.706 20832.547 212 
hH1.3 H1c NM_005320 HIST1H1D 22218.7  22205.278 21817.119 220 
hH1.4 H1b NM_005321 HIST1H1E 21734.0  21720.963 21332.804 218 
hH1.5 H1a NM_005322 HIST1H1B 22580.1  22566.468 22047.268 225 
hH10   NM_005318   20731.7  20719.154   193 
hH1x   NM_006026   22355.9 22342.492   212 
         
  
III IV 
accession 
number 
GenBank  
Official Symbol 
average 
MW 
monoisotopic 
MW 
 -SETA 
MW 
aa 
m
o
u
s
e
 
mH1.1 H1a NM_030609 Hist1h1a 21653.9 21640.866 21252.706 212 
mH1.2 H1c NM_015786 Hist1h1c 21235.4 2122.681 20764.532 211 
mH1.3 H1d NM_145713 Hist1h1d 21968.3 21955.085 21566.925 220 
mH1.4 H1e NM_015787 Hist1h1e 21846.1 21832.975 21444.816 218 
mH1.5 H1b NM_020034 Hist1h1b 22444.9 22431.395 22043.235 222 
mH10   NM_008197     20729.7  20717.15   193 
mH1x   NM_198622   20019.9 2008.059   187 
Nomenclature proposed (I) for human H1 based on gene sequence (Albig et al., 1991), (II) 
for human H1 based on protein sequence [34, 35], (III) for mouse H1 based on gene 
sequence (Drabent et al., 1995), (IV) for mouse H1 based on 2-D gel separation (Lennox 
and Cohen, 1984)    
 
Table 2.2 
The Relative Abundance of Phosphorylated H1.2 and H1.4 
in Asynchronously Growing HeLa S3 Cells 
H1.2 H1.4 
 0p 1p 0p 1p 2p 
A142 48% 20% 
59% 29% 12% T142 23% 8% 
Total 72% 28% 
 
Phosphorylated and nonphosphorylated forms of H1.2 and H1.4 in crude H1 are 
expressed as a percentage of the total of the respective variant detected by Top Down 
mass spectrometry according to the method described in (Pesavento et al., 2008a). 
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Table 2.3 
Sites Phosphorylated in H1.2 and H1.4 during Interphase and Mitosis 
in HeLa S3 cells 
  
  Molecular weight
a
 (Da)  
 
HIC 
peak
b
 
Measured Predicted
c
 m Variant
d
 Modifications
e
 
Interphase 
1 21491.6 21332.8 +160 H1.4 pS172, pS187 
2 21412.3 21332.8 +80 H1.4 pS187 
3 21333.1 21332.8 0 H1.4 none 
4 
20912.1 20832.6 +80 
H1.2 
(A142) 
pS173 
20941.7 20832.6 +110 
H1.2 
(T142) 
pS173 
5 
20832.3 20832.6 0 
H1.2 
(A142) 
none 
20862.2 20832.6 +30 
H1.2 
(T142) 
none 
Mitosis 
6p-H1.4 21813.9 21332.8 +480 H1.4 
pT18, pS27, 
pT146, pT154, 
pS172, pS187 
4p-H1.2 
21153.3 20832.6 +320 
H1.2 
(A142) 
pT31, pT146, 
pT154, pS173 
21182.9 20832.6 +350 
H1.2 
(T142) 
pT31, pT146, 
pT154, pS173 
a
  Reported as neutral monoisotopic species. 
b
  HIC peaks are labeled as in Fig. 1B. 
c
  Predicted from Genbank accession numbers NP_005312 (H1.4) and NP_005310 
(H1.2) assuming the loss of Met1 during protein maturation in vivo and residues 2-5 
during electrospray ionization. 
d
  Peak identifications are based on MS/MS sequencing of multiple ECD fragment ions.  
The A142 and T142 allelic variants of H1.2 were detected initially by mass spectrometry 
and confirmed by genotyping as described in Supp. Fig. 1. 
e
  Phosphorylated residues were identified by MS/MS sequencing of ECD fragment 
ions.  Analyses of the H1.2(T142) forms indicated that phosphorylated residues were 
identical to those determined for the H1.2 (A142) forms. 
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Figure 2.1 
 
H1 Variant Expression and Phosphorylation in HeLa S3 Cells  
The presence of H1 variants shown were confirmed by intact mass and/or gas phase 
fragmentation during MS/MS analysis.  Phosphorylation levels were inferred from the 
difference between the molecular mass measured for each component and the value 
predicted for the respective unmodified H1 variant.  Molecular masses are reported for 
the neutral monoisotopic species.  PCAS = perchloric acid extracted crude H1 
(A) The mass spectrum of crude H1 purified from asynchronously growing HeLa S3 cells.  
Three charge states are shown here and the relative abundances of H1.2 cluster and H1.4 
cluster are similar in three charge sates.  The charge for the H1.5 is one more than 
labeled. 
(B) Z= +25 in the H1.2/H1.4 cluster and Z= +26 for H1.5.  H1.2 and H1.4 are major 
variants with minor variant of H1.5.  Percentage of phosphorylation for H1.2 and H1.4 
is relative high.  The Ala142Thr polymorphism in H1.2 was confirmed by genotyping 
(see text).  All forms were missing Met1 and -N-acetylated at Ser2.  
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Figure 2.2 
 
The Levels of Phosphorylated H1.2/H1.4 Are Low in G1 Phase but High in M Phase 
Phosphorylation levels were inferred from the difference between the molecular mass 
measured for each component and the predicted mass for the unmodified H1 variants.   
Molecular masses are reported for the neutral monoisotopic species.  Only the spectrum 
of the most abundant charge state is shown.  Both forms missing Met1 and 
-N-acetylated at Ser2 and missing residues 2-5 (SETA) during electrospray ionization 
(see text) were observed.  PCAS = crude H1  
The mass spectrum of crude H1 purified from HeLa S3 cells arrested in G1 by sodium 
butyrate (A), cells arrested in late G1 by mimosine (B) and cells arrested in M phase by 
colchicine (C). 
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Figure 2.3 
 
 
FTMS Analyses of H1 Phosphorylation during the Cell Cycle  
The mass spectra of crude H1 prepared from HeLa S3 cells at selected times after release 
from double thymidine block synchronization.  The time point of release and the cell 
cycle stages it represents is labeled in the left of each spectrum.  The identities of each 
peak in the spectrum were determined by the intact mass or MS/MS analysis as described 
in the text and are labeled in the top of figure.  Molecular masses are reported for the 
neutral monoisotopic species.  Only the spectrum of the most abundant charge state is 
shown.  All forms were missing Met1 and -N-acetylated at Ser2. 
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Figure 2.4 
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Figure 2.4 (cont.) 
H1 Variant Identification and Phosphorylation Site Mapping  
(A) Crude H1 prepared from HeLa S3 cells was analyzed by Hydrophobic Interaction 
Chromatography (HIC).  PolyPROPYL A column (PolyLC), 100 x 4.6 mm, base = 3 
μm spherical silica with 1500 Ǻ diam. pores.  Buffer A: 2.5 M (NH4)2 SO4 + 50 mM 
ethylendiamine pH 7.0, Buffer B: 1.5 M (NH4) 2SO4 + 50 mM ethylendiamine pH 7.0.  
Column eluate absorbance at 214 nm is plotted for equivalent portions of each separation.  
Peaks are numbered according to elution order.  Each peak was desalted by RP-HPLC 
and recovered by Speed-Vacuum, then identified by mass spectrometry.  (B) ESI-FT 
mass spectrum (28 scans) of intact H1 purified from HIC peak 1.  Intact ions with 
charges ranging from +25 to +32 are shown.  Both intact form of 2p-H1.4 with 
N-terminal acetylation and the form losing the first 4 residues (2p-H1.4-SETA) are 
observed in most charge states.  (C) The most abundant form with +28 charge and 
losing SETA residues were selected by quadrupole and further accumulated by SWFT.  
(D) ECD spectrum of fragment ions from isolated ion species, only part of spectrum is 
shown here.  (E) ECD and IRMPD fragmentation map was generated by comparing the 
manually assigned mass value for ions in the ECD and IRMPD MS/MS spectrum with 
theoretical fragment mass value to map the phosphorylation sites.  Blue “└” represents 
Z ions from ECD, orange “└” represents Y ions from IRMPD and the circle around a 
residue represents phosphorylation in this site.  
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Figure 2.5 
 
Interphase Phosphorylation of H1 Variants is Unexpectedly Homogenous   
The mass spectra of H1 sample recovered from HIC peaks 1-5 of the 4 hour post-release 
from double thymidine block synchronization (mid-S phase).  Molecular masses are 
reported for the neutral monoisotopic species.  The sites of phosphorylation identified 
by direct MS/MS analysis are indicated.  The Ala142Thr polymorphism of H1.2 in 
peaks 4 and 5 was confirmed by genotyping (see text).  Residues 2-5 (SETA) were lost 
from all of the forms during electrospray ionization (see text).  Molecular masses are 
reported for the neutral monoisotopic species.  Only the spectrum of the most abundant 
charge state is shown in each case.  Blue “└” represents Z ions from ECD, blue “┐” 
represents C ions from ECD, and the circle around a residue represents phosphorylation 
in this residue. 
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Figure 2.6 
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Figure 2.6 (cont.) 
Identification of Phosphorylation Sites in H1 Purified by Cation Exchange 
Chromatography from Mid-S Phase Cells 
(A) Crude H1 prepared from HeLa S3 cells was separated by Synchropack CM300 
analytical (250 x 4.6 mm, 6 μm spherical silica) cation exchange column using 100 to 
300 mM NaCl gradient in 23 mM sodium phosphate pH 7.0, 8 M freshly deionized urea.  
Column eluate absorbance at 214 nm is plotted for equivalent portions of each separation.  
Peaks are numbered according to elution order. Each peak was desalted by RP-HPLC and 
recovered by Speed-Vacuum, then identified by mass spectrometry. 
(B) Intact mass of the components from IEC peaks in broadband FT-MS was used to 
infer the variants identity and phosphorylation levels.  Molecular masses are reported 
for the neutral monoisotopic species. 
(C) The sites of phosphorylation identified by direct MS/MS analysis are indicated in the 
ECD map.  Blue “└” represents Z ions from ECD, blue “┐” represents C ions from 
ECD, the circle around a residue represents phosphorylation in this site. 
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Figure 2.7 
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Figure 2.7 (cont.) 
Identification of H1 Phosphorylation Sites in M Phase 
(A) The hydrophobic interaction chromatography (HIC) profiles of crude H1 prepared 
from HeLa cells arrested in G1, asynchronously growing, and mitosis arrested (1 μM 
colchicine 20 hrs).  Column eluate absorbance at 214 nm is plotted for equivalent 
portions of each separation.  Peaks for the stationary phase and growing samples are 
numbered and identified as in Figure 2.  The peaks corresponding to 
hexaphosphorylated H1.4 (6P) and tetraphosphorylated H1.2 (4P) in the 
colchicine-arrested sample were identified by MS/MS.  The elution order of induced 
H1
0
 in HIC was demonstrated in the further analysis described later (Figure 3.1).  Black 
triangular indicates the presence of hexaphosphorylated H1.4 in the asynchronous 
sample. 
(B) Quantification of the relative abundance of unphosphorylated and phosphorylated 
H1.2 and H1.4 to total pool of H1.2 and H1.4.  Note: percentage of 1p-H1.4 and 
2p-H1.4 were slightly overestimated due to the presence of low level of H1
0
. 
(C) Intact mass of the components from HIC peaks in broadband FT-MS was used to 
infer the variants identity and phosphorylation levels.  Molecular masses are reported 
for the neutral monoisotopic species. 
(D) The sites of phosphorylation identified by direct MS/MS analysis are indicated in the 
ECD map.  Blue “└” represents Z ions from ECD, blue “┐” represents C ions from 
ECD, the circle around a residue represents phosphorylation in this residue. 
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Figure 2.8 
 
 
HIC Analyses of H1 Phosphorylation during the Cell Cycle    
(A) Crude H1 prepared from HeLa S3 cells at selected times after release from double 
thymidine block synchronization was analyzed by HIC.  Column eluate absorbance at 
214 nm is plotted for equivalent portions of each separation.  The cell cycle profile from 
flow cytometry is shown in the left and the approximate cell cycle stage determined by 
each sample is noted.  Peaks are numbered according to elution order and identified 
based on SDS gel analysis (panel B) and mass spectrometry (Figure 2.6).   
(B) SDS polyacrylamide gel analysis of HIC fractions from mid-S phase cells (4 hours 
post-release).  Lanes are identified by the peak numbers shown in (A).  The relative 
mobilities of H1.5 (peaks a), H1.4 (peaks 1-3), and H1.2 (peaks 4 & 5) are shown on the 
right.  Molecular weight standards (MW) in kilodaltons are shown on the left.  PCAS = 
crude H1 from asynchronously growing cells.   
(C) The quantification of HIC chromatography is showing the different phosphorylation 
dynamic of three phosphorylated H1 forms (pS173-H1.2, pS172-H1.4 and 
pS172+pS187-H1.4). 
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Figure 2.9 
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Figure 2.9 (cont.) 
Hierarchical Phosphorylation of S187 Is Not Required for S172 Phosphorylation in 
H1.4 but S172 Mutagenesis affects S187 Phosphorylation 
(A) Crude H1 prepared from asynchronous HeLa S3 and H1.4-S187A-flag stable cell line 
was analyzed by SDS polyacrylamide gel analysis.  Appearance of more slowly 
migrated band above the H1 doublet is the flag tagged H1.4 S187A mutation. 
(B) Expression of H1.4-S187A-flag was confirmed by blot with flag M2 antibody and 
phosphorylation levels of both endogenous H1.4 and overproduced H1 was tested by 
pTetH1. 
(C) HILIC analysis of phosphorylation levels of both endogenous H1.4 and overproduced 
H1 mutant.   
(D) Relative abundances of phosphorylated and unphosphorylated H1 to the pool of total 
endogenous H1 were quantified from HILIC chromatography.  Increase of H1-to-core 
ratio due to the overproduction is normalized for the relative abundance in H1.4-S187A 
overproduction cell line (see text).  
(E) SDS-PAGE of crude H1 purified from stable cell lines expressing different H1.4 
mutants.  H1 purified from similar amount of cells were loaded in each lane. 
(F) Mass spectrum of crude H1 prepared from H1.4-S172A-flag stable cell line.  
Substitution of S172A reduced the phosphorylation abundance of H1.4. 
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Figure 2.10 
 
 
Summary of H1 Phosphorylation Sites 
The superscript indicates the peptides detected are conserved among variants and 
underline indicates the peptides are detected from tissues, otherwise from cell lines 
(Garcia et al., 2004; Sarg et al., 2005; Wisniewski et al., 2007).  The cartoon of H1 
molecule is not drawn with the scale to its tripartite structure but just the indication of 
where the mapped sites located within the molecule.  
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Figure 2.11 
 
Alignment of Human and Mouse H1 Variants by ClustalW 
All serine and threonine are indicated as blue.  All CDK motifs (S/TPXX) are indicated 
by yellow box. The interphase phosphorylation sites we identified are indicated by red 
start (human) and red dot (mice). Global domain is indicated with black line. 
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CHAPTER 3  
H1 VARIANT EXPRESSION AND PHOSPHORYLATION 
IN DIFFERENT CELL LINES 
3.1 Introduction 
As discussed in chapter 1, there is five DNA replication-dependent, non-allelic variants 
(H1.1, H1.2, H1.3, H1.4 and H1.5), together with the DNA replication-independent 
variants (H1
0
 and H1x).  Two reports have demonstrated all five somatic H1 variants 
were expressed in mouse cells.  The first report, all five somatic variants were found in 
several mouse tissues being tested (liver, lung, spleen and thymus) whereas H1
0
 was 
present in liver and lung but not in spleen and thymus using 2D gel separation 
(SDS-PAGE and acid urea gel) (Lennox and Cohen, 1983).  The second one 
demonstrated all H1.2-H1.5 and H1
0
 were expressed in roughly equal amount with minor 
amount of H1.1 in NIH 3T3 cells using RP-HPLC separation followed by SDS-PAGE 
analysis (Talasz et al., 1993).  On the opposite hand, survey for the expression of 
variants in mRNA levels by RNase protection in several human cell lines has 
demonstrated that only H1.2 and H1.4 are expressed in all cells at a high level and no 
H1.1 mRNA was detected in most of the cell lines except testis (Meergans et al., 1997).  
Similar results have also been shown by comparing variants at protein levels using 
capillary zone electrophoresis (CZE) separation (Kratzmeier et al., 1999).  These 
observations have indicated the H1 variants expression pattern in human cells is not as 
uniform as that in mouse cells. 
 
In addition, the phosphorylation levels have also been analyzed for mouse H1 in 3T3 
cells by acid urea gel analysis of RP-HPLC purified H1 fraction (Talasz et al., 1996).  
Interestingly, the maximum phosphorylation sites achieved for H1 variants, including 
H1.1, H1.3, H1.4 H1.5 and H1
0
, in colcemid treated 3T3 cells are exactly the same as the 
number of CDK substrate motif whereas maximum phosphorylation sites for H1.2 is one 
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more than its three CDK substrate motifs (Figure 2.11).  In addition, the interphase 
phosphorylation sites mostly follow the rule of Ser-containing CDK motif as discussed in 
chapter 2, which proposed phosphorylation only occurs in the Ser-containing CDK motifs 
during interphase.  However, three exceptions have been observed: only 
monophosphorylation is observed for H1.1 which has 2 Ser-containing CDK motifs; a 
possible triphosphorylation is observed for H1.4 which possesses only 2 Ser-containing 
CDK motifs (the 3p-H1.4 might actually be 2p-H1.3) and monophosphorylation for H1
0
 
which lacks such motif (Talasz et al., 1996). 
 
We have found phosphorylation of both H1.2 and H1.4 is rather abundant in HeLa 
(~30%).  However, the stable cell line carrying H1.4-S172A mutation generated from 
HeLa S3 cells can survive with extreme low abundance of phosphorylation, which 
suggests this abundant phosphorylation might be just the result of abnormal high level of 
kinase activity in the HeLa cells (Contreras et al., 2003) and might not necessary for cell 
survival.  In this chapter, I will describe our efforts to answer this question by expanding 
our analysis to different cell lines. 
 
3.2 H1 Variant Expression and Phosphorylation in Different Cell Lines  
As shown in Figure 3.1, three H1 variants, major forms of H1.2 and H1.4 and minor 
forms of H1.3, were observed from the crude H1 in asynchronous human fibroblasts, 
VA13 transformed WI-38 cells.  Similar to the results described in chapter 2, most ion 
species lost the first four residues (-SETA).  Three interesting results have been 
observed from TDMS analysis.  First, the number of phosphorylation in H1.4 achieved 
in asynchronous WI-38 VA13 is three instead two in HeLa S3 cells as indicated by 
triphosphorylated H1.4 in the broadband spectra (Figure 3.1 A); second, abundances of 
phosphorylation in both H1.2 and H1.4 were slightly higher than those in HeLa S3.  
Third and most unexpectedly, no apparent phosphorylation was observed in the 
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broadband spectra for H1.3 (the mass for several small peaks indicated by the question 
marks does not match to H1.3 with phosphorylation or the combination of modifications).  
Moreover, the relative abundant phosphorylation in H1.2/H1.4 and the underdetectable 
phosphorylation in H1.3 were confirmed by HIC (Figure 3.2).  For colon 
adenocarcinoma HT-29 cells, three H1 variants, H1.2, H1.4 and H1.5 with very low 
abundances of phosphorylation were observed.  In addition, the polymorphism of H1.2 
identified in HeLa S3 is not seen in WI-38 VA13 and HT-29.  These data indicates both 
the expression and phosphorylation levels of H1 variants vary in different cell lines.  
However, differences in the efficiency of electrospray ionization between non-allelic H1 
variants complicates the quantification of distinct forms of one variant relative to 
mixtures containing multiple variants, i.e. total H1 (Pesavento et al., 2006).  To 
circumvent this problem, we decide to use the HIC chromatography reported in chapter 2 
for better comparison. 
 
The identify of major peaks for total H1 from HeLa S3 cells has been determined by 
TDMS and gel analysis as described in chapter 1 and labeled in the top of Figure 3.2 A.  
The identity of each peak in the HIC chromatograph from the new cell lines was 
determined by aligning them with the HIC from HeLa S3 cells.  The identity of the new 
cluster of peaks eluted later than H1.2, which was not present in HeLa S3 and thus was 
not identified by TDMS so far, was deduced as H1.3 from the commercial available H1 
variant specific antibody (Figure 3.2 C).  In addition, the SDS-PAGE analysis of peaks 
recovered from HIC of WI-38 VA13 cells clearly demonstrated which variants is present 
in the peak by gel mobility difference (H1.5/H1.4 slowest with H1.5 slightly slower than 
H1.4, H1.2 fastest, H1.3 in the between of H1.2 and H1.4, H1
0
 faster than H1.2), which 
confirms the determination of identity of peaks in new cells line by aligning with those 
have been identified.  One small unsatisfactory fact for HIC is the overlapping of H1
0
 
with H1.5, which limits its ability to measure the amount of H1.5 correctly. 
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Several interesting patterns can be observed from this comparison: (1) H1.2 and H1.4 are 
the only two variants that expressed in all 6 cell lines and with roughly equaled 
expression levels except HepG2 in which expression of H1.4 is twice as much as H1.2 (2) 
H1.5 is not expressed or expressed in low abundance except in neuroblastoma cell line 
IMR32; (3) H1.3 is not expressed or only expressed as minor form (all <15% of total) 
and phosphorylation abundance is very low in this variant; (4) the relative abundances of 
phosphorylation vary quite a lot for different cell lines, the abundances of 
phosphorylation in two hematopoietic cell lines (HL-60 and U937) is surprisingly low 
whereas the abundance of monophosphorylated H1.2 in HepG2 is even higher than 
unphosphorylated H1.2.  The extreme low abundances of phosphorylation in 
hematopoietic cell lines suggest either H1 phosphorylation is not necessary for these cells 
or the function of this modification can be substituted by other modification.  
Interestingly, H4-K16 acetylation is substantially higher in hematopoietic cells 
(Pesavento et al., 2008b), which might substitute the roles of H1 phosphorylation in 
opening chromatin.  In addition, it is highly impossible that histone H1 kinase, CDK2, is 
inactive in hematopoietic cells since CDK2 is an essential kinase in dividing cells.  Thus, 
the extreme low abundances of phosphorylation in H1 imply that phosphorylation of H1 
is a highly regulated process and therefore H1 phosphorylation is not dispensable and 
simply the byproduct of CDK2 kinase activity.  
 
As mentioned in introduction, Doenecke group has surveyed H1 variants expression 
pattern for several human cell lines using capillary zone electrophoresis (CZE) 
(Kratzmeier et al., 1999).  The expression levels of H1 variants in HeLa were reported 
as 48%, 6%, 26%, 17% and 3% for H1.2, H1.3, H1.4, H1.5 and H1
0
, respectively.  
Comparing this expression pattern with our HIC result from HeLa S3 culture, it seems 
the disappearing of H1.3 and significant decrease of H1.5 are compensated by the 
increase of H1.4 in the HeLa S3 suspension culture.  In fact, the similar expression 
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pattern difference between HeLa and the suspension adapted S3 has been documented 
before (Meergans et al., 1997).  However, expression pattern do not switch back when 
HeLa S3 cells was grown as attached instead of in suspension (Meergans et al., 1997) and 
thus such change of variants expression pattern might be the result of selection during 
suspension adaption.  
 
Doenecke group has also reported that the expression level of H1.5 in HL-60 and U937 is 
high whilst H1.3 is low (Kratzmeier et al., 1999), which is quite opposite with what we 
found in HIC.  To exclude the possibility of misalignment of H1 variants in the HIC, we 
analyzed H1 variants composition in different cell lines by immunoblot, gel 
electrophoresis and RP-HPLC.  First, western blot with H1.5-specific antibody, which 
was able to detect fairly low abundant H1.5 from HeLa (5%), indicated H1.5 expression 
in HL-60 is way below 5%.  Second, intermediate format gel, which was longer than 
mini-gel and thus separated H1 variants better, was used to show the expression of H1.3 
in HL-60.  Moreover, H1.3 was visible as the middle band appearing between H1.2 and 
H1.4 in both IMR-32 and HL-60 cells (Figure 3.3 A).  RP-HPLC has been used to 
separate H1.5 from other H1 variants by several groups (Kratzmeier et al., 2000; Sarg et 
al., 2005).  The peaks in RP-HPLC were collected and recovered for subsequent 
analysis by SDS-PAGE.  Based on the gel mobility, three resolved RP-HPLC peaks for 
H1 from WI-38 VA13 were identified as H1
0
, H1.5 and H1.2/H1.3/H1.3.  When 
RP-HPLC chromatography from different cell lines were aligned together, it clearly 
demonstrated there was no detectable peak in the elution position of H1.5 in both HL-60 
and U937 (Figure 3.3 B), which suggest the expression level of H1.5 was very low in this 
two cell lines.  Taken together, these analyses using alternative techniques have 
corroborated our conclusion drawn from HIC.  The variants composition and extents of 
phosphorylation in different cell lines with varied analysis techniques have been 
summarized in Table 3.1.  
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3.3 Resolving Phosphorylated H1 Variants by HILIC 
Although the condition we developed for HIC has successfully resolve all five H1 
somatic variants and their phosphorylation forms, we were not satisfied with the fact they 
elute in broad peaks.  How broad peak shape affecting the resolution was very obvious 
in the HepG2 separation, where it was impossible to determine whether 0p-H1.4 or 
1p-H1.4 was the major form of H1.4 (Figure 3.2).  Therefore we tried to improve the 
peak shape by changing pH, solvent or column, but noting worked so far (Appendix 6.2).  
Since the tertiary structure also affects HIC, it is likely that H1 is conformationally labile 
and tends to elute in a broad peak.  Therefore such broad peak is the characteristic of H1 
itself and thus it might be futile to try to improve it.  
 
Mizzen and Lindner have developed Hydrophilic Interaction Liquid Chromatograph 
(HILIC) to separate H1 variants (Mizzen et al., 2000) or phosphorylation forms from a 
single H1 variant (Lindner et al., 1997).  Ionization of the polyCAT A (weak 
cation-exchange column) support is suppressed under high percentage of acetonitrile, 
thus the hydrophilic interaction between the stationary phase and tails of histone becomes 
dominant.  Since the heterogeneity due to both non-allelic amino acid sequence 
variation and to phosphorylation mostly lies within the tails, this technique should be a 
good choice for H1 separation.  For the purpose of comparing variants expression and 
phosphorylation levels in different samples, it is very important to be able to separate 
total H1 in one single chromatography.  For this reason, we analyzed total H1 from 
HeLa cells directly by HILIC, instead of resolve non-allelic H1 variants irrespective of 
modification by RP-HPLC first and then separate phosphorylated forms for each variant 
fraction individually by HILIC (Lindner et al., 1996).  Total of 6 peaks were resolved in 
HILIC for H1 samples from asynchronous growing or double thymidine release at 4 hrs 
and 14 hrs (Figure 3.4 A).  The identity of HILIC peak 1~3 for mid S phase sample 
(post release 4 h) were identified by TDMS as unphosphorylated H1.2, 
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monophosphorylated H1.2 at S173 and unphosphorylated H1.4 respectively using the 
procedure described in chapter 2 (Figure 3.4 B, C).  Our previous HIC study has clearly 
demonstrated that abundance of 2p-H1.4 decreases faster than 1p-H1.4 when cells enter 
next G1 (Figure 2.8 A, C).  According to this finding, the peak 4 and 5 in HILIC was 
inferred as 1p-H1.4 and 2p-H1.4 since abundance of peak 5 decrease faster than peak 4 
when comparing post release 14 h (G1) sample with post release 4 h (mid S) sample.  
The last peak was inferred as H1.5 since the relative abundance of this peak to total H1 
match the observation from HIC study.  In addition, all the peaks were further confirmed 
by their mobility on SDS-PAGE and by their reactions with phosphor-specific antibody in 
western blot (data not shown).   
 
3.4 Major and Rare Forms of Hyperphosphorylated H1.4 
The mass spectrum analyses of tryptic H1 peptide using the bottom up approach have 
identified as much as 9 phosphorylation sites in H1.4 (Figure 2.10) (Garcia et al., 2004; 
Wisniewski et al., 2007).  It is reasonable to believe some of these sites identified in 
bottom-up were rare and thus below our detection limit.  Our lab has successfully use 
chromatograph to enrich the rare forms of histones for the analyzing by TDMS 
(Pesavento et al., 2008a).  However, HIC does not suit well for this purpose since the 
condition we used to resolve H1 caused significant change in baseline (Appendix 6.2), 
which affect our ability to detect low abundant protein. 
 
With the HILIC separation condition established for crude H1 from HeLa, we decided to 
pursuit the rare form of H1.4 having more than 6 phosphorylation sites.  The HILIC 
chromatograph of crude H1 purified from colchicine arrest HeLa S3 cells was shown in 
Figure 3.5.  Based on the peak assignment analysis we described in section 3.3 and the 
fact that 4p-H1.2 and 6p-H1.4 was accounting near ~80% of total H1 in the HIC analysis, 
we can infer the first major peak appearing in the HILIC is 4p-H1.2 while the second is 
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6p-H1.4.  The peak appearing at the beginning of HILIC was due to the overlapping of 
0p-H1.2 with some other components which have been carried to this place with starting 
gradient set too high for this separation.  However, there was no obvious peak after 
6p-H1.4 looking like a valid candidate for H1.4 having more than 6 phosphorylation 
sites. 
 
To test the possibility that the rare form of H1.4 having more than 6 phosphorylation sites 
might accumulated after prometaphase, we set up a procedure to enrich cells after 
prometaphase.  In order to decrease the adverse effect of long exposure to tubulin drug, 
cells were first synchronized at G2 by releasing 8 h from double thymidine block, and 
then treated with 0.5 μg/ml of nocodazole for 4.5 hr before they were released to fresh 
medium to allow the progress of the mitosis for 30 min (TdR-Noc 30 min).  When such 
sample was analyzed by HILIC (Figure 3.5), a tiny peak, which represented roughly 3% 
of total H1, was appeared after 6p-H1.4 (peak 6).  We then used TDMS to analyze all 
the peaks from TdR-Noc 30 min sample, the phosphorylation levels was determined from 
the intact molecule mass in the broadband spectra but no sites were further mapped by 
MS/MS.  Series of intermediate phosphorylation forms were identified.  As we have 
discussed in the chapter 2, it was not easy to determine such intermediate 
phosphorylation forms were just the degradation products during sample handling or the 
real existing forms in the cells.  However, the existence of 7p-H1.4 is clearly 
demonstrated by the TDMS broadband spectra with +560 Da mass.  Since the main ion 
species for this study were all lost first residues, such 7
th
 site was very likely to be S37, 
which was the only left candidate in H1.4 (not counting the first five residues) for 
phosphorylation sites mapped in cell lines (Figure 2.11).  In addition, the elution 
distance between 6p-H1.4 and peak 6 is clearly larger than one phosphorylation can cause 
(Figure 3.5) as evidence by smaller distance between peak 5 (4p-H1.4) and 6p-H1.4.  It 
suggests this rare hyperphosphorylated form of H1.4 is very likely phosphorylated in all 
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the 9 sites that have been mapped by bottom-up approach.  Taken together, the major 
form of hyperphosphorylated H1.4 in the M phase is hexaphosphorylated whilst approx 
1% of H1.4 can achieve even higher phosphorylation levels, which is very likely to be 
nonaphosphorylated.   
 
3.5 H1 Variant Expression and Phosphorylation in Mouse 3T3 Cells  
As discussed in the introduction, the previous report has indicated the H1 variants except 
H1.1 in the mouse 3T3 fibroblast are expressed in a roughly equal fashion.  We felt 
there might be some advantages to use this cells line as the model to study H1 
phosphorylation, thus we decided to analyze H1 from this cell line. 
 
As shown in Figure 3.6, 15 peaks were resolved in HILIC for crude H1 purified from 
asynchronous growing 3T3 cells.  These peaks were recovered by TCA precipitation and 
analyzed by both SDS-PAGE and TDMS.  Peak 4 was very likely a HMG protein by the 
gel mobility and thus excluded from TDMS analysis.  Based on the intact mass 
measured in the broadband spectra, identity for all other peaks except peak 5~7 were 
determined.  H1.3 and H1.5 was not resolved in HILIC, but they are expressed at similar 
level as indicted by FTMS spectrum in the inset.   Combining the HILIC and TDMS, 
our data indicated the expression levels for all H1 variant except H1.1 in the 3T3 were 
similar, which agrees with previous finding (Talasz et al., 1993).  For the 
phosphorylation levels, H1.2 only gets monophosphorylation while H1.3, H1.4 and H1.5 
all get both mono- and diphosphorylation.  Thus, our results showed the number of 
phosphorylation sites in H1.2, H1.3 and H1.4 variants from 3T3 is the same as the 
number of Ser-containing CDK motif.  For H1.5, two monophosphorylated forms were 
observed in HILIC (peak 10 and peak 11) but only one diphosphorylated form was 
observed, which agrees with the recent report (Sarg et al., 2005).  The triphosphorylated 
H1.5 reported in 3T3 by AU gel in the previous report might represent a very low 
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abundant form.  When the relative abundance of 3p-H1.5 in CCRF-CEM analyzed by 
HILIC in a recent paper was quantified, it turned out only account for approx. 5% of total 
H1.5.  To detect such low abundant forms of H1.5 in HILIC will require purified H1.5 
first to eliminate the interference from other protein which might coelute in the same 
place as 3p-H1.5. 
 
When crude H1 purified from contact inhibited culture of 3T3 was analyzed in HILIC, 
the peaks representing the phosphorylation forms were mostly disappeared with little of 
monophosphorylated H1 left but no diphosphorylated H1 at all.  This observation of the 
lost of H1 phosphorylation was also confirmed by the western blot using pS187-H1.4 
antibody (described in chapter 4). 
 
3.6 Disruption of Three H1 Variants in Mouse ES Cells Does Not Affect 
Phosphorylation of the Remaining H1 or Core Histone Modifications  
Skoultchi Lab has taken great efforts to generate mouse embryonic stem cells null for 
three H1 genes (H1.2, H1.3 and H1.4) (Fan et al., 2005).  The characterization of this 
H1 triple knockout ES cells (3KO-H1 ES) revealed a 50% reduction of H1 expression 
level comparing to the normal ES cells (WT ES) and dramatic chromatin structure 
changes, including decreased global nucleosome spacing and reduced local chromatin 
compaction (Fan et al., 2005). 
 
We were very interested in how the phosphorylation in histone H1 and some 
modifications in core histones might change in the 3KO-H1 ES cells.  Total H1 purified 
from WT ES and 3KO-H1 ES were separated in HILIC and some of the peaks were 
further analyzed by TDMS.  As shown in Figure 3.7 A, H1.5 and H1.3 were resolved in 
HILIC when a new column was used, indicating the lost of resolution for H1.5 and H1.3 
seen in 3T3 separation (Figure 3.6) was due to column deterioration.  We identified two 
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monophosphorylated forms of H1.5 (peak 8 & 9 in WT ES and peak 6 & 7 in 3KO-H1) 
and localized the phosphorylation in first eluted form to S18 for H1.5 by MS/MS study 
(peak 8 in WT and peak 6 in 3KO).  In addition, the first eluted 1p-H1.5 is more 
abundant than second eluted 1p-H1.5, which was consistence with previous report (Sarg 
et al., 2005).  Very likely, the second eluted 1p-H1.5 was phosphorylated at S173 
according to previous mapping result (Sarg et al., 2005).  Then the relative abundance of 
phosphorylated and unphosphorylated H1 variants was quantified from HILIC for wild 
type and 3KO-H1 and the number for 3KO-H1 was corrected for the 50% decrease of H1 
stoichiometry.  The relative abundance of both H1.1 and H1.5 increase but the 
percentage of phosphorylated H1.5 remains the same while some small increase was seen 
for H1.1 (Figure 3.7 C).  Similar to the effects on remaining H1 by triple knockout, no 
change in core histone modification was observed (Figure 3.8 A). 
 
To confirm the HILIC result, we compare the phosphorylation levels between WT and 
3KO-H1 using pTeH1, the antibody raised against highly phosphorylated Tetrahymena 
H1 (Lu et al., 1994).  Surprisingly, this antibody failed to detect any phosphorylation 
from 3KO-H1 (Figure 3.8 B).  To reconcile the difference, we analyzed the H1 purified 
from WT and 3KO-H1 ES cells by acid-urea PAGE.  The results (Figure 3.8C) clearly 
demonstrated that the remaining H1 in the 3KO-H1 can be phosphorylated to the same 
extent as WT ES when arrested in mitosis by colchicine treatment.  Interestingly, the 
maximum phosphorylation levels in mouse were five instead of six in human, which can 
be explained by lacking the S27 (RKS motif) in mouse H1.4 is (Figure 2.11).  The 
reason that pTetH1 failed to see the phosphorylation form in 3KO-H1 is that the 
crossreactivity of this antibody with mammalian H1 is limited (one of the recognition 
sites for pTetH1 was pS172-H1.4., described in chapter 4).  Therefore, some cautions 
should be applied for this widely used phospho-specific H1 antibody.   
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3.7 Conclusions and Discussions 
I have made some surveys for H1 variants expression and phosphorylation levels 
(including how many phosphorylation forms existed and the abundance of these 
phosphorylation forms) for several cell lines and cells with overexpression or deletion of 
H1.  Several interesting observations have been found: (1) Variants expression differs 
among human cell lines but H1.2 and H1.4 are the two variants expressed at relative high 
levels for all human cell lines tested; H1.1 is not detected in human cell lines but present 
in both mouse 3T3 and ES cells (Table 3.1).  (2) The number of phosphorylation sites 
one H1 variant can obtain during interphase is usually the same as the number of the 
Ser-containing CDK motifs in that variant with only one exception observed, which is the 
3p-H1.4 observed in the TDMS broadband spectrum of asynchronous WI-38 VA13 
PCAS.  (3) The number of phosphorylation sites one H1 variant can attain as a major 
form in mitosis is usually the same as the number of the CDK motifs (including both Ser 
and Thr) in that variant.  The one exception for this rule is the S27 in H1.4 which posses 
RKS motif resembling that of aurora kinase substrate.  For the rare form of 
hyperphosphorylated H1.4, as much as 9 phosphorylations can be achieved but the 
abundance is as low as 1% of total H1.4.  (4) The relative abundant overall 
phosphorylation is not observed for all cell lines; some cell lines such as HL-60, U937 
and HT-29 have relative low phosphorylation (Table 3.1).  Importantly, it does not 
suggest H1 phosphorylation is nonessential since H1 kinase in these cell lines is still 
active and the fact that H1 phosphorylation is maintained at low levels actually indicate 
H1 phosphorylation is highly regulated.   One of intriguing possibility is another 
histone modification can substitute roles played by H1 and acK16-H4 might be such 
candidate since it is abundant in peripheral lymphocyte (Pesavento et al., 2008b) where 
H1 phosphorylation is particularly low.  Actually, it has been reported that no 
phosphorylated H1 is present in the chromatin containing acetylated H4 (Ryan, 1999).  
We speculate that only one histone modification that marks the open chromatin 
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conformation is required as the mechanism underlying this mutually exclusive presence 
of H1 phosphorylation with H4 acetylation.  (5) Abundances of phosphorylation in 
different H1 variants differ significantly in human cells but much less so in mouse 
(H1.2-H1.5).  Especially all the H1.3 has extremely low or no phosphorylation in all the 
human cell lines tested.  (6) Abundances of phosphorylation in overexpressed 
H1.4-S183A mutant protein is relative high while H1.4-S173A is extremely low.  
Intriguingly, both H1.3 and H1.4-S173A proteins share a same feature that they have the 
hindmost CDK substrate motif (S189 of H1.3 and S187 of H1.4) but lack the motif in the 
second most C-terminal position (S174 of H1.3 and S173 of H1.4-S173A) (Figure 2.11).  
This feature suggests the phosphorylatability of one CDK substrate motif in H1 variants 
is influenced by the sequence in the nearby site.  Such low abundant phosphorylation of 
H1.3 is not observed in mouse since the feature describe here is not conserved in any 
mouse H1 variant.  On the contrary, such crosstalk is not vice versa.  Losing the 
hindmost CDK substrate motif while still having the second most such site, as the 
example in H1.2 (S173PKK, S187AAK) and H1.4-S187A, has no effect in the 
phosphorylatability of second most C-terminal site.   
 
To explain low levels of phosphorylation in H1.3 or other H1 in hematopoietic cells in 
the presence of CDK2, we propose that H1 can only be phosphorylated when it is bound 
in the chromatin and H1 kinase (CDK2 or other kinase) is targeted to the chromatin.  
When H1 disassociates from chromatin, it is quickly dephosphorylated.  The 
dephosphorylation has been supported by the observation of increase of H1 
phosphorylation when cells were treated with phosphatase inhibitor okadaic acid (Ryan, 
1999).  However, this model still can not explain the low level phosphorylation of H1.3.  
Human H1.3 binds chromatin with intermediate affinity among H1 variants, binding loser 
than H1.4 and H1.5 which have two SPXK motif in the C-terminus but slightly stronger 
than H1.2 (Th'ng et al., 2005) (multiple reports have demonstrated different binding 
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affinity for H1 variants, this is the only test involved the human H1.3).  Taking the 
account of the important roles of SPXK motif in DNA binding (Suzuki, 1989), we 
speculate the conformation caused by the SPXK in the position ~50 amino acid away 
from the C-terminal is critical for H1 to receive phosphorylation.  However, why human 
cells need a H1 variant that unphosphorylatable in the interphase requires further 
investigation to reveal.    
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3.9 Tables and Figures 
Table 3.1 
Summary of H1 Variant Expression and Phosphorylation 
in Different Cell Lines 
 
% of 
phos 
 H1.1 H1.2 H1.3 H1.4 H1.5 H10 
h
u
m
a
n
 high 
HeLa S3 a,b,c,d,e - +++ - +++ + + 
WI-38 VA13 a,b,c,d - +++ ++ +++ + ++ 
IMR32 b,c,d - +++ ++ +++ +++ + 
HepG2 b - +++ - +++ + + 
low 
HL-60 b,c,d - ++ + ++ - - 
U937 b,c,d - ++ + ++ - - 
HT-29 a - ++ - ++ ++ - 
m
o
u
s
e
 
high 
NIH 3T3a, c, e + ++ ++ ++ ++ + 
ES cell a, c, e + ++ ++ ++ ++ - 
3KO-H1 ES a, c, e + - - - ++ + 
 
a TDMS, b HIC, c SDS-PAGE, d RP-HPLC, e HILIC 
- below detection level, + low expression level, ++ medium expression level, +++ 
high expression level. 
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Figure 3.1 
 
Comparison of H1 Variant Expression and Phosphorylation in Different Cell Lines 
by FTMS  
(A) The mass spectrum of crude H1 purified from asynchronously growing WI-38 VA13 
cells.  Residues 2-5 (SETA) were lost from majority of forms during electrospray 
ionization (see text) but missing Met1 and -N-acetylated at Ser2 were still present in 
minor forms of H1.2, H1.4 and H1.5.  Abundances of phosphorylation for H1.2 and 
H1.4 were slightly higher to H1 in HeLa and triphosphorylated H1.4 was also observed.  
No phosphorylation was seen for H1.3.  Peaks noted with “▲” had charge from +16 to 
+17 and were not H1 since mass was lower than any H1 variant. 
(B) The mass spectrum of crude H1 purified from asynchronously growing HT-29 cells.  
Both forms missing Met1 and -N-acetylated at Ser2 and missing residues 2-5 (SETA) 
during electrospray ionization (see text) were observed.  Percentages of phosphorylation 
for H1.2, H1.4 and H1.5 were relative low compared with H1 in HeLa.  Additional 
N-terminal fragmented ions, i.e. H1.4-SETAPAA and H1.3-SETAPLA were also 
observed. 
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Figure 3.2 
 
Comparison of H1 Variant Expression and Phosphorylation in Different Cell Lines 
by HIC 
(A) Crude H1 prepared from different cell lines was analyzed by Hydrophobic Interaction 
Chromatography (HIC).  PolyPROPYL A column (PolyLC), 100 x 4.6 mm, base = 3 
μm spherical silica with 1500 Ǻ diam. Pores, gradient from 2.5 M to 1.5 M (NH4)2SO4 in 
50 mM ethylendiamine pH7.0, flow rate of 0.8 ml/min.  The identity of each peak is 
noted on the top. 
(B) Western blot of crude H1 from different cell lines by H1 variants specific antibody 
from abcam (H1.1: ab17584, H1.3: ab24174, H1.5: ab24175). 
(C) SDS polyacrylamide gel analysis of HIC fractions of H1 from WI-38 VA13 cells. 
(D) Abundances of phosphorylation relative to total H1 were quantified by peak area 
integration in chromatograph from HIC. 
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Figure 3.3 
 
 
Comparison of H1 Variant Expression in Different Cell Lines by RP-HPLC 
(A) SDS polyacrylamide intermediate gel analysis of crude H1 prepared from different 
cell lines.  The relative motilities of H1 variants are shown on the left.  
(B) RP-HPLC separation of crude H1 prepared from different cell lines.  Vydac 250 x 
4.6 mm, C8, flow rate of 0.8 ml/min.  Buffer A: 5% ACN, 0.1% TFA, Buffer B: 90% 
ACN, 0.094% TFA.  SDS polyacrylamide gel analysis of recovered peaks or fractions 
of RP-HPLC is shown on the right.  PCAS = crude H1 from asynchronously growing 
cells.   
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Figure 3.4 
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Figure 3.4 (cont.) 
Identification of Phosphorylation Sites in H1 Purified by HILIC from Mid S HeLa 
Cells  
(A) Crude H1 prepared from HeLa S3 cells was analyzed by Hydrophilic Interacting 
Liquid Chromatography (HILIC) using polyCAT A 100x4.6 mm, 3μm, 1500Ǻ.  Buffer 
A: 65% ACN, 20 mM TEA, pH 3.0; Buffer B: 60% ACN, 20 mM TEA, 0.5M NaClO4, 
pH 3.0.  Peaks are numbered according to elution order.  Each peak was desalted by 
TCA precipitation and identified by mass spectrometry. 
(B) Intact mass of the components from HILIC peaks in broadband FT-MS was used to 
deduce the variants identity and phosphorylation levels.  Molecular masses are reported 
for the neutral monoisotopic species. 
(C) The sites of phosphorylation identified by direct MS/MS analysis are indicated in the 
ECD map.  Blue “└” represents Z ions from ECD, blue “┐” represents C ions from 
ECD, the circle around a residue represents phosphorylation in this site. 
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Figure 3.5 
 
Evidence for a Rare Form of Hyperphosphorylated H1.4 in HeLa Cells  
(A) HILIC separation of crude H1 prepared colchicine treated or 30 min release from 
nocodazole treated HeLa S3 cells.  To shorten the treatment time course, 0.5 μg/ml of 
nocodazole were added to cells released 8 hrs from double thymidine synchronization, 
after 4.5 hr treatment cells were released to fresh medium to allow the progress of the 
mitosis for 30 min (TdR-Noc 30 min).  All the peaks in TdR-Noc 30 min were analyzed 
by TDMS and their identity were determined by intact mass.  “▼” noted that mass 
spectrum quality was too bad to determine the identity of the peak. 
(B) Broadband mass spectra for the indicated peaks from TdR-Noc 30 min.  The main 
ion species were H1.4-SETA with +31 or +30 charge.  The phosphorylation levels in 
H1.4 were determined by the fold increase of 80 Da in molecule mass. 
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Figure 3.6 
 
HILIC Analyses of H1 Variant Expression and Phosphorylation in 3T3 Cells    
(A) Crude H1 prepared from asynchronous NIH 3T3 cells was analyzed by Hydrophilic 
Interacting Liquid Chromatography (HILIC) using polyCAT A.  Peaks were numbered 
according to elution order.  Each Peak was desalted by TCA precipitation and analyzed 
by SDS-PAGE and TDMS (panel C).   
(B) Peaks numbered in (A) were desalted and analyzed by SDS polyacrylamide gel 
analysis.  
(C) Intact mass of the components from HILIC peaks in broadband FT-MS was used to 
infer the variants identity and phosphorylation levels.  Molecular masses are reported 
for the neutral monoisotopic species. 
(D) HILIC result of crude H1 prepared from contact-inhibited 3T3 cells and the 
phosphorylation levels in H1.4 was tested by western blot using pS187-H1.4 antibody.  
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Figure 3.7 
 
Phosphorylation of the Remaining H1 Variants is Unaltered in H1.2/H1.3/H1.4 
Triple Knockout ES Cells  
(A, B) Crude H1 prepared from asynchronous wild type mouse ES (WT ES) cells (A) or 
asynchronous H1.2/H1.3/H1.4 triple knockout ES Cells cells (3KO-H1 ES) (B) were 
analyzed by Hydrophilic Interacting Liquid Chromatography (HILIC).  Peaks are 
numbered according to elution order and the identification was based on mass 
spectrometry analysis.  The number of C and Z ions identified was listed for MS/MS 
analysis; otherwise the intact mass was used to identify the variant and the modifications. 
(C) Relative abundance of phosphorylated and unphosphorylated H1 variants quantified 
from HILIC for wild type vs. 3KO-H1.  The number for 3KO-H1 was corrected for the 
50% decrease of H1 stoichiometry (Fan et al., 2005). 
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Figure 3.8 
 
Disruption of Three H1 Variants in Mouse ES Cells Does Not Affect 
Phosphorylation of the Remaining H1 or Core Histone Modifications  
A panel of core histone modification antibodies was used to test the PTMs levels in WT 
ES vs. 3KO-H1 ES.  Recombinant H3 and H4 (rH3+rH4) were used as negative control.  
Even loading was indicated by ponceau S staining.   
(A) pTetH1 antibody was used to monitor the phosphorylation levels in H1. 
(B) Acid-Urea PAGE was used to analyze the phosphorylation levels of H1 from WT ES 
vs. 3KO-H1 ES. 
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CHAPTER 4 * 
NUCLEAR AND NUCLEOLAR H1 PHOSPHORYLATION 
ASSOCIATED WITH TRANSCRIPTION 
*: Some material was adapted from manuscript: 
Histone H1 Phosphorylation is Associated with Transcription by RNA Polymerases I and II 
Yupeng Zheng, Sam John, James J. Pesavento, Jennifer R. Schultz-Norton, R. Louis Schiltz, Sonjoon Baek, 
Ann M. Nardulli, Gordon L. Hager, Neil L. Kelleher and Craig A. Mizzen 
 
4.1 Introduction 
As discussed in the chapter 1, antibodies have been proven to be an invaluable tool for 
histone post-translational modifications study, especially in the immunofluorescence (IF) 
and Chromatin immunoprecipitation (ChIP) study.  However lacking the phospho- and 
site-specific H1 antibodies has become a great obstacle for H1 phosphorylation research, 
thus we decided to generate these important reagents by ourselves and apply them to IF 
(chapter 4) and ChIP (chapter 5) study. 
 
4.2 Generation and Characterization of H1 Phosphorylation Site-Specific Antibodies  
We used synthetic phosphopeptides coupled to keyhole limpet hemocyanin to generate 
antisera specific for pS173-H1.2 and pS187-H1.4, the two most abundant interphase 
phosphorylations in HeLa S3 cells.  We also generated antisera against the pS27-H1.4 
and pT154-H1.4 M sites.  The specificity of these antisera was characterized by 
immunoblotting, ELISA and immunocytochemical assays.  Commercially available 
antiserum for human pT146-H1.4 and control antisera we generated against unmodified 
recombinant human H1.4 were also employed. 
 
Synthetic peptide antigens were designed as shown in Figure 4.1 A.  Amino acid 
sequence substitutions within individual H1 variants enabled antisera to be generated 
which recognize a single site of phosphorylation identical to the respective antigen 
peptide in just one variant (pS27-H1.4, pT146-H1.4, pS187-H1.4), or at a single site that 
is completely conserved in just two variants (pT154-H1.2/H1.4 and pS173-H1.2/H1.5).  
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Immunoblots revealed that the pS27 antisera recognized H1.4 from colchicine-treated 
cells but not mid-S phase cells (Figure 4.1 B, lanes 1 and 2), confirming our TDMS 
evidence that H1.4-S27 is phosphorylated exclusively during mitosis.  Similarly, H1.4 
from colchicine-treated cells, but not mid-S phase cells, was detected by the pT146-H1.4 
antisera (Figure 4.1 B, lanes 3 and 4).  This is consistent with previous 
immunocytochemical analyses suggesting that phosphorylation at H1.4-T146 is 
mitosis-specific (Sarg et al., 2005).  The analogous Thr is present in H1.2 and H1.3, but 
absent from H1.1 and H1.5 (Figure 4.1 A, Figure 2.11).  However, it is unlikely that any 
of the signal in lane 4 (Figure 4.1 B) is attributable to H1.2/H1.3 phosphorylated at this 
site since the band aligns with H1.4 rather than H1.2 (i.e. the upper band of the major H1 
doublet), and since H1.3 is not expressed appreciably in HeLa S3 cells (chapter 2).  
Moreover, the corresponding epitopes of H1.2 and H1.3 each contain an amino acid 
substitution expected to diminish antibody binding (Figure 4.1 A).  Mitosis-specific 
phosphorylation was also observed for the pT154 antiserum, raised against a motif that is 
completely conserved between the H1.2 and H1.4 variants.  This antiserum detected 
H1.2 and H1.4 in samples from colchicine-treated cells but not mid-S phase cells (Figure 
4.1 B, lanes 5 and 6).  The signals in lane 6 appear to represent T154 phosphorylation 
primarily in H1.2 and H1.4 since the antiserum failed to recognize H1.5 (a minor species 
immediately above H1.4), and since the corresponding motifs in H1.1, H1.3 and H1.5 
each contain one or more substitutions (Figure 4.1 A). 
 
In contrast, the antisera to pS173-H1.2/H1.5 and pS187-H1.4 recognized H1 from both 
mid-S phase and colchicine-treated cells in immunoblots.  The pS173 antiserum 
detected a major band aligning with H1.2, and a minor band aligning with H1.5, in both 
types of samples (Figure 4.1 C, lanes 3 and 4).  We presume the latter represents 
phosphorylation at H1.5-S173 since the phosphopeptide epitope is completely conserved 
between H1.2 and H1.5, and signals for pS173-H1.5 are expected to be weaker than that 
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observed for pS173-H1.2 since H1.5 is much less abundant than H1.2 in HeLa S3 cells 
(chapter 2).  The pS187 antisera recognized a single band aligning with H1.4 in both 
types of samples (lanes 7 and 8).  Consistent with ELISA assays performed to assess 
antisera specificity (Figure 4.2), the signals detected by the pS173 and pS187 antisera are 
phosphorylation-dependent and specific for the respective sites.  Neither antisera 
recognized purified fractions of non-phosphorylated H1.2/H1.4 (lanes 1, 2, 5 and 6), the 
pS187 antisera did not cross-react with H1.2, and the pS173 antisera did not cross-react 
with H1.4 (compare lanes 3, 4, 7 and 8).  Moreover, little cross-reactivity with 
nonhistone proteins was observed for these antisera: a single band corresponding to H1.4 
was observed when 2 % SDS extracts of asynchronous or colchicine-treated cells were 
immunoblotted with the pS187 antisera (Figure 4.1 G, lanes 1, 2, 4 & 5). 
 
We attempted to raise control antisera that would recognize all H1 variants regardless of 
phosphorylation.  Recombinant human H1.4 (rH1.4) expressed in bacteria was used as 
antigen.  The corresponding antisera recognized rH1.4 and HPLC-purified fractions of 
HeLa H1.4 bearing 0, 1, 2 or 6 phosphorylations with similar affinity in immunoblots 
(Figure 4.1 D, lanes 3-7).  However, it was surprisingly specific for H1.4, displaying 
little or no binding to purified HeLa H1.2 with 0 or 1 phosphorylations (Figure 4.1 D , 
lanes 1 & 2), or to variants other than H1.4 from different sources (not shown).  The 
antisera detected a single major band aligning with H1.4 in immunoblots of whole cell 
extracts from asynchronous (Figure 4.1 G, lanes 3 & 6) and colchicine-treated HeLa cells 
(not shown), validating the use of this antisera to detect H1.4 regardless of 
phosphorylation. 
 
Since pTetH1 antisera, which was raised against highly phosphorylated H1 from 
Tetrahymena, was widely used in H1 phosphorylation research, we attempted to identify 
which sites it can recognize by using the samples with phosphorylation sites already 
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determined.  As shown in Figure 4.1 E, HPLC-purified H1.4-2p (lane 1), H1.4-1p (lane 
2), H1.4-0p (lane 3), H1.2-1p (lane 4), H1.2-0p (lane 5), crude histones from 
asynchronous growing (lanes 6) and colchicine-arrested HeLa S3 cells (lanes 7) were 
analyzed by immunoblotting with pTetH1.  The apparent affinity of the pTetH1 antisera 
for H1.4-2p phosphorylated at S172 and S187 (lanes 1) was much stronger than that for 
H1.4-1p phosphorylated at S187 (lane 2), whereas binding to H1.4-0p, H1.2-1p and 
H1.2-0p were negligible (lanes 6 and 7).  These data suggests pTetH1 can recognize 
pS172-H1.4 but not pS173-H1.2 and pS187-H1.4.  We attribute the weak signal 
observed in H1.4-1p (lane 2) is solely due to the carry over of the H1.4-2p in the 
chromatograph fraction.  However, we were unable to exclude the possibility that the 
increasing intensity seen in the colchicine-arrested sample is due to the recognition of 
mitotic specific phosphorylation described in chapter 2.  We also tested three antisera 
that recognize interphase specific phosphorylation with crude histones from MCF-7 cells 
(Figure 4.1 F).  Compared with HeLa cells, the band intensity observed in MCF-7 cells 
in the upper band aligning with H1.4 and H1.5 increased in immunoblot with pS173-H1.2 
specific antisera whereas decreased with pS187-H1.4 specific antisera (lanes 1~3 and 
7~9).  This observation can be attributed to higher expression level of H1.5 variants in 
MCF-7 cells.  In addition, band intensity in MCF-7 detected by pTetH1 was stronger 
than that by pS187-H1.4 suggesting pTetH1 also recognizes other phosphorylated H1 in 
addition to pS172-H1.4 in the interphase cells (lanes 5~7) and it is very likely to be 
phosphorylation in H1.5.  It is also worth noting that no apparent global H1 
phosphorylation changes were observed when MCF-7 was treated with 10 nM estradiol 
for 45 min. 
 
To further compare the specificity of the pS173-H1.2 and pS187-H1.4 antibodies, we 
employed peptide competition ELISA (Figure 4.2).  Specifically, different amount of 
unmodified, irrelevant phospho- and antigen phospho-peptide were immobilized in the 
 115 
plate to test the binding of antibodies.  In addition, these binding were challenged with 
no competition, competition with unmodified, irrelevant phospho- and antigen 
phospho-peptide.  As results shown in Figure 4.2, both antibodies reacted well with 
phosphopeptide but not with unmodified peptide and such reactivity was competed off by 
the phosphopeptide.  It is worth noting that pS187-H1.4 discriminated antigen peptide 
from irrelevant phosphopeptide better than pS172-H1.2.  Taken together, we conclude 
the specificity of both pS172-H1.2 and pS187-H1.4 is high enough for us to specifically 
recognize pS173-H1.2 and pS187-H1.4 in the protein for the analyses we want to apply. 
 
4.3 Progressive Phosphorylation of H1 during Cell Cycle 
We have determined the dynamic of the H1 phosphorylation abundance in HeLa cells by 
various techniques including TDMS, HIC (chapter 2) and HILIC (chapter 3).  To 
confirm our results in MCF-7 cells, whole cell extracts from synchronized cells were 
subjected to western blot with three antisera, namely pT154-H1.2/H1.4, 
pS173-H1.2/H1.5 and pT187-H1.4.  As expected, the signal intensity in pT154 blot was 
negligible initially and had sharp increase in 10 hrs sample, then steadily decrease and 
totally disappeared in 16 hrs sample (Figure 4.3).  We attributed the detection of pT154 
in 12 hrs and 14 hrs sample to the factions of cells exiting mitosis slower than most cells 
(i.e. lost of synchrony) and thus concluded that this phosphorylation is only present in the 
mitosis with further evidence from immunofluorescence study described below.  For 
both pS173 and pS187, they increased when cells progressed through S phase, reached 
the maximum abundance in mitosis and decreased as cells entered the next G1.  One 
interesting phenomena we observed from previous cell cycle study is the slower decrease 
of 1p-H1.4 compared with 2p-H1.4 and 1p-H1.2 in the G1, which indicates Ser187 in 
H1.4 might be regulated differently form other I sites.  Phosphorylation of Ser187 is 
present in both 1p-H1.4 and 2p-H1.4 molecules but previous studies only analyzed the 
behavior of 1p-H1.4.  With newly raised pS187 antibody, which recognizes both 
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1p-H1.4 and 2p-H1.4 forms, we can analyze the behavior of all phosphorylated Ser187 in 
H1.4 coming from 1p-H1.4 together with 2p-H1.4 molecules.  As expected, the signal in 
the western blot clearly indicated abundance of pS187 remained at higher levels after 
cells reenter G1 and also maintained at higher levels in early S phase compared with 
pS173 (Figure 4.3). 
 
To overcome the limitation of cell synchronization and understand when the mitosis 
specific phosphorylation of H1 appears and disappears, we employed the 
immunofluorescence study using pT146-H1.4 and pT154-H1.2/H1.4 antisera.  As 
predicted by our previous analysis, both pT146 and pT154 failed to stain the nuclei of 
interphase HeLa cells above background levels (Figure 4.4 A, B top row).  On the 
contrary, intense staining was observed in condensed chromosomes from prophase and 
metaphase cells, and such staining started to diminish in anaphase and became very dim 
in telophase cells (Figure 4.4 A, B).  Obviously, such diminish is not the result of losing 
H1 from chromosome since no diminish in anaphase or telophase was found for total H1 
staining (Figure 4.4 C).  Very interestingly, less intense staining was also seen in the 
cytoplasm for both pT146 and pT154 antibodies in mitosis, in addition to the intense 
staining of condensed chromosome (Figure 4.4 A, B).  In fact, similar pattern was also 
seen for pTetH1 staining (data not shown), which is confirmed by reports of IF and 
immuneEM study using pTetH1 antibody (Bleher and Martin, 1999; Boggs et al., 2000).  
By contrast, only condensed chromosome was stained with total H1 antibody (AE-4 
monoclonal or α-H1.4 polyclonal that we generate).  The observation of 
hyperphosphorylated H1 localizes to both chromosomes and cytoplasm in M phase 
suggests that hyperphosphorylation of H1 (6p-H1.4, 4p-H1.2) results in the higher 
exchange rate between chromatin bound state and nuclear free state.  Taken together, 
these data provide direct evidence to support our conclusion that T146 and T154 are 
phosphorylated only in mitosis. 
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4.4 pS173-H1.2/H1.5 and pS187-H1.4 Are Enriched in Nucleoli  
To understand the nuclear distribution of interphase specific H1 phosphorylation, we set 
out confocal microscopy study using the novel phosphospecific antibodies we generated.  
Confirming the previous result from epifluorescence study, the pT154-H1.2/H1.4 antisera 
only stained the condensed chromosomes of mitotic HeLa cells (Figure 4.5).  In contrast, 
antisera to pS173-H1.2/H1.5 or pS187-H1.4 stained the chromatin of both interphase and 
mitotic cells.  Interphase cells displayed finely stippled staining that was distributed 
uniformly throughout the nucleus, together with clusters of more punctate staining in 
regions poorly stained for DNA that appeared to be nucleoli (Figure 4.5).  Staining by 
the pS173-H1.2/H1.5 and pS187-H1.4 antisera was suppressed by incubation with 
antigen peptide prior to immunostaining whereas preincubation with the 
nonphosphorylated peptide had no effect (Figure 4.6).  This suggests that both the 
stippled and punctate types of staining are attributable to phosphorylated H1.  In 
contrast, the general H1.4 (-H1.4) antisera stained nuclei uniformly in a finely stippled 
fashion.  The punctate nucleolar staining typical of pS173-H1.2/H1.5 and pS187-H1.4 
was not observed with the -H1.4 antisera, and the latter often stained nucleoli less 
intensely than the surrounding chromatin.  Extensive colocalization of fibrillarin with 
the clustered punctate staining for pS173-H1.2/H1.5 and pS187-H1.4 confirmed that H1 
phosphorylated at these sites is enriched in nucleoli (Figure 4.7 A).  This suggested the 
intriguing possibility that pS173-H1.2/H1.5 and pS187-H1.4 may be associated with 
transcriptionally active rDNA and facilitate transcription by RNA polymerase I.  As a 
first test of this hypothesis, we incubated cells briefly with BrUTP to facilitate selective 
detection of nascent 45S pre-rRNA transcripts using antibodies to BrdU (Koberna et al., 
2002; Olson and Dundr, 2005).  As shown in Figure 4.7 B, punctate pS187-H1.4 
staining coincided with the centers of Br-UTP incorporation foci.  These data support 
the notion that interphase phosphorylated H1.2 and H1.4 are associated with transcribing 
rDNA. 
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The nucleoli of higher eukaryotes contain three distinct ultrastructural elements, the 
fibrillar center (FC), the dense fibrillar component (DFC) and the granular component 
(GC) whose relative structure is thought to reflect vectorial organization of major steps in 
ribosome biogenesis: pre-rRNA transcription, pre-rRNA processing and ribosome 
assembly on mature rRNA (Hernandez-Verdun, 2006a; Hernandez-Verdun, 2006b; Olson 
and Dundr, 2005).  Both inhibition of pre-rRNA transcription by actinomycin D and 
perturbation of pre-rRNA processing have been shown to alter nucleolar organization 
(Jordan et al., 1996; Olson and Dundr, 2005).  We investigated how the drug affects the 
colocalization of pS187-H1.4 with markers for each of these nucleolar compartments.  
In growing cells, fibrillarin is normally distributed over much of the nucleolar area, 
localizing primarily to the DFC in a punctate staining pattern that rings FCs.  Upon 
actinomycin D treatment, the FC and DFC dissociate from each other and fibrillarin 
staining becomes concentrated in a few large foci at the nucleolar periphery.  Although 
there was extensive partial colocalization of pS187-H1.4 and fibrillarin in untreated cells, 
actinomycin D caused a characteristic change in this relationship (Figure 4.7 D, compare 
top two rows).  Both proteins formed a similar number of foci near the nucleolar 
periphery, but pS187-H1.4 foci were typically smaller and their centers were shifted 
relative to those of the fibrillarin foci. 
 
pS187-H1.4 showed extensive colocalization with upstream binding factor (UBF) within 
the nucleoli of both control and actinomycin D-treated cells (Figure 4.7 D, compare 
middle two rows).  UBF is a positive transcription factor for RNA pol I that normally 
localizes preferentially to the FC (McStay and Grummt, 2008; Zatsepina et al., 1997).  
In agreement with previous work, we observed that actinomycin D caused the 
characteristic punctate UBF staining to coalesce into a few large granules at the nucleolar 
periphery (Zatsepina et al., 1993).  However, in contrast to the results described above 
for fibrillarin, these UBF foci colocalized completely with the foci formed by 
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pS187-H1.4 in actinomycin D-treated cells.  Actinomycin D had similar effects on 
staining for RNA pol I (RPA 194, bottom two rows of Figure 4.7 D).  Punctate RPA 194 
staining localized to the central portions of nucleoli in untreated cells but was 
concentrated into a few dense clusters at the edge of nucleoli in treated cells.  
pS187-H1.4 co-localized extensively with RPA 194 before and after actinomycin D 
treatment.  Both UBF and RPA 194 are thought to localize preferentially to the FC in 
untreated cells (Matera et al., 1994).  The persistence of H1.4-S187 phosphorylation and 
its colocalization with UBF and RPA 194 in foci formed upon actinomycin D treatment 
are consistent with previous reports that a fraction of these latter proteins remain 
associated with rDNA under these conditions (Jordan et al., 1996).  Taken together, 
these data suggest that pS187-H1.4 localize largely to the FC or the FC/DFC interface in 
untreated cells.   
 
4.5 Nucleolar H1 Phosphorylation Appears in G1  
We have previously demonstrated that the abundance of phosphorylated H1.2 has 
significantly decreased from ~30% of total H1.2 in asynchronous cells to ~10% in G1 
cells (chapter 2).  To investigate the potential difference in staining patterns for 
phosphorylated H1 in G1, cells prevented from entering S phase by mimosine were 
stained with pS173-H1.2.  Interestingly, both the uniformly distributed nuclear staining 
and the punctate nucleoli staining were present in the G1 cells but decreased to the 
similar extent (Figure 4.8 A).  More specifically, when the pS173-H1.2 fluorescence 
intensity profiles were examined in an arbitrary drawn line, which crossed both nuclear 
and nucleoli regions, the intensity for nuclear and nucleoli in asynchronous cells was 
roughly 150 and 200 respectively.  Such intensity dropped to 100 and 150 for cells arrest 
in G1 (Figure 4.8 B).  This data suggests both nuclear and nucleolar H1 
phosphorylations have similar cell cycle regulated dynamics. 
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To further test when the interphase H1 phosphorylation appears after cells exiting mitosis, 
mechanical released mitotic cells which were enriched by nocodazole, were replated into 
fresh medium and stained with pS173-H1.2 antisera after certain amount of time.  
Strikingly, the nucleolar staining was detected in cells immediately following cytokinesis 
in the 1 h release sample (Figure 4.9, arrow head and enlarged in the inset, cell stages 
were indicated by DNA staining and DIC morphology), and cells already in G1 (Figure 
4.9 A, arrow).  In 2 h release, more nucleolar staining became visible as more cells 
reentering G1.  In 3 h and 10 h release (mid G1 and mid S), the staining was observed in 
most of the cells and no significant difference staining pattern except increase of overall 
intensity was observed in 10 hr release when compared with 3 hr release (Figure 4.9 B).  
Taken together, these data clearly demonstrated interphase specific H1 phosphorylation 
appears in the early G1 and raises the likelihood that such H1 phosphorylations might 
involve in ribosome biogenesis and pol II transcription occurring in early G1.  However 
it is not clear whether all the interphase phosphorylations have been erased completely 
before cytokinesis similar to mitotic specific phosphorylation or some of such 
phosphorylations actually survive through mitosis.  
 
4.6 Evidence That Nucleolar H1 Phosphorylation is Downstream of mTOR 
To further test the possibility that interphase specific H1 phosphorylations are involved in 
pol I transcription, we tried to compare the fluorescence intensity of pS173-H1.2 in the 
nucleoli before and after rapamycin treatment, which inhibits the mTOR pathway that 
regulates ribosome biogenesis (Mayer and Grummt, 2006).  Since the fluorescence 
intensity of both nucleolar and nuclear staining for pS173-H1.4 increase from G1 to S 
phase with similar extent (Figure 4.8), only comparing cells at the same cell cycle stages 
can obtain a valid comparison of how rapamycin affect nucleolar H1 phosphorylation.  
To eliminate the necessary of costaining with cell cycle marker and normalization of the 
random fluorescence intensity variation, we compare the fluorescence intensity ratio 
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between nucleolar staining and nuclear staining.  Significant decrease of the 
pS173-H1.2 nucleolar staining was observed for HeLa cells after rapamycin treatment 
using this quantification scheme (data not shown).  To test the effect of rapamycin in 
nucleolar H1 phosphorylation in a better physiology meaningful model, we chose c2c12 
cells which can be differentiated to myotube.  We analyzed myoblast cell in two 
physiology conditions: resting condition and stimulating condition.  The first one is 
growing c2c12 to 100% confluence and maintaining in 2% horse serum for 4 days; the 
second one is stimulating resting myoblast cells with addition of nutrition by 20% FBS 
for one day.  As shown in Figure 4.10, 20% serum stimulation caused the ratio of 
nucleolar staining of pS187-H1.4 increased from 13% to 19%.  Moreover, such increase 
was eliminated when stimulated cells were treated with rapamycin in the last 3 hrs of 
stimulation and this loss of induction was not caused by global decrease of H1 
phosphorylation as indicated by western blot from whole cell lysate (Figure 4.10).  This 
result sheds the light on the regulation mechanism of nucleolar H1 phosphorylation.  
Considering the result that rRNA transcription is not affected when CDKs activity are 
inhibited (Chapter 5), it suggests that a kinase that not CDKs but downstream of mTOR 
pathway is the kinase for nucleolar H1 phosphorylation.  
 
4.7 Ligand-Dependent Colocalization of H1 Phosphorylation with ERα  
Since the existence of interphase specific H1 phosphorylation in the G1 can not be 
attributed to the old notion of H1 phosphorylation involving in DNA replication (Ajiro et 
al., 1981),  we decided to test the possibility that H1 phosphorylation involves with pol 
II transcription in addition to pol I transcription.  We first tested our idea by comparing 
the costaining pattern of pS173-H1.2/H1.5 with ERα in the MCF-7 cells before and after 
the stimulation of estradiol.  As shown in Figure 4.11, the ERα loci became more 
localized after estradiol stimulation while no visible change of staining pattern was seen 
for phosphorylated H1.  However, the colocalization of ERα and phosphorylated H1 
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were observed in the estradiol stimulated MCF-7 cells but not in the cells before 
stimulation and such difference was more obvious in the line profile over an arbitrary 
drawn line (Figure 4.11).  These results have clearly demonstrated the correlation 
between H1 phosphorylation and transcription by pol I and pol II.  We will further 
investigate this correlation in greater details to specific gene regions by ChIP in chapter 5.  
 
4.8 Materials and Methods 
Western Blot 
Purified histones or whole cell extract in 2x sample buffer (20 mM Tris pH 8.0, 20 mM 
EDTA, 2% SDS, 20% glycerol) were separated in 15% SDS-PAGE, transferred to 
nitorcellulouse membrane using seim-dry transfer apparatus using Towbin’s buffer (192 
mM glycine, 25 mM Tris, 1.3 mM SDS, 10% methanol) buffer.  Membrane was stained 
with 0.4% ponceau S in 8%TCA and 2% acetic acid, blocked in 5% milk in TBS (20 mM 
Tris, 150 mM NaCl, pH 7.5) for at least 1 h, incubated with antibodies diluted in TBST 
(TBS + 01.% Tween) for 2 h, washed 3x in TBST, incubated with HRP-conjugated 
secondary, followed by another 3 x TBST washes and detected by ECL substrate.  
Antibodies dilution: crude pS27-H1.4 (rabbit 88) 1:1000, crude pT154-H1.2/H1.4 (rabbit 
89) 1:1000, pT146-H1.4 (abcam ab3596) 1: 1000, crude pS173-H1.2 (rabbit UI82) 1: 200, 
crude pS187-H1.4 (rabbit UI86) 1:5000, pTetH1 1:2000.  When primary antibodies 
from different host were used to reprobe different antigens, membrane can be simply 
incubated with 5 mM NaN3 + 5% milk in TBS to kill the peroxidase activity before 
reprobing.  If antibodies from same host are desired or same antigen is required to be 
tested, stripping is necessary and boiling membrane in water for 1 min in microwave is an 
easy alternative.  However, it tends to lose more proteins near the margin of membrane. 
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ELISA 
Coat 96-wll plates with peptide ranging from 0 to 40 ng peptide in sodium carbonate 
buffer pH 9.6 overnight at 4 C, block with 1% BSA in PBST (PBS, 0.05% Tween) for 1 
h at room temperature.  Incubate antibody without or in the presence of unmodified, 
irrelevant or antigen phosphopeptide at final concentration of 10 μg/ml in PBST for 1 hr 
at room temperature.  Preincubated antibodies were add to the peptide coated wells and 
incubated for 2 h ar room temperature.  Wells were rinsed twice with PBST and diluted 
HRP-conjugated secondary antibodies were added and incubated for 1 h.  Then wells 
were rinsed twice with PBST and OPD substrate was added for detection by measuring 
absorbance at 492 nm. 
 
Immunofluorescence Microscopy Staining 
The IF staining protocol is described in appendix III.  Different fixation procedure was 
applied for different antibody for best result.  For general purpose, cells growing in 
coverslip was washed in PBS, fixed in 4% PFA in PBS for 12 to 15 min at room 
temperature, washed in TBST (TBS + 0.1% Tween), permeabilized in 0.2%Triton X-100 
in TBS for 10min, washed in TBST again, blocked in 2% NCS + 2% BSA in TBST for 1 
hr at room temperature and incubated with primary antibodies diluted in blocking buffer 
in a humidified chamber for at least 2 hrs.  Then coverslip was further washed with 
TBST, incubated with diluted secondary antibody conjugated with FITC or Cy3 together 
with 1: 5k diluted TO-PRO-3.  However, for some unknown reasons, nucleoli staining 
of phosphorylated H1 might be lost some time when using PFA in PBS fixation.  
Alternatively, better nucleoli staining can be achieved by fixation with 4% PFA in CSK 
(see Appendix III).  In addition, temperature also affects the quality of nucleoli staining 
and it seems shorter fixation and permeabilization at lower temperature such as fixing 
with 4% PFA in CSK for 10 min followed by permeabilizing with 0.2% Triton X-100 in 
TBS for 5 min at 17 C can achieve better result for nucleoli staining.  The adverse 
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effect of fixation with CSK is the cross-reacting of pS187-H1.4 with SR protein in the 
nuclear speckles.  
 
Antibodies Dilution for Immunofluorescence Microscopy Staining 
pT146-H1.4 (Abcam ab3596) 1:1000, pT154-H1.4 crude serum (rabbit 89) 1:1000, 
pS173-H1.2 crude serum (rabbit UI82) 1:200, pS187-H1.4 affinity purified antibody 
(rabbit UI86) 1:200, α-H1.4 crude serum (rabbit UI100) 1:200, general H1 (Abcam AE-4) 
1:100, fibrillarin (Abcam ab18380) 1:1000, UBF (Santa-Cruz sc-13125) 1:100, RPA194 
(Santa-Cruz sc-48385) 1:100, bromo-deoxyuridine (Neomarkers, clone BRD.3) 1:100, 
ER-α(Santa-Cruz F10) 1:100. 
 
Images Process 
Image J Plot Profile function was used to generate line profile values which were then 
plotted in Excel.  Photoshop was used to calculate the fluorescence intensity by multiply 
mean value by pixel number in the histogram. The nucleoli regions were defined by 
inverting the selection of the dark region in red channel (fibrillarin staining) using magic 
wand.  Three single cell images scanned using 63x objective in Zeiss LSM510 were 
used to calculate intensity and the mean value was reported with standard deviation 
plotted in Excel. 
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4.10 Figures 
Figure 4.1 
 
Detection of Individual Mitotic and Interphase Phosphorylations by Highly-Specific 
Phosphopeptide Antisera    
(A) Synthetic peptides representing phosphorylation sites and flanking sequence present 
in just one (pS27-H1.4, pT146-H1.4, pS187-H1.4) or just two (pT154-H1.2/H1.4, 
pS173-H1.2/H1.5) human H1 variants were used to generate antisera in rabbits.  
Phosphorylated residues are underlined.  Potentially homologous Ser/Thr-containing 
motifs in other human H1 variants are shown below each antigen peptide (see also Figure 
2.11).  Only the core portion of the peptide antigen used by Abcam Inc. to generate 
antisera to pT146-H1.4 is shown.   
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Figure 4.1 (cont.) 
(B) Crude histones from mid-S phase (lanes 1, 3, 5) and colchicine-arrested HeLa S3 
cells (lanes 2, 4, 6) were analyzed by immunoblotting with antisera to pS27-H1.4, 
pT146-H1.4 or pT154-H1.2/H1.4 (upper panels).  Duplicate gels stained with 
Coomassie Blue confirmed equivalent loading (lower panels).  In each case, bands were 
detected at the expected positions only in colchicine-arrested samples, suggesting that 
these three sites are phosphorylated exclusively in mitosis.   
(C) HPLC-purified nonphosphorylated H1.2 (H1.2-0p, lanes 1 & 5), H1.4-0p (lanes 2 & 
6), crude histones from mid-S phase (lanes 3 & 7) and colchicine-arrested HeLa S3 cells 
(lanes 4 & 8) were analyzed by immunoblotting with antisera to pS173-H1.2/H1.5 or 
pS187-H1.4 (upper panels).  Ponceau S staining of the transfer membranes confirm 
equivalent loading (lower panels).  Both antisera detected bands at the expected 
positions in mid-S and colchicine-arrested samples, but nonphosphorylated H1.2/H1.4 
were not bound.  The weak signal apparent for H1.5 in lanes 3 and 4 is consistent with 
the low abundance of this variant in HeLa cells (described in chapter 2).   
(D) HPLC-purified H1.2-0p (lane 1), H1.2-1p (lane 2), H1.4-0p (lane 3), H1.4-1p (lane 4), 
H1.4-2p (lane 5), H1.4-6p (lane 6) and purified recombinant human H1.4 (rH1.4, lane 7) 
were analyzed by immunoblotting with antisera (α-H1.4) for total H1.4 that was raised 
against rH1.4 (upper panels). Ponceau S staining of transfer membranes confirmed 
equivalent loading (lower panels).  The apparent affinity of the α-H1.4 antisera for 
native H1.4 with defined levels of phosphorylation (lanes 3-6) was similar to that for 
rH1.4 (lane 7), whereas binding to H1.2 was negligible (lanes 1 and 2).  
(E) HPLC-purified H1.4-2p (lane 1), H1.4-1p (lane 2), H1.4-0p (lane 3), H1.2-1p (lane 4), 
H1.2-0p (lane 5), crude histones from asynchronous growing (lanes 6) and 
colchicine-arrested HeLa S3 cells (lanes 7) were analyzed by immunoblotting with 
antisera pTetH1 that was raised against highly phosphorylated Tetrahymena H1 (upper 
panels). Ponceau S staining of transfer membranes confirmed equivalent loading (lower 
panels).  The apparent affinity of the pTetH1 antisera for H1.4-2p with identified 
phosphorylation sites at S172 and S187 (lanes 1) was much stronger than that for 
H1.4-1p with identified phosphorylation sites at S187 (lane 2), whereas binding to 
H1.4-0p, H1.2-1p and H1.2-0p were negligible (lanes 6 and 7). 
(F) Crude histones from HeLa S3 (lanes 1, 4, 7), MCF-7 cells without 10 nM E2 
treatment (lanes 2, 5, 8) and MCF-7 cells treated with 10 nM E2 for 45 min (lane 3, 5, 9) 
were analyzed by immunoblotting with antisera to pS173-H1.2, pTetH1 or pTS187-H1.4 
(upper panels).  Ponceau S staining of transfer membranes confirmed equivalent loading 
(lower panels).  
(G) Whole cell extracts of growing asynchronous (lanes 1, 3, 4, 6) and colchicine-treated 
cells (lanes 2, 5) were analyzed by immunoblotting with antisera to pS187-H1.4 (lanes 4, 
5) or total H1.4 (lane 6).  Ponceau S staining of transfer membranes confirmed 
equivalent loading (lanes 1-3). 
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Figure 4.2 
 
 
Antigen Preadsorption of the pS173-H1.2 and pS187-H1.4 Antisera Demonstrates 
Their Specificity in ELISA  
(A)  Increasing amounts of the pS173-H1.2 (squares), pS187-H1.4 (diamonds), and 
unmodified S173-H1.2 (triangles) peptides were bound to separate wells of 96 well plates 
before incubation with antisera to pS173-H1.2 that had been preincubated with no 
peptide (upper left panel), unmodified S173-H1.2 peptide (upper right), the similar but 
non-identical pS187-H1.4 peptide (lower left), or the pS173-H1.2 antigen peptide (lower 
right).  The highest affinity binding was observed for the relevant pS173-H1.2 antigen 
peptide.  The relative abilities of the unmodified S173-H1.2 and pS173-H1.2 peptides to 
compete for this binding indicate that it is phosphorylation-dependent.  Intermediate 
binding affinity was observed for the pS187-H1.4 peptide.  This may be attributable to a 
subpopulation of antibodies since the pS187-H1.4 peptide competed efficiently for this 
binding without detectably affecting recognition of the relevant pS173-H1.2 peptide.   
(B)  Same as in (A) except that plates were incubated with antisera to pS187-H1.4 that 
had been preincubated with no peptide (upper left panel), unmodified S187-H1.4 peptide 
(upper right), the similar but non-identical pS173-H1.2 peptide (lower left), or the 
pS187-H1.4 antigen peptide (lower right). The highest affinity binding was observed for 
the relevant pS187-H1.4 antigen peptide.  The relative abilities of the unmodified 
S187-H1.4 and pS187-H1.4 peptides to compete for this binding indicate that it is 
phosphorylation-dependent.  This antiserum did not show appreciable binding to the 
irrelevant pS173-H1.2 peptide.  
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Figure 4.3 
 
Progressive Phosphorylation of H1 during Cell Cycle 
(A) FACS analysis of MCF-7 cells released from double thymidine block at indicated 
time point. 
(B) The H1 phosphorylation levels in synchronized MCF-7 cells were tested by pT154, 
pS173 and pS187 antibodies using whole cell extracts.  Tubulin (DM1A) was used to 
monitor the loading. 
(C) Quantification of the western blot results in B.  The intensity of phosphorylated H1 
from different time point was plotted as the percentage to the intensity from 10 hrs 
sample  
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Figure 4.4 
 
 
Mitotic Specific Phosphorylation of T146-H1.4 and T154-H1.2/H1.5 
(A, B) Asynchronously growing HeLa cells were stained with antisera to pT146-H1.4 or 
pT154-H1.2/H1.5 and examined by epifluorescence microscopy.  DNA was 
counterstained with DAPI.  Cells at different cell cycle staged were determined by 
DAPI staining and DIC. 
(C) Asynchronously growing HeLa cells were stained with general H1 antibody (AE-4) 
and examined by confocal microscopy.  DNA was counterstained with TO-PRO 3. 
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Figure 4.5 
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Figure 4.5 (cont.) 
Interphase Phosphorylated H1.4 and Total H1.4 Are Localized Distinctly Within 
Nuclei  
Asynchronously growing HeLa cells stained with antisera to pT154-H1.2/H1.4, 
pS173-H1.2/H.5, pS187-H1.4 or rH1.4 were examined by confocal immunofluorescence 
microscopy.  DNA was visualized using TO-PRO-3.  The antisera to pT154-H1.2/H1.4 
preferentially stained the condensed chromatin of cells in or near mitosis but did not stain 
interphase cells appreciably.  In contrast, the antisera to pS173-H1.2/H1.5 and 
pS187-H1.4 stained the nuclei of interphase cells in a stippled pattern and stained the 
condensed chromatin of mitotic cells (inset for pS173, arrows for pS187).  The nucleoli 
of most interphase cells were conspicuously stained by clusters of punctate pS173 and 
pS187 staining.  The antisera for total H1.4 (α-H1.4) stained interphase nuclei in a finely 
stippled pattern that was more uniformly distributed than that observed for either pS173 
or pS187.  In contrast to pS173 or pS187, the pattern of nucleolar staining for total H1.4 
resembled that of the surrounding nuclear chromatin but was generally less intense.  
Clusters of punctate staining for total H1.4 were not observed in interphase cells.  Scale 
bar = 20 microns.   
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Figure 4.6 
 
 
Antigen Preadsorption of the pS173-H1.2 and pS187-H1.4 Antisera Demonstrates 
Their Specificity in Immunofluorescence Microscopy  
(A) Crude antisera to pS173-H1.2/H1.5 was mock-treated (none) or preincubated with 
the pS173-H1.2/H1.5 antigen peptide (phospho) or the corresponding nonphosphorylated 
peptide (unmodified) prior to use in staining asynchronous growing HeLa cells.  DNA 
and nucleoli were subsequently stained with TO-PRO-3 and anti-fibrillarin, respectively.   
(B) As in (A) except that crude antiserum to pS187-H1.4 and the corresponding peptides 
were used.   
Scale bar = 20 microns. 
Nuclear and nucleolar staining in both (A) and (B) was significantly reduced following 
preincubation with the respective phosphopeptide but was unaffected by preincubation 
with the nonphosphorylated peptide.   
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Figure 4.7 
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Figure 4.7 (cont.) 
Subnuclear Localization of Phosphorylated H1 
(A) Asynchronously growing HeLa cells co-stained with antisera to pS173-H1.2/H1.5 or 
pS187-H1.4 and the nucleolar marker fibrillarin were examined by confocal microscopy.  
Clusters of punctate staining for pS173-H1.2/H1.5 and pS187-H1.4 overlapped 
extensively with fibrillarin staining.  Scale bar = 5 microns.   
(B) Asynchronously growing HeLa cells co-stained with antisera to pS187-H1.4 and 
monoclonal antibody to BrdU were examined by confocal microscopy after 
pulse-labeling of nascent transcripts with BrUTP.  Br-UTP incorporation co-localized 
extensively with pS187-H1.4.  Scale bar = 5 microns. 
(C) Untreated and actinomycin D-treated HeLa cells were co-stained with antibodies to 
fibrillarin, upstream binding factor (UBF) or the large subunit of RNA polymerase I 
(RPA194) and pS187-H1.4 prior to confocal microscopy.  DNA was visualized using 
TO-PRO-3.  Scale bar = 5 microns.   
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Figure 4.8 
 
Both Nuclear and Nucleolar H1 Phosphorylation Decrease during G1  
(A) Asynchronously growing or mimosine treated HeLa cells stained with antisera to 
pS173-H1.2/H.5 were examined by epifluorescence microscopy.  DNA was visualized 
using DAPI.   
(B) Profiles of pS173 fluorescence intensity along the drawn red line (asynchronous) or 
green line (mimosine). 
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Figure 4.9 
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Figure 4.9 (cont.) 
H1 Phosphorylation Reappears after Mitosis in Early G1  
Mechanical released nocodazole enriched mitotic cells were replated in fresh medium.  
Cells were fixed after release at indicted time and stained with pS173-H1.2 antisera.  
Cells remained in mitosis or just entered the next G1 were determined by DAPI staining 
of DNA and DIC image of cell morphology.  Prophase: a bright condensed DAPI 
staining all over nuclear; Metaphase: a single alignment of bright DAPI staining occupied 
in the equator; Anaphase: a double alignments of bright DAPI staining presents in a 
single cells with constriction ring in the formation; Telophase: a double alignments of 
bright DAPI staining presents in a single cells with 2 daughter cells connected by 
cytoplasm bridge; Cells just enter next G1: two cells contacted each other without 
condensed chromatin with rigid DIC pattern contrast to those spread out flatten pattern 
from cells entered G1 phase longer. 
(A) Cells from 1h release, arrow indicates cells in the interphase and arrow head indicates 
newly divided cells.  The pS173-H1.2 nucleolar staining of newly divided cells was 
enlarged in the inserted panel.  pS173-H1.2 nucleolar staining as indicated by arrow in 
the 2 h release increased compared to 1 h release.  
(B) The staining of pS173-H1.2 nucleolar staining appeared in most of cells after 3 h of 
release and was seen in every cell after 10 h release. 
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Figure 4.10 
 
Evidence that Nucleolar H1 Phosphorylation is Downstream of mTOR 
(A) c2c12 cells maintained at 2% horse serum were stimulated with 20% FBS without or 
with the addition of 100 nM rapamycin in the last 3 hrs.  Cells were fixed in 4% PFA in 
CSK for 12 min at room temperature, permeabilized in 0.2 % Triton X-100 in PBS for 15 
min.  Cells were costained with antisera to pS187-H1.4 and the nucleolar marker 
fibrillarin were examined by confocal microscopy.  
(B) Quantification of the intensity of pS187-H1.4 staining in the nucleoli regions defined 
by fibrillarin staining over the total intensity of pS187-H1.4 in the nuclear.   
(C) The effect of 3 hrs treatment with 100 nM rapamycin in the level of pS187-H1.4 in 
the resting c2c12 cells were analyzed by western blot by pS187-H1.4 antibody (upper 
panel).  Equivalent loading of whole cell lysate was confirmed by probing with tubulin 
antibody (DM1A, lower panels). 
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Figure 4.11 
 
Ligand Dependent Colocalization of H1 Phosphorylation with ERα 
Asynchronously growing MCF-7 cells were maintained in 7% charcoal stripped FBS in 
phenol free DMEM for 3 days before addition of 10 nM E2.  Cell treated with ethanol 
(A) and E2 (B) for 30 min were co-stained with antisera to pS173-H1.2/H1.5 (1:200) and 
the ERα mAb (Santa Cruz F10, 1:100) and examined by confocal microscopy.  Cells 
were permeabilized in 0.5% Triton X-100 in 4% PFA-CSK for 2 min at room temperature 
and then further fixed in 4% PFA-CSK for 10 min.  The fluorescent intensities of 
pS173-H1.2/H1.5 (green) and ERα (red) over the arbitrary line drawn across an enlarged 
area are shown.  Scale bar = 5 microns. 
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CHAPTER 5 * 
HISTONE H1 PHOSPHORYLATION ASSOCIATED WITH TRANSCRIPTION 
BY RNA POLYMERASE I AND II 
*: Some material was adapted from manuscript: 
Histone H1 Phosphorylation Associated with Transcription by RNA Polymerases I and II 
Yupeng Zheng, Sam John, James J. Pesavento, Jennifer R. Schultz-Norton, R. Louis Schiltz, Sonjoon Baek, 
Ann M. Nardulli, Gordon L. Hager, Neil L. Kelleher and Craig A. Mizzen 
 
5.1 Introduction 
Since the discovery of nucleosome, great efforts have been taken to address how 
elongating RNA-polymerase can transcribe through nucleosomes.  Although the 
mechanism still remains elusive, there is strong evidence that pol II transcription through 
chromatin is coupled with nucleosome survival at the original position on DNA (Kulaeva 
et al., 2009).  As we discussed in chapter 1.6.1, multiple ChIP experiments have 
demonstrated H1 is partially depleted upon transcriptional activation in the pol II genes 
especially in the promoter regions (see review in (Paranjape et al., 1994; Zlatanova and 
Van Holde, 1992)).  The global distribution pattern of H1 along genome has been 
reported in two recent analyses using ChIP-chip by H1 monoclonal antibody (AE-4) in 
human cells and DamID in Drosophila cells respectively, which is pervasive binding 
interrupted by thousands of local dips that mostly coincide with TSSs (transcription start 
site) of active genes and putative regulatory elements (Braunschweig et al., 2009; 
Krishnakumar et al., 2008).  
 
On the other hand, nucleosomes are believed to be altered or even removed in rDNA 
transcribed by pol I, possible to cope with the demand of highly active transcription.  
There are at least three observations to support this notion: first, when the nascent rRNA 
genes was removed by RNAse, short gap of DNA were visible between polymerase in 
electron microscopy, indicating lost of nucleosome (Labhart and Koller, 1982); second, 
MNase digestion revealed nucleosomal repeat and smearing pattern for inactive and 
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active rRNA gene, respectively (Lucchini et al., 1987); third, two distinct types of 
ribosomal chromatin were revealed by psoralen crosslink study (Conconi et al., 1989), in 
which the heavily crosslinked DNA represented nucleosome-free transcribed gene since 
its accessibility to psoralen whereas the slightly crosslinked DNA represented silent 
copies containing intact nucleosome organization since its inaccessibility to psoralen.  
Moreover, the limited run-on in the presence of radioactive precursors demonstrated 
heavily psoralen crosslinked rDNA represents genes engaged in transcription elongation 
(Conconi et al., 1989).  These evidences were interpreted as absence of nucleosome in 
active transcribed rRNA genes.  However ChIP assay showed histones were still 
associated with active transcribed rRNA genes in X. laevis in embryos at stage 40.  In 
more detail, both H2A and H4 were associated with rDNA in amounts similar to those 
found for bulk DNA, whilst the content of H1 was reduced to ~50% (Dimitrov et al., 
1990).  Moreover, observation of histones in active transcribed rRNA genes is not 
limited in Xenopus, H1 is also found in Drosophila and Tetrahymena rRNA genes 
(Belikov et al., 1990; Dedon et al., 1991) and yeast H1 is required for maximal pol I 
processivity during rDNA transcription (Levy et al., 2008).  In addition to ChIP 
approach, direct labeling of histones in immuneEM has identified both H2A/H2B and H1 
in the nucleoli for mammalian cells (Raska et al., 1995).  Two more recent reports have 
further demonstrated the association of rDNA with specific PTM of histone: first, 
pS10-H3 was shown to localize in the fibrillar center in nucleoli by IF and found 
associated with rDNA by ChIP in the plant (Granot et al., 2009); second, pS10-H3 was 
correlated with DNA-less region whereas repressive histone marks in the DNA-speckle 
regions of Drosophila rRNA in polytene chromosome spread (Plata et al., 2009).  Taken 
these together with our nucleoli localization of phosphorylated H1 results, we decided to 
further investigate the correlation between H1 and pol I transcription by ChIP.  As we 
have discussed in chapter 1.8, some interesting correlation between H1 phosphorylation 
and MMTV transcription has been revealed by ChIP using pTetH1 antibody, thus we also 
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investigated the correlation between H1 and pol II transcription by our novel 
phospho-specific antibody.  
 
5.2 pS187-H1.4 Is Preferentially Associated with Active rDNA Promoters   
Mammalian cells contain several hundred copies of the rDNA repeat.  The proportion of 
these which are transcriptionally active in individual cells is regulated by mechanisms 
including histone modifications to match cellular demand for ribosome biogenesis 
(Lawrence and Pikaard, 2004; McStay and Grummt, 2008; Moss et al., 2007).  To 
investigate whether interphase H1 phosphorylation contributes to this regulation, we used 
chromatin immunoprecipitation (ChIP) to compare the association of pS187-H1.4 with 
the rDNA promoter before and after selective inhibition of RNA pol I transcription with 
0.05 μg/ml of actinomycin D (Jordan et al., 1996; Olson and Dundr, 2005).  The levels 
of 45S pre-rRNA, normally processed quickly to yield smaller mature rRNA species, 
were assessed using RT-PCR to provide a semi-quantitative measure of rDNA 
transcription (James and Zomerdijk, 2004; Murayama et al., 2008).  Consistent with the 
colocalization of Br-UTP incorporation and pS187-H1.4 staining within nucleoli (Chapter 
4.5, Figure 4.7 B), ChIP revealed a robust association of pS187-H1.4 with the rDNA 
promoters in untreated growing HeLa cells (Figure 5.1 A).  Strikingly, this association 
was significantly reduced after 3 hours of actinomycin D treatment (0.05 g/ml), in 
concert with a nearly quantitative reduction in the levels of nascent 45S pre-rRNA 
transcripts (Figure 5.1 B).  The reduction in promoter-associated pS187-H1.4 was not 
attributable to H1 depletion since the level of total H1.4 at the promoter was actually 
enhanced by actinomycin D treatment (Figure 5.1 A).  Since, the global levels of both 
pS187-H1.4 and total H1.4 were unaffected by actinomycin D under these conditions 
(Figure 5.1 C), our data reveals that pS187-H1.4 is preferentially associated with the 
promoters of transcriptionally active rDNA repeats and that this association is regulated 
dynamically.   
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5.3 pS187-H1.4 Is Preferentially Associated with Pol II-Transcribed Genes 
Data from approaches which did not account for the possible effects of interphase H1 
phosphorylation have often suggested that H1 binding is associated with repression of 
transcription by RNA pol II (Cheung et al., 2002; Kim et al., 2008; Laybourn and 
Kadonaga, 1991; Lee et al., 2004).  In contrast, ChIP analyses employing antiserum to 
phosphorylated Tetrahymena H1 suggest that phosphorylated H1 is required for 
glucocorticoid-dependent transcription from the MMTV promoter in mammalian cells 
(Bhattacharjee et al., 2001; Lee and Archer, 1998; Lu et al., 1994).  However, the 
phosphorylated forms of H1 in mammals that can cross-react with this antiserum have 
not been clearly identified.  Nonetheless, given our evidence because that pS187-H1.4 is 
distributed somewhat differently than total H1.4 and is enriched at active rDNA 
promoters (Figure 5.1 A), we next investigated whether pS187-H1.4 is involved in 
regulating gene transcription by RNA polymerase II.  We chose to test the association of 
phosphorylated and total H1 in two constitutively active housekeeping genes and one 
constantly inactive gene in HeLa cells, i.e. GAPDH and ALDOA for active genes and 
MyoD for inactive genes.   As shown in Figure 5.2, ChIP revealed a robust association 
of both pS187-H1.4 and total H1.4 around TSSs in both active and inactive genes in 
growing HeLa cells.  Importantly, association of pS187-H1.4 is greater than total H1.4 
in active genes whilst opposite relationship is observed in inactive genes.  Due to 
differences in the affinities of the primary antibodies for their respective antigens and 
primer amplification efficiency in different loci, it is not appropriate to directly compare 
the ChIP enrichment for different antibodies in same locus or same antibody in different 
loci.  Therefore, at least two different modes can be proposed for gene activation: first, 
no change for total H1 but increase of abundance of H1 phosphorylation; second, 
decrease of total H1 concurrent with increase of abundance of H1 phosphorylation.  We 
have shown that the second scenario is what happened for pol I transcription activation in 
the promoter of rRNA.  To further clarify whether similar mechanism is also underlying 
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the pol II gene activation, we need to compare the H1 association before and after 
transcription activation in the same locus. 
  
5.4 Induction of Interphase H1 Phosphorylation by Nuclear Hormone Receptors  
We used ChIP-qPCR to compare the association of pS187-H1.4 with hormone response 
elements for the glucocorticoid receptor (GR) in murine 3134 mammary tumor cells and 
estrogen receptor-alpha (ER) in human MCF-7 breast cancer cells before and after 
stimulating cells with the respective ligands (Figure 5.3).  3134 cells carrying multiple 
copies of the glucorticoid response element (GRE) associated with the murine mammary 
tumor virus long terminal repeat (MMTV-GRE).  Stimulation of 3134 cells with 
dexamethasone rapidly induced the association of pS187-H1.4 with the MMTV-GRE.  
The level of pS187-H1.4 at this locus increased by approx. 2.5 fold after 30 minutes of 
hormone treatment and by more than 3 fold after 60 minutes of treatment (Figure 5.3 A).  
Similarly, a robust enrichment of pS187-H1.4 was also observed at the GRE of the single 
copy serum/glucocorticoid regulated kinase (Sgk) gene following hormone treatment 
(Figure 5.3 B).  These data demonstrate that glucocorticoid treatment stimulates the 
enrichment of interphase phosphorylated H1 at the MMTV-GRE and suggests that 
phosphorylation of a site resembling H1.4-S187 is likely to have contributed to the 
hormone-dependent enrichment of phosphorylated H1 described previously for this GRE 
(Bhattacharjee et al., 2001; Lee and Archer, 1998).  They also provide the first evidence 
that interphase phosphorylated H1 is enriched at the GRE of a single copy natural gene in 
response to the binding of liganded GR, and suggest that dynamic changes in the 
association of phosphorylated H1 are likely to be a general feature of the chromatin 
response to glucocorticoid signaling. 
 
We also compared how the association of ER and pS187-H1.4 with the estrogen 
response element (ERE) of the pS2 gene (trefoil factor 1, TFF1) changed in MCF-7 cells 
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following estradiol treatment (Figure 5.3 C).  Both ER and pS187-H1.4 were markedly 
enriched at the pS2-ERE after just 15 minutes of estradiol treatment and became further 
enriched after 45 minutes of treatment.  Differences in the affinities of the primary 
antibodies for their respective antigens preclude comparing the results directly, but the 
similar nature and time courses of enrichment of ER and pS187-H1.4 that were 
observed to converge on this ERE suggest they are tightly-linked events.  Taken together, 
the inducibility of pS187-H1.4 association with the response elements analyzed in Figure 
5.3 argues strongly that pS187-H1.4, and possibly other interphase phosphorylated forms 
of H1, facilitate gene-specific activation of RNA polymerase II transcription by nuclear 
hormone receptors.   
 
5.5 pS187-H1.4 Marks the Transcribed Regions of Active Genes  
In order to gain more precise and complete view of the patterns of pS817-H1.4, we 
performed ChIP-sequencing to determine the genome wide distribution of pS187-H1.4.  
A typical result comparing the association of pS187-H1.4 at a gene activated by the 
glucocorticoid receptor (GR), Irs1, before and after treatment of murine 3134 with 
dexamethasone, is shown in Figure 5.4 A.  Hormone treatment induces the enrichment 
of pS187-H1.4 along the entire length of the Irs1 gene, starting right at the TSS and 
extended ~5 kb beyond the 3’UTR.  In addition, enrichment of pS187-H1.4 was also 
observed in the 5’ upstream regulatory element locus where GR binds.  On the contrary, 
the levels of pS187-H1.4 at hormone-repressed genes, Tgm2, actually fell compared to 
untreated cells, whilst the levels of pS187-H1.4 at constantly active genes, Hsp90, were 
kept at the same levels (Figure 5.4 B, C).  Thus, pS187-H1.4 appears to be a novel 
marker for ongoing transcription by RNA polymerase II.   
 
In summary, pS187-H1.4 is associated with active transcribed gene in the regulatory 
element and along the whole gene body, starting right at the beginning of TSSs and 
extended several kb beyond the 3’ UTR.  In addition, there is no dip for pS187-H1.4 
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occupancy in the TSSs as reported for total H1 in the active transcribed genes, which 
suggest more H1 molecules in the TSSs regions are phosphorylated.  
 
5.6 CDK2, CDK8 and CDK9 Are Potential Interphase H1 Kinases but Are Not 
Required for rRNA Transcription  
There are 13 cyclin-dependent kinase (CDKs) based on PSTAIRE motif and 25 
cyclin-box-containing proteins in human genome.  CDKs play critical roles in multiple 
cellular activities including, but not limited to, proliferation and transcription.  CDK1, 
CDK2, CDK4 and CDK6 are involved in regulating progression through the G1, S, G2 
and M phases of the cell division cycle.  In early-mid G1, CDK4 and CDK6 can 
phosphorylate Rb protein to release the E2F and DP1 transcription factors for the 
expression of genes required for G1/S transition and S phase progression.  During S 
phase, CDK2/cyclin A phosphorylates various key substrates necessary for DNA 
replication.  Later, CDK1/cyclin B appears and phosphorylates a large set of substrate to 
trigger the G2/M transition and complete the mitosis (Knockaert et al., 2002).  In 
addition to cell cycle regulation, there are three CDK/cyclin involved in transcription and 
all are found within larger complex.  CDK7/cyclin H (part of the TFIIH) and 
CDK8/cyclin C (part of mediator) regulate transcription initiation (Akoulitchev et al., 
2000; Fisher, 2005) whereas CDK9/cyclinT (core of the p-TEFb) is important for 
transcription elongation (Wang and Fischer, 2008). 
 
CDK phosphorylation site preferences have been well established as S/TPXK/R, but 
recent studies have revealed subtle differences in substrate preference.  For example, 
CDK2 has a very strong preference for a basic residue at the position P+3 whereas CDK4 
phosphorylates either SPXK/R or SPXX with similar efficiency.  In addition, lack of 
preference for a basic residue at the P+3 residue is also true for CDK7, CDK8 and CDK9, 
which can phosphorylate the heptad repeats present within the C-terminal domain (CTD) 
of the RBP1 subunit of pol II (YSPTSPS) (Echalier et al.).  
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Identifying the kinase for H1 phosphorylation will greatly improve our understanding of 
how H1 phosphorylation regulates.  As discussed in chapter 1.5.2, multiple evidences 
have indicated CDK2 is the kinase for H1 interphase phosphorylation whereas CDK1 is 
the kinase for H1 mitosis phosphorylation.  However the observation of tight correlation 
between pS187-H1.4 and transcription suggests other kinase might be involved in H1 
phosphorylation at least in G1 when both CDK1 and CDK2 are inactive.  In addition, it 
has been reported that CDK2 is not required for metallothionein transcription activation 
despite it is necessary for MMTV (Bhattacharjee et al., 2001).  To test this hypothesis, 
we set out to examine whether any other CDKs can modulate the global H1 
phosphorylation in interphase by siRNA knocking down single CDK or small molecule 
inhibitors.  Both approaches have their advantages and disadvantages: CDK siRNA 
approach offers greater specificity but might cause some indirect effects as has been 
reported that CDK1 or CDK2 knockdown can cause cell cycle defects (Cai et al., 2006); 
the shorter treatment by CDK specific inhibitor minimizes the indirect effects but the 
selectivity of CDK inhibitor is not satisfying enough to draw unambiguous conclusion on 
their own (Karaman et al., 2008).   
 
Before testing the effects on global H1 phosphorylation in the CDK1, 2, 4, 7, 8 and 9 
siRNA treated cells, the knockdown efficiencies of siRNA were monitored by RT-PCR 
and the results indicated a great reduction in the mRNA level after 72 hrs treatment 
(Figure 5.5 B).  Furthermore, the reduction in protein levels for CDK 1, 7 and 9 in the 
siRNA experiment were confirmed by immunoblot (data not shown).  Then the 
abundance of pS187-H1.4 in the HeLa cells, where individual CDK was knockdown by 
siRNA, was examined by immunoblot.  As expected, pS187-H1.4 was increased in 
CDK1 siRNA sample since cells were unable to enter mitosis and thus arrested in G2 
phase where levels of pS187-H1.4 is much higher than asynchronous (chapter 2, Figure 
5.5 A).  Similar elevation of pS187-H1.4 has also been observed in FT210 cell line 
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(CDK1 mutation) when CDK1 was inactivated for as short as 3 hrs at 42 C 
(nonpermissive temperature, data not shown).  In addition, decrease of pS187-H1.4 in 
CDK4 siRNA was mostly caused by indirect effects of cell cycle arrest in G1/S, which 
was corroborated by the observation of no decrease of pS187-H1.4 when CDK4 was 
inhibited by specific inhibitor CDK4i (Zhu et al., 2003).  Consistence with previous 
studies, abundance of pS187-H1.4 (Figure 5.5 A, C) decreased when CDK2 activity was 
inhibited by either siRNA or various CDK1/2 drug (purvalanol A, olomoucine II, 
roscovitine).  Interestingly, abundance of pS187-H1.4 decreased in CDK8 and CDK9 
siRNA samples but no change was seen in the CDK7 siRNA (Figure 5.5 A).  In addition, 
3 hrs treatment with CDK9 inhibitor flavopiridol (FLVP) also greatly reduced the global 
abundance of pS187-H1.4 (Figure 5.5 C).  These results raised an interesting possibility 
that CDK8 and CDK9 are the kinase in transcription machinery that phosphorylates the 
histone H1 in the ongoing transcribe gene body we observed in ChIP-seq study.  Similar 
role for CDK8 has been reported, which can efficiently phosphorylate serine 10 in H3 in 
chromatin templates (Knuesel et al., 2009).  However, we can not rule out the possibility 
that decrease in the global phosphorylation of H1 is the indirect consequence of 
inhibition of H1 kinase transcription.  It has been reported inhibition of CDK9 impairs 
the transcription, whilst inhibition of CDK7, kinase in the TFIIH that is required to 
initiate transcription, does not impair transcription (Garriga et al.; Kanin et al., 2007).   
As described in chapter 4.6, the decrease of nucleolar H1 phosphorylation in rapamycin 
suggests kinase for H1 phosphorylation in rRNA transcription lies in the downstream of 
mTOR pathway.  Since there is no CDKs is known in the signaling pathway of mTOR, 
we hypothesized CDK is not the kinase for nucleolar H1 phosphorylation and predicted 
there will be no effects in rRNA transcription when CDKs is inhibited.  A shown in 
Figure 5.5 D, E, none of knockdown of CDKs by siRNA or inhibiting CDKs by drug has 
significant effects in rRNA transcription, suggesting H1 phosphorylation in rRNA loci 
might is not involved CDKs. 
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5.7 Evidence That H1 Phosphorylation Facilitates the Transcriptional Activation of 
Metallothionein Genes  
In order to directly test whether S187 phosphorylation in H1.4 is necessary for the 
transcription, we designed an experiment to knockdown endogenous H1.2 and H1.4 in 
the HeLa cells by siRNA first and then express exogenous H1.4 carrying synonymous 
substitutions in the siRNA targeted region, which made the plasmid resist to siRNA 
silencing.  As reported previously (Dou and Gorovsky, 2000), we then introduced 
mutations that mimics unphosphorylated (serine to alanine) or phosphorylated status 
(serine to glutamic acid) in the silencing resisting H1.4 plasmid to directly investigate 
effects of phosphorylation in H1 in transcription.   
 
We chose metallothionein genes as our model gene since their expression can be easily 
induced by dexamethasone or metal.  As shown in the Figure 5.6 A, hormone induced 
association of pS187-H1.4 along the entire length of the metallothionein genes was 
similar to other example we discussed above.  The levels of the steady state transcript of 
MT1A and MT2A were assayed by qRT-PCR for different mutant replacements before 
and after induction and all the measurements were reported as the relative fold change 
against the basal level (-ZnCl2) in the control sample.  As shown in Figure 5.6 B, robust 
induction of approx 20-fold increase was seen for MT1A and approx 10-fold increase for 
MT2A.  As expected, inducibility of transcription increased when H1 was knockdown 
but returned to the same levels when wild type of H1 was introduced into the H1 siRNA 
cells.  These results imply histone H1 acts as repressor in the metallothionein loci and 
displace of H1 can relieve the repression during induction.  In addition, 
unphosphorylated mimic form of H1 inhibits transcription induction by ZnCl2 whilst 
phosphorylated mimic form of H1 facilitates such transcription induction (Figure 5.6 B), 
which suggests H1 phosphorylation is very likely to be the mechanism that causes 
displacement of H1 for the transcription activation.  CDK2 inhibitor purvalanol and 
CDK9 inhibitor flavopiridol were served as control since CDK2 is not required for MT 
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transcription as previously reported (Bhattacharjee et al., 2001) and CDK9 inhibition by 
flavopiridol causes global transcription inhibition (Garriga et al.). 
 
5.8 Conclusions and Discussion 
Interphase H1 Phosphorylation and rDNA Transcription 
The growth and proliferation of cells is proportional to their capacity for ribosome 
biogenesis, one of the most energy intensive processes they perform.  45S pre-rRNA 
synthesis is thought to be limiting for ribosome biogenesis and aspects of chromatin 
structure including nucleosome positioning, DNA methylation and histone H3 and H4 
modifications have all been implicated in determining the transcriptional activity of 
rDNA repeats (Birch and Zomerdijk, 2008; McStay and Grummt, 2008; Moss et al., 
2007).  The HMG class protein UBF plays key roles in rDNA transcription.  UBF 
dimers bind rDNA promoters and activate transcription by recruiting SL1/TIF-IB and 
enhancing PIC formation (McStay and Grummt, 2008; Moss et al., 2007).  UBF binding 
throughout the transcribed portions of rDNA repeats may also affect other aspects of 
RNA pol I transcription and be involved in maintaining the euchromatic state of rDNA 
(Moss et al., 2007; O'Sullivan et al., 2002; Sanij and Hannan, 2009; Sanij et al., 2008).  
UBF competes with H1 for binding to reconstituted mononucleosomes in vitro and 
depletion of UBF in vivo is associated with a decrease in the proportion of active rDNA 
repeats and an increase in H1 association with rDNA (Kermekchiev et al., 1997; Sanij et 
al., 2008).  Since rDNA promoter methylation inhibits UBF binding (Santoro and 
Grummt, 2001), these results suggest a model in which UBF promotes chromatin 
decondensation of hypomethylated rDNA repeats by limiting the ability of H1 to bind 
and stabilize higher order chromatin folding.  This is consistent with ChIP data that 
UBF is preferentially associated with hypomethylated rDNA promoters whereas H1 tends 
to be associated preferentially with methylated promoters (Sanij et al., 2008). 
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The dependence of pS187-H1.4 and rDNA promoter association on RNA pol I activity 
(Figure 5.1 A), and the colocalization of pS187-H1.4 with UBF and RNA pol I before 
and after ActD treatment (Figure 4.7 C), suggest the possibility that H1 kinases are 
recruited to transcriptionally active/competent rDNA repeats via interactions with UBF or 
other components of the RNA Pol I machinery.  The effect of S187 phosphorylation on 
H1.4 chromatin binding dynamics could promote rDNA decondensation and transcription 
by facilitating UBF binding, as suggested by FRAP analyses of GFP-H1 phosphorylation 
site mutants (Contreras et al., 2003; Hendzel et al., 2004).  Moreover, the nucleolar 
staining observed for pS172-H1.2 suggests that this form may play a similar role, but the 
poor performance of this antisera in ChIP has precluded testing this hypothesis directly.   
 
Interphase H1 Phosphorylation and Transcriptional Regulation by Nuclear Hormone 
Receptors 
A clear consensus regarding the roles of linker histones in transcriptional regulation 
mediated by nuclear hormone receptors has remained elusive.  Analyses of 
GR-regulated transcription at the MMTV promoter in different systems suggest that H1 is 
depleted immediately following hormone stimulation (Belikov et al., 2007; Bresnick et 
al., 1992), but reassociates with refractory promoters after prolonged hormone treatment 
(Lee and Archer, 1998), consistent with the notion that H1 generally acts as a repressor.  
In contrast, overexpression of H1.2 or H1
o
 enhanced basal and hormone-stimulated 
transcription of stably-integrated MMTV-LTR reporter genes in murine 3T3 cells and 
prevented repression of these reporters during prolonged hormone stimulation (Gunjan 
and Brown, 1999).  Our data are consistent with the proposal that H1 affects 
nucleosome positioning or other aspects of MMTV promoter chromatin architecture to 
facilitate the binding of liganded nuclear hormone receptors, their synergism with 
transcription factors such as NF1 and AP-1, and the recruitment or activation of kinases 
which phosphorylate and facilitate H1 displacement following hormone stimulation 
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(Vicent et al., 2002).  Considered together with recent evidence that estradiol stimulates 
the exchange of HMGB for H1 in the ERE-containing nucleosome of the pS2 gene, and 
that HMGB is exchanged for H1 at other sites recognized by AP-1 or by other nuclear 
hormone receptors (Ju et al., 2006), our data suggests that H1.4-S187 phosphorylation 
promotes nuclear hormone receptor-mediated transcriptional activation by enhancing 
chromatin access for other regulatory factors. 
Interphase H1 Phosphorylation as a Modulator of H1 Binding Dynamics 
The predominant expression of H1.2 and H1.4 in HeLa S3 cells, the abundant nature and 
high specificity of interphase phosphorylation for just one site in H1.2 and just two sites 
in H1.4, and our evidence that H1.4-S187 phosphorylation facilitates transcription by 
both RNA polymerases I and II, all imply that interphase H1 phosphorylation at a limited 
number of specific sites plays a general role in enhancing chromatin access for factors 
involved in transcription and other chromatin-templated activities.  Our data are 
consistent with evidence from FRAP analyses of GFP-H1 that mutations which mimic 
constitutive phosphorylation or dephosphorylation of CDK sites enhance or diminish H1 
dissociation from chromatin, respectively. 
 
Our evidence that the association of pS187-H1.4 with specific chromatin loci is dynamic 
also implies that H1 kinases and phosphatases are recruited to these loci in a targeted 
fashion, presumably via mechanisms similar to those which mediate dynamic 
locus-specific core histone modification (Berger, 2007).  Kinases which mediate 
interphase H1 phosphorylation in vivo have not been directly identified before but several 
lines of evidence implicate CDK2 (Bhattacharjee et al., 2001; Contreras et al., 2003; 
Herrera et al., 1996).  Our data has suggested CDK8 and CDK9 are very likely the 
kinase in the transcription machinery that can phosphorylate the H1 which marks the 
active transcribed gene body and regulatory elements.  We had demonstrated H1 
phosphorylation is highly dynamic and required constant modulation by kinase and 
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phosphatase as evidence that H1 phosphorylation greatly decreased when cells were 
treated with CDK inhibitor for 3 hrs or greatly increased when treated with phosphatase 
inhibitor okadaic acid (Ryan, 1999).  We also found H1 phosphorylation is diminished 
when treated with protein synthesis inhibitor cycloheximide, which is corroborated by the 
similar finding reported previously (Ryan, 1999).  In addition, the diminishing of H1 
phosphorylation caused by cycloheximide can be reverted by proteosome inhibitor (Ryan, 
1999), which also implies that H1 phosphorylation requires constant action of kinase.  
 
5.9 Materials and Methods 
Cell Culture 
3134 cells were maintained as described previously (John et al., 2009).  Cells
 
were 
transferred to 10% charcoal-dextran-treated, heat-inactivated
 
fetal bovine serum for 48 h 
before treatment with 100 nM dexamethasone.  MCF-7 cells were maintained as 
described previously (Schultz-Norton et al., 2007).  Cells were transferred to phenol 
red-free MEM containing 5% charcoal-dextran-treated calf serum for 72–96 h before 
treatment with 10 nM estradiol. 
 
Silencing Resistance Plasmid Construction 
To prevent transfected plasmid of H1.4 being silenced by siRNA targeting H1.4, four 
nucleotide synonymous substitutions were introduced to the H1.4-FLAG plasmid 
including WT, S187A, S187E, S172A+S187A, S172E+S187E within the sequence 
recognized by H1.4 siRNA (targeting sequence: TC AAG AGC CTG GTG AGC AA).  
The four underline nucleotides were mutated with following primers: GGT CTC AAG 
AGC CTG GTC TCA AAG GGC ACC CTG GTG C. 
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siRNA and Plasmid Transfection 
siRNA oligos were introduced to cells using oligofectamine (Invitrogen) using following 
conditions for 24-well format: 3.0 μl of oligofectamine was added to 12 μl of 
OPTI-MEM,3.0 μl of 20 μM siRNA oligo was added to 50 μl of OPTI-MEM, two 
complexes were mixed and incubated for 20 min before added to cells in 2.0 ml 10% 
FBS DMEM.  Plasmids transfection using FuGENE HD (Roche) was found achieving 
maximum transient expression of histone H1 in pCMV driving pcDNA plasmid in 48 hrs 
with 7:2 ratio (1.75 μl of FuGENE, 0.5μg of plasmid) in 24-well.  Alternatively, 1.0 μl 
of Lipofectamine 2000 and 0.4 μg of plasmid were used to transfect cells in 24-well plate.  
100 μl FuGENE 6 and 30 μg plasmid were first mixed individually to 1.7 ml OPTI-MEM 
and then combined together for transfection of P150 dish. 
 
Real-time PCR 
ChIP products or RT products were quantified by real-time PCR using SYBR Green 
master mix (Applied Biosystems) following the protocol described in Appendix III.  The 
measured relative amount in ChIP was expressed as percentage to input and further 
calculated as fold change against no antibody control or folded change against no 
hormone treatment.  The measured relative amount of cDNA was expressed as relative 
expression unit per μg RNA or further normalized to internal control such as β-actin.  
Both melting curve and agarose gel electrophoresis were implemented to monitor the 
amplification specificity.  Although gel electrophoresis or melting curve analysis alone 
may not be 100% reliable, the combination of both should reveal PCR specificity very 
well.  Primers used in the PCR are listed in the Table 5.1. 
 
RT-qPCR 
Total RNA was extracted from monolayer of cells in 24-well or 6-well with Trizol 
(Invitrogen) according to manufacture manual and dissolved in 20~50 μl of TE.  The 
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concentration and the quality of RNA were assayed by UV spectrometry.  1.0 μg of total 
RNA was used in reverse transcription using SuperScript first-strand synthesis system for 
RT-PCR (Invitrogen) with random hexamers.  Reactions with no reverse transcriptase 
were also performed together as negative control.  The synthesis products were further 
diluted 20~100x for the real time PCR according to the abundance of transcripts. 
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5.11 Tables and Figures 
Table 5.1 
Oligonucleotide Primers Used 
ChIP 
loci   primer 
acession 
number 
amplified 
region 
product 
length 
rDNA 
promoter 
for GTGGCTGCGATGGTGGCGTTTT 
HSU13369  -152..-23 130 bp 
rev TGCCGACTCGGAGCGAAAGA  
GAPDH 
for AAGGAGAGCTCAAGGTCAG 
NM_002046 145..282 138 bp 
rev GAGTAGGGACCTCCTGTTTC 
ALDOA 
for AGGAAGGAAATCCAGGTTAG 
NM_000034 440..541 102 bp 
rev AATGTCGAGTAAATGCCCTA 
MyoD 
for GCCAGCACTTTGCTATCTAC 
NM_002478  -111..14 125 bp 
rev CGACAGTAGCTCCATATCCT 
MMTV GRE 
for TTTCCATACCAAGGAGGGGACAGTG 
      
rev CTTACTTAAGCCTTGGGAACCGCAA 
Sgk GRE 
for CTTCCCTTATCCAGCATGTCTTGTG 
  
1 kb  
downstream  
98 bp 
rev TGCATCGTGCAATCTGTGGC 
pS2 ERE 
for CCCGTGAGCCACTGTTGTC 
NM_007344  -390..-293 96 bp 
rev CCTCCCGCCAGGGTAAATAC 
 
qRT-PCR 
gene   primer 
acession 
number 
amplified 
region 
product 
length 
pre-rRNA 
for GAACGGTGGTGTGTCGTTC 
HSU13369  851..980 130 bp 
rev GCGTCTCGTCTCGTCTCACT 
BACT 
for ATCGTCCACCGCAAATGCTTCTA  
NM_001101 
1189..1293 105 bp 
rev AGCCATGCCAATCTCATCTTGTT 
MT1A 
for CTCGAAATGGACCCCAACT 
NM_005946 68..286 219 bp 
rev ATATCTTCGAGCAGGGCTGTC 
MT2A 
for CCGACTCTAGCCGCCTCTT 
NM_005953 63..321 259 bp 
rev GTGGAAGTCGCGTTCTTTACA 
H1.2 
for ACACCGAAGAAAGCGAAGAA 
NM_005319 460..576 117 bp 
rev AGCCTTAGCAGCACTTTTGG 
H1.4 
for CTCAAGAGCCTGGTGAGCA 
NM_005321 250..373 124 bp 
rev CGCCTGCCTTTTTAGCCTTA 
H1.4-flag-SR 
for CGAAGGCCAAAGCAGTTAAA 
N/A N/A 108 bp 
rev GTACCGGATCCGTCGACTT 
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Table 5.1 (cont.) 
conventional RT-PCR 
gene   primer 
acession 
number 
amplified 
region 
product 
length 
CDK1 
for CTGGGGTCAGCTCGTTACTC 
NM_001786  655..970 326 bp 
rev CCATTTTGCCAGAAATTCGT 
CDK2 
for CATTCCTCTTCCCCTCATCA 
NM_001798 527..829 303 bp 
rev CGAGTCACCATCTCAGCAAA 
CDK7 
for GGCTCTGGACGTGAAGTCTC 
NM_001799 91..436 346 bp 
rev GGCTTTGATGTGTGATGGTG 
CDK8 
for AGGCTATGCAGGACCCCTAT 
NM_001260 1009..1321 313 bp 
rev GGATAGGCAGCATGTGGATT 
CDK9 
for AGGGACATGAAGGCTGCTAA 
NM_001261 540..901 362 bp 
rev ACCAGCTCCAGCTTTTCGTA 
GAPDH 
for TGGCGTCTTCACCACCAT 
NM_002046 399..1077 679 bp 
rev CACCACCCTGTTGCTGTA 
 
siRNA oligo 
histone 
H1.2/H1.4 
sense UCAAGAGCCUGGUGAGCAAUU 
NM_001786  
antisense UUGCUCACCAGGCUCUUGAUU 
CDK1 
sense CAAACGAAUUUCUGGCAAAUU 
NM_033379 
antisense PUUUGCCAGAAAUUCGUUUGUU 
CDK2 
sense GAAACAAGUUGACGGGAGAUU 
NM_052827 
antisense PUCUCCCGUCAACUUGUUUCUU 
CDK7 
sense GAUGACUCUUCAAGGAUUAUU 
NM_001799 
antisense PUAAUCCUUGAAGAGUCAUCUU 
CDK8 
sense CGUCAGAACCAAUAUUUCAUU 
NM_001260 
antisense PUGAAAUAUUGGUUCUGACGUU 
CDK9 
sense UAUAACCGCUGCAAGGGUAUU 
NM_001261 
antisense PUACCCUUGCAGCGGUUAUAUU 
CDK4 
  
pool of 4 target-specific 20-25 nt 
siRNAs (sc-29261) 
NM_000075 
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Figure 5.1 
 
Interphase Phosphorylated H1.4 is Preferentially Associated With Transcriptionally 
Active rDNA 
(A) The relative levels of pS187-H1.4 and total H1.4 at the 45S pre-rRNA promoter 
following treatment of asynchronously growing HeLa cells with actinomycin D (50 
ng/ml, 3 hours) was compared to that of untreated cells using ChIP-qPCR.  The data are 
expressed as fold change relative to immunoprecipitations performed without primary 
antibody from untreated cells.   
(B) The levels of the 45S pre-rRNA transcript assayed by RT-PCR after three hours of 
treatment with actinomycin (3 hours at 50 ng/ml) are shown relative to untreated cells.  
The data were normalized according to β-actin expression.   
(C) The global phosphorylation abundance at S187 was monitored by western blot using 
pS187-H1.4 antibody.  Total H1.4 and tubulin were served as loading control. 
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Figure 5.2 
 
Interphase Phosphorylated H1.4 is Preferentially Associated with Transcriptionally 
Active Genes 
The relative levels of pS187-H1.4 and total H1.4 at the housekeeping genes and inactive 
genes in HeLa cells were measured using ChIP-qPCR.  The data are expressed as fold 
change relative to immunoprecipitations performed without primary antibody. 
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Figure 5.3 
 
Nuclear Hormone Receptors Induce Enrichment of Interphase Phosphorylated H1.4 
at Their Response Elements  
(A) The association of pS187-H1.4 with the GRE of the MMTV-LTR array in 3134 cells 
was assessed by ChIP-qPCR before and after dexamethasone stimulation.   
(B) The association of pS187-H1.4 with the GRE of the single copy Sgk gene in 3134 
cells was assessed by ChIP-qPCR before and after dexamethasone stimulation.   
(C) The association of ER-α and pS187-H1.4 with the ERE of the TFF1 gene in MCF-7 
cells was assessed by ChIP qPCR before and after estradiol stimulation. 
The data in panels A, B and C are normalized to the signal obtained for each antibody 
prior to hormone stimulation. 
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Figure 5.4 
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Figure 5.4 (cont.) 
Examples of Enrichment of pS187-H1.4 Revealed by Genome Wide Analysis   
A. Hormone treatment induces the enrichment of pS187-H1.4 along the entire length of 
the hormone activated gene, Tgm2, starting right at the TSS and extending ~5 kb beyond 
the 3’UTR.  In addition, enrichment of pS187-H1.4 was also observed in the 5’ 
upstream regulatory element locus where GR binds.   
B. The levels of pS187-H1.4 at hormone-repressed genes, Tgm2, fell compared to 
untreated cells.  The association of pS187-H1.4 with genes before hormone treatment 
starts right at the TSS and extends ~1 kb beyond the 3’UTR. 
C. The levels of pS187-H1.4 at constantly active genes, Hsp90, are kept at the constant 
levels.  The association of pS187-H1.4 with genes in both before and after hormone 
treatment starts right at the TSS and extends ~2 kb beyond the 3’UTR. 
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Figure 5.5 
 
CDK2, CDK8 and CDK9 Are Potential H1 Kinases But Are Not Required For Pol I 
Transcription 
(A) The global phosphorylation abundance at S187 in HeLa cells after CDKs knocked 
down by siRNA was monitored by western blot using pS187-H1.4 antibody.  Total H1.4 
and tubulin were served as loading control.  Sample = cells lysate in 2x SDS sample 
buffer 
(B) The mRNA expression level of CDKs after siRNA treatment was monitored by 
RT-PCR.  GAPDH was served as loading control.  (m: mock, si: siRNA)  
(C) The global phosphorylation abundance at S187 was monitored by western blot using 
pS187-H1.4 antibody.  Total H1.4 and tubulin were served as loading control. 
(D) The levels of the 45S pre-rRNA transcript were assayed by qRT-PCR after 
expressions of CDKs were knocked down by siRNA. 
(E) The levels of the 45S pre-rRNA transcript were assayed by qRT-PCR after CDKs 
activities were inhibited by specific CDK inhibitors. 
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Figure 5.6 
 
H1 Phosphorylation Is Necessary for Transcription Activation of Metallothionein 
(A) Hormone treatment (-/+ 100 nM dexamethasone) induces the enrichment of 
pS187-H1.4 along the entire length of the metallothionein genes.  The association starts 
right at the TSSs for both MT1 and MT2, extends ~2 kb beyond the 3’UTR of MT1 and 
~1 kb beyond the 3’UTR of MT2.   
(B) Endogenous H1.2 and H1.4 in HeLa cells are knocked down by siRNA for 72 hrs and 
were replaced with different mutants for 48 hrs.  Cells were stimulated with 200 μM 
ZnCl2 for 6 hrs.  The inhibitors were also included for 6 hrs with 5.0 μM purvalanol A 
and 1.0 μM flavopiridol.  The levels of the steady state transcript of MT1A and MT2A 
were assayed by qRT-PCR for different mutant replacements.     
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APPENDIX A 
 
A.1 Optimization of RP-HPLC for Histone H1 Separation 
We have found the condition of RP-HPLC using acetonitrile as organic modifier and TFA 
as ion-paring agent in mobile phase is unable to resolve most of H1 variants as indicated 
in Figure 3.3.  We have demonstrated H1 variants from HeLa S3 are remarkably simple 
with only two major forms of H1.2 and H1.4 (chapter 2).  Thus, we decided to use total 
H1 purified from HeLa S3 cells in our optimization efforts. As shown in Figure A.1 A, 
two partially resolved peaks were obtained in standard condition of RP-HPLC.  First, 
the degree of separation was analyzed by TDMS and mass spectrum was shown in Figure 
A.1 E, demonstrated both H1.2 and H1.4 are present in the partially separated peak 2.  
Then we tried to improve the resolution of H1 variants in RP-HPLC with different 
organic modifier as well as ion pairing agent (Delgado et al., 2003; Shibue et al., 2005).  
Unfortunately, no better resolution was obtained with either isopropanol/methanol as 
organic modifier (Figure A.1 B, C, D) or perchlorate anion as ion-pairing agent (Figure 
A.1 F).  Although it has been reported H1.2 and H1.4 can be separated in RP-HPLC 
when isopropanol gradient was used in 1 M pyridine-formic acid (pH 5) at 50 °C (Ohe et 
al., 1986), running at elevated temperature is not a good option for us.  Therefore 
RP-HPLC is not a good chromatograph method for H1 separation. 
 
A.2 Optimization of HIC for Histone H1 Separation 
The facts that HIC is not able to fully resolve phosphorylated H1 down to the baseline 
and H1
0
 is overlapped with 2p-H1.4 (Figure A.2 A) motivated us to optimize the 
conditions.  Crude H1 purified from asynchronous and colchicine arrested HeLa S3 
cells are used for the test.  Low pH was first tested to see whether it might change the 
conformation of H1 to benefit the separation.  It turned out only two peaks was resolved 
when pH < 6, which suggested even the slight decrease of charge in phosphate group will 
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compromise the separation (Figure A.2 A).  We theorized better resolution can be 
achieved at higher pH since the negative charge in the phosphate increase at higher pH 
and indeed both phosphorylated H1.2 and H1.4 was better separated at pH 8.0 (Figure 
A.2 A).  However, the slight improvement did not outweigh the inconvenience of 
column life shortening under basic condition (silica beads dissolve in basic solution).  
Therefore we tested different salt/buffer and column with different material but no 
improvement was found.  It is worthy of noting that polyPROPYL A with spherical 
silica having 1000 Ǻ diam. pores was not able to resolve phosphorylated H1 while the 
same stationary phase immobilized in silica with 1500 Ǻ diam. pores was able to resolve 
the phosphorylated H1 (Figure A.2 D) 
 
A.3 Optimization of HILIC for Histone H1 Separation 
Despite the well separation of H1 variants and their phosphorylation forms achieved by 
HIC, the significant changes in the baseline limits its ability to resolve minor forms.  
Such changes is caused by the great changes in the refractive index of the mobile phase 
resulted from marked change in salt concentration necessary to separate H1 in HIC.  
HILIC is a good choice among the alternative approaches to overcome this limitation.  
When the weak cation exchanger polyCAT A column under predominant organic mobile 
phase, the hydrophilic interactions will be superimposed on the electrostatic effects and 
thus resolve solutes that differ in polarity but not charge.  The condition for HILIC 
running at neutral pH (nHILIC) developed by Mizzen has successfully resolve the 
nonallelic H1 variants (Mizzen et al., 2000) whereas the condition running at acidic pH 
(aHILIC) developed by Lindner is able to resolve different phosphorylation forms from 
RP-HPLC purified H1.5 (Lindner et al., 1997).  As described in chapter 3, we have 
determined the identity of most peaks for the total H1 separated by aHILIC in the mass 
spectrometry analyses (Figure 3.7).  However, H1.3, H1.4 and H1.5 turned out to elute 
closely together before their phosphorylation forms.  When total H1 from asynchronous 
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HeLs S3 was tested using the nHILIC, better resolution was found for variants as 
indicated by the separation of H1.2 polymorphism we discovered in HeLa S3 cells (H1.2 
eluted earlier than H1.2-A142T in both H1.2-0p and H1.2-1p fractions).  The 
determination of identity for each peak was based on the relative abundance of each form 
we identified previously by mass spectrometry analysis (Figure A.3 A).  However, 
retention of H1 in the nHILIC condition was too strong, which was demonstrated by the 
proteins carried from one run with injection of total H1 to the three following washes 
with no injection (Figure A.3 B).  This retention problem prevents us from using 
nHILIC for routine analysis of mammalian H1. 
 
In recent years, several new stationary phases have been applied for HILIC approaches 
(Boersema et al., 2008).  Among them, the weak anion exchanger PolyWAX has been 
used to retain phosphopeptide through hydrophilic interaction (Alpert, 2008).  Such new 
separation technique is termed electrostatic repulsion-hydrophilic interaction 
chromatography (ERLIC).  Two different interaction modes will happen when 
phosphorylated H1 was running in polyWAX with predominantly organic mobile phase: 
first, the positively charged H1 will retain through hydrophilic interaction even if they 
have the same charge as the stationary phase; second, phosphate group in the H1 can 
interact with stationary phase through electrostatic interaction.  To test whether we can 
improve H1 separation by exploiting the repulsion effects, total H1 from asynchronous 
HeLa S3 was separated by HILIC with polyWAX column using the condition indicated in 
the Figure A.3 C.  However, only five peaks were partially resolved demonstrating this 
technique was not suitable for H1 separation with current condition. 
 
A.4 Optimization of CZE for Histone H1 Separation 
CZE has been demonstrated to be well suited for resolving histone H1 (Kratzmeier et al., 
1999; Lindner et al., 1993; Mizzen and McLachlan, 2000) with great sensitivity.  
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However, the migration order of H1 variants established in a species usually can not 
apply to other species appropriately due to the sequence divergence in the H1 variants 
among species.  In addition, the buffer concentration and composition also influence 
migration order and resolution of H1 variants (Lindner, 2008).  
 
To establish a good running condition of CZE for H1, total H1 from asynchronous 
growing HeLa S3 was used to test several conditions since the relative abundance of all 
H1 variants and their phosphorylation forms in HeLa S3 has been well characterized by 
us.  In order to increase the difference causing by phosphorylation, we decided to run at 
the pH 2.5 instead of pH 2.0 (Lindner et al., 1993) and we found 10 fold increase of 
HPMC to 0.2% was necessary to block the histone-wall interaction caused by the 
electrostatic attraction between negatively charged silanol and positively charged H1.  
Five peaks were obtained using the condition described in the Figure A.4 A.  To 
determine the identity of these peaks, RP-HPLC purified recombinant H1.4 (rH1.4) was 
spiked in the total H1 from HeLa S3 and was found eluting earlier than all human H1 
(Figure A.4 B), which was very likely caused by the N-terminal acetylation of H1 in 
mammal cells.   
 
Addition of sodium perchlorate has been demonstrated to be able to improve the 
resolution of H1 variants (Lindner et al., 1993) possibly by increasing α-helix content as 
suggested by circular dichroism (CD) spectroscopy study (Mizzen et al., 2000).  To 
prevent the electrical current from collapsing when using the high ionic strength buffer 
containing NaClO4, 25 μm ID tube was used to replace 50 μm ID tube.  The six peaks 
separated with this condition and their relative abundance was shown in the Figure A.4 C.  
Compared to the known relative abundance, the predicted identity for each peak was also 
listed in the Figure A.4 C. 
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A.6 Figures 
Figure A.1 
 
 
Optimization of RP-HPLC for for Histone H1 Separation 
 (A-D) Compare the separation of Histone H1 with RP-HPLC using different mobile 
phase.  ES industries Chromega MC18 analytical column, 25 cm x 4.6 mm, 1000 Ǻ 
diam. pores, flow rate of 0.8 ml/min. (A) Buffer A: 5% ACN, 0.1% TFA, Buffer B: 90% 
ACN, 0.094% TFA, gradient: 20%-40% in 140 min. (B) Buffer A: 5% ACN, 0.1% TFA, 
Buffer B: 40% ACN+20% IPA, 0.094% TFA, gradient: 55%-95% in 140 min. (C, D) 
Buffer A: 5% ACN, 0.1% TFA, Buffer B: 40% ACN+20%MeOH, gradient: 0.094% TFA 
gradient: 55%-75% in 140 min 
(E) The mass spectrum of H1 from partially separated peak 2 in RP-HPLC, blue: H1.2, 
orange: H1.4. 
(F) Compare the separation of Histone H1 using Vydac RP column with different length 
of carbon base under percolate modified condition, Buffer A: 20% ACN, 0.1 M NaClO4, 
10 mM phosphate, pH 2.35; Buffer B: 60% ACN, 0.1 M NaClO4, 10 mM phosphate, pH 
2.5. 
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Figure A.2 
 
 
Optimization of HIC for Histone H1 Separation  
Crude H1 prepared from HeLa S3 cells was analyzed by Hydrophobic Interaction 
Chromatography (HIC). PolyPROPYL A column (PolyLC), 100 x 4.6 mm, base = 3 μm 
spherical silica with 1500 Ǻ diam. Pores, gradient: 1% B per min, flow rate of 0.8 
ml/min.   
(A, B, C) Effects of different pH or buffer were compared for H1 from asynchronous or 
colchicine arrested M phase.  Ethylenediamine buffer: gradient from 2.5 M to 1.5 M 
(NH4)2SO4 in 50 mM ethylendiamine, phosphate buffer: gradient from 2.0 M to 0 M 
(NH4)2SO4 in 40 mM sodium phosphate. 
(D) Effects of different columns (listed on the left) were compared. 1~5: gradient from 
2.5 M to 1.5 M (NH4)2SO4 in 50 mM ethylendiamine pH7.0; 6: gradient from 2.0 M to 0 
M (NH4)2SO4 in 40 mM sodium phosphate, pH7.0; 7: gradient from 2.3 M to 0 M 
(NH4)2SO4 in 80 mM sodium phosphate + 20% MeOH, pH7.0. 
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Figure A.3 
 
Optimization of HILIC for Histone H1 Separation  
(A) Total H1 from asynchronous HeLa S3 was separated in the neutral pH by HILIC 
(nHILIC) using the condition noted in the figure.  Compared with aHILIC (A: 70% 
ACN, 15 mM TEA / H3PO4 pH 3.0; B: A + 0.68 M NaClO4), nHILIC achieved better 
resolution for variants as indicated by the separation of H1.2 polymorphism we 
discovered in HeLa cells (H1.2 eluted earlier than H1.2-A142T in both H1.2-0p and 
H1.2-1p fraction) 
(B) Retention of H1 in the nHILIC condition was too strong to elute.  Top panel: a 
nHILIC run of total H1 from colchicine arrested HeLa S3 with a shallow gradient; 
bottom panel: three washes following one run in the top panel using a fast gradient of 
0-100% B in 30 min. 
(C) Total H1 from asynchronous HeLa S3 was separated by HILIC using the polyWAX 
column and the condition noted in the figure. 
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Figure A.4 
 
 
Optimization of CZE for Histone H1 Separation  
Uncoated fused silica capillary with length of 60 cm, 50 cm to window and inner 
diameter as indicated was used in Beckman P/ACE System MDQ system under following 
conditions: temperature, 20 °C; voltage, 12 kV; separation time, 40 min; sample injection 
by pressure, 2 psi; injection time, 10 s; absorbance detection at 200 nm.  HPMC: 
hydroxypropylmethylcellulose  
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APPENDIX B 
 
B.1 Histone H1 Phosphorylation in Drosophila 
Before we started to investigate H1 phosphorylation in HeLa cells, we first tried to map 
the H1 phosphorylation sites in Drosophila melanogaster S2 cells since there is only a 
single H1 variant in Drosophila.  The rationale is to take the advantage of single variant 
in order to establish the TDMS method for H1 analysis.  In fact, we were able to obtain 
nice broadband for RP-HPLC purified H1 from Drosophila S2 cells.  As shown in Figure 
B.1 A, up to 2 phosphorylations could be added to Drosophila H1 and the abundance of 
phosphorylation was relative high, with un-, mono- and diphosphorylated H1 accounting 
roughly ~20%, 50% and 30% of total H1.  Due to some technique difficulties, we were 
unable to identify phosphorylation sites except localizing the phosphorylation sites to the 
N-terminal in the MS/MS analysis by ECD. 
 
To test whether the levels and the abundance of phosphorylation in Drosophila H1 will 
increase like mammalian during mitosis, S2 cells were treated with 5 μM colchicine for 
20 hrs but no increase of phosphorylation were observed in the mass spectrum (Figure 
B.1 A).  However, we later found out 30 μM colchicine of colchicine is necessary to 
arrest S2 cells, which was much higher than the 1μM concentration we used for 
mammalian cells (Lemos et al., 2000).  Thus whether phosphorylation in Drosophila H1 
increases in mitosis remained unknown yet.  The insufficient arrest was also evidenced 
by the absence of obvious increase of pS10-H3 intensity in the histone purified from 
colchicine treated S2 cells (Figure B.1 C).  Although the 26.2 kDa Drosophila H1 is 
slightly heavier than human H1.4 (21.7 kDa), they ran to the similar position in the SDS-
PAGE.  However Drosophila H1 ran significantly slower than human H1 in acid urea 
PAGE and only two bands was visible for there different phosphorylation forms which 
was different from human H1 (addition of every phosphorylation resulted in a band up 
shifting, 0 to 6-p of H1 was indicated as 0~6 in Figure B.1 D). 
 
Recent mass spectrometry mapping of the Drosophila H1 purified from embryo at 
different ages has localized the phosphorylations to the first 10 amino acid and identified 
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a monophosphorylated form with major site located at S10 and some minor site possible 
at S1 or S3.  In addition, two subpopulations were found for diphosphorylated forms, one 
was mapped to S10 together with T7 or S8, another was mapped to S10 together with S1 
or S3 (Villar-Garea and Imhof, 2008) (Figure B.1 E).  The authors could not distinguish 
between S1 and S3 phosphorylation and T7 and S8 phosphorylation.  These data 
demonstrated Drosophila H1 is phosphorylated to the moderately levels with relative 
high abundance in the interphase despite lacking CDK substrate motif (S/T)PXZ (where 
X is any amino acid and Z a basic amino acid). 
 
B.2 Targeted H1 Phosphorylation during Transcriptional Activation 
Belmont lab has developed a powerful tool that able to visualize the effects of 
transcription factor at a targeted chromatin locus.  In this system, multiple copies of lacO/ 
DHFR vector were stably integrated and amplified in CHO cell.  When LacI-GFP or 
LacI-GFP derivative in trans was provide in this derivative cell line (A03_1 cells), a 
homogenously staining region (HSR) can be visualized (Tumbar and Belmont, 2001).  
We have demonstrated phosphorylated H1 is partially colocalized with ERα after 
estradiol stimulation, which suggests H1 phosphorylation might play roles in the 
transcription activation.  However, the fact that ERα is all over the nucleus make it 
difficult to determine which loci are actually transcribed without doing RNA FISH.  Thus 
we decided to take advantage of CHO system by studying the phosphorylated H1 patterns 
in the presence of transcription activator. 
 
To identify which H1 antibody can be used in CHO cells, whole cell lysate from CHO 
was used to test a panel of antibodies.  Among them, pS173-H1.2 and α-H1.4 turned out 
to be able to react with H1 in CHO cells (Figure B.2 A).  CHO cell line harboring 
integrated lacO repeats (A03_1) was fist transient transected with dlacI-EGFP control 
vector or dlacI-EGFP-VP16 plasmid, and then subjected to immunofluorescence staining 
of pS173-H1.2 and GFP.  As expected, lacO repeat locus remained closed as indicated by 
a small dot-like staining of GFP when no transcription activator was targeted to the locus.  
By contrast, such locus became open as indicated by dramatic decondensation staining of 
GFP when VP16 fusion protein was targeted to the loci (Figure B.2 B).  Importantly, 
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phosphorylated H1 was observed in the open chromatin (Figure B.2 B, C).  Thus this 
preliminary data suggests H1 phosphorylation is present in the transcription activated loci. 
 
To further test whether present of H1 phosphorylation in the transcription activation loci 
is the result of recruitment of H1 kinase, we decided to perform histone H1 kinase assay 
from immunoprecipitated ERα.  Although we successfully pulled down ERα from MCF-7 
cells (Figure B.3 B), no kinase activity was found in the immunoprecipitate as indicated 
by no CPM reading above the background in either recombinant H1.4 or peptide 
substrate (Figure B.3 A).  Nonetheless, we believed it was not sufficient to disprove the 
hypothesis of kinase being recruited to the activated transcription loci for the 
phosphorylation of H1.  It is possible that the interaction between kinase and ERα is 
transient and thus difficult to capture or H1 kinase is recruited by other component in the 
transcription machinery for ERα transactivation.  Actually, it has been reported that 
CDK2 is recruited to the MMTV array upon hormone stimulation (Stavreva and McNally, 
2006).  Taken this result with our evidence that association of phosphorylated H1 in the 
MMTV array increases after dexamethasone treatment, it is reasonable to propose H1 is 
phosphorylated by targeted kinase. 
 
B.3 What is the Role of H1 Phosphorylation in DNA Replication? 
As described in chapter 1.9, the observation that H1 phosphorylation increases as cells 
transverse S phase has led to the speculation that H1 phosphorylation plays some roles in 
DNA replication near 30 years ago(Ajiro et al., 1981).  However the direct evidence has 
not been reported until 5 years ago (Alexandrow and Hamlin, 2005).  Once we obtained 
the good phosphospecific H1 antibody, we started to test this old speculation with IF 
staining of BrdU labeled cells.  Very soon, we found out the conventional protocol 
requiring 2 N HCl treatment to denature the DNA for the recognition of BrdU antigen 
was not compatible with phosphorylated H1 staining since the acid extraction of basic H1 
disrupted phosphorylated H1 staining pattern.  Therefore, we used the DNAse I digestion 
to expose BrdU antigen.  Using this approach, a partial colocalization for pS173-H1.2 or 
pS187-H1.4 with BrdU was found (Figure B.4 A, B), i.e. not all phosphorylated H1 were 
colocalized with BrdU and vice versa.  Since H1 phosphorylation involves some other 
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processes such as transcription, thus it is reasonable that not all H1 phosphorylation are 
colocalized with BrdU.  On the other hand, not all BrdU loci colocalized with 
phosphorylated H1 was a surprise to us.  Does it indicated H1 phosphorylation only 
function in a short lived process right after replication firing?  In other word, only those 
replication loci firing not long before the end of BrdU labeling (stop by fixation) will 
have phosphorylated H1.  To solve this problem, we can label cells with shorter pulse of 
BrdU but it requires better imaging technique since DNAse I is not very efficient to 
expose the antigen thus signal from 30 min of labeling is already very weak.  Another 
possibility for the partial colocalization observed is caused by chance since both BrdU 
foci and H1 phosphorylation foci are abundant and distributed all over the nuclear.  To 
test this possibility, we rotated the green channel left for 90 degree and similar 
colocalization pattern were still observed indicated some of the staining do come by 
chance (Figure B.4 C).  Taken these data together, whether H1 phosphorylation is 
involved in DNA replication remained unclear.  As discussed in chapter 3, the relative 
abundant phosphorylation in HeLa seems not necessary for the cell survival.  Hence it is 
reasonable to argue that fair amount of phosphorylation foci we visualized might not 
actively participated in any of cellular process.  It might be wise to choose cells with 
relative low percentage of phosphorylation for immunofluorescence study of DNA 
replication.  
 
B.4 Interphase Phosphorylation Diminishes Chromatin Binding by H1 
Salt extraction has been adopted to investigate the association of structural proteins with 
chromatin as an alternative to FRAP experiments (Meshorer et al., 2006).  Having the 
phosphospecific H1 antibody, we can directly measure the relative amount of 
phosphorylated H1 in the salt extraction fractions.  As shown in Figure B.5, isolated 
nuclei were incubated with different concentration of (NH4)2SO4 and the H1 being 
extracted to the supernatants or remained in the pellet were recovered by acid extraction 
and separated in SDS-PAGE.  The amount of total H1.4 was measured by commassie 
blue stain while amount of phosphorylated H1.4 was monitored by western blot using 
pS187-H1.4.  All measurements of both total H1.4 and pS187-H1.4 were normalized as 
percentage to the intensity from pellet with no salt extraction.  This experiment clearly 
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demonstrated phosphorylated H1 is much easier to extract, as 80% of phosphorylated H1 
was released from chromatin while only 40% of total H1 were released at 250 mM 
(NH4)2SO4 (Figure B.5).  These data are consistence with the predication that 
phosphorylation in H1 increase its dynamic from FRAP (Contreras et al., 2003) study. 
 
B.5 References 
Ajiro, K., T.W. Borun, and L.H. Cohen. 1981. Phosphorylation states of different histone 
1 subtypes and their relationship to chromatin functions during the HeLa S-3 cell 
cycle. Biochemistry. 20:1445-1454. 
Alexandrow, M.G., and J.L. Hamlin. 2005. Chromatin decondensation in S-phase 
involves recruitment of Cdk2 by Cdc45 and histone H1 phosphorylation. J. Cell 
Biol. 168:875-886. 
Contreras, A., T.K. Hale, D.L. Stenoien, J.M. Rosen, M.A. Mancini, and R.E. Herrera. 
2003. The dynamic mobility of histone H1 is regulated by cyclin/CDK 
phosphorylation. Mol Cell Biol. 23:8626-36. 
Lemos, C.L., P. Sampaio, H. Maiato, M. Costa, L.V. Omel'yanchuk, V. Liberal, and C.E. 
Sunkel. 2000. Mast, a conserved microtubule-associated protein required for 
bipolar mitotic spindle organization. EMBO J. 19:3668-82. 
Meshorer, E., D. Yellajoshula, E. George, P.J. Scambler, D.T. Brown, and T. Misteli. 2006. 
Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem 
cells. Dev Cell. 10:105-16. 
Stavreva, D.A., and J.G. McNally. 2006. Role of H1 phosphorylation in rapid GR 
exchange and function at the MMTV promoter. Histochemistry and Cell Biology. 
125:83-89. 
Tumbar, T., and A.S. Belmont. 2001. Interphase movements of a DNA chromosome 
region modulated by VP16 transcriptional activator. Nat Cell Biol. 3:134-9. 
Villar-Garea, A., and A. Imhof. 2008. Fine Mapping of Posttranslational Modifications of 
the Linker Histone H1 from Drosophila melanogaster. PLoS ONE. 3:e1553. 
 
 
184 
 
B.6 Figures 
Figure B.1 
 
 
 
H1 Phosphorylation in Drosophila S2 Cells  
(A) The mass spectrum of RP-HPLC purified H1 from asynchronously growing or 
colchicine arrested Drosophila S2 cells.  Missing Met1 and -N-acetylated at Ser2 were 
present in H1.  Phosphorylation levels were inferred from the difference between the 
molecular mass measured and the value predicted for the unmodified H1.  Molecular 
masses are reported for the neutral monoisotopic species.  Abundance of phosphorylation 
for H1 was not increased in the cells treated with 5 μM colchicine.  
(B) SDS polyacrylamide gel analysis of H1 from asynchronous or colchicine treated 
HeLa S3 or Drosophila S2 cells (1 μM for HeLa, 5 μM for S2).  Molecular weight 
standards (MW) in kilodaltons are shown on the left.   
(C) Total H1 purified from asynchronous or colchicine treated HeLa S3 or Drosophila S2 
cells in were analyzed by immunoblotting with antisera of pTetH1 or pS10-H3. 
(D) Acid urea polyacrylamide gel analysis of H1 from asynchronous or colchicine treated 
HeLa S3 or Drosophila S2 cells  
(E) Sequence alignment of Drosophila H1 and human H1.4 variant.  Globular domain in 
H1.4 was indicated by blue shade.  Monophosphorylation of Drosophila H1 was mapped 
to S1, S3 or S10 (red circle) and diphosphorylation was mapped to S10 plus T7/S8 or S10 
plus S1/S3 (red diamond) according to the MALDI-TOF analysis from Villar-Garea et al. 
(Villar-Garea and Imhof, 2008). 
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Figure B.2 
 
 
Targeted H1 Phosphorylation is Associated With Chromatin Decondensation In 
Vivo  
(A) Whole cell lysate from CHO were used to test which antibody can be used to study 
H1 in CHO cells.  PCAS from HeLa was used as control.  1. pS173-H1.2 (rabbit UI82 
crude serum) 1:200, 2. pS187-H1.4 (rabbit UI86 crude serum ) 1: 5k, 3. pS187-H1.4 
(affinity purified, 0.5 μg/ml), 4. pTetH1 1:1k, 5. pT154-H1.4 (rabbit 89 crude serum) 
1:500, 6. αH1.4 (rabbit UI99 crude serum) 1:1k, 7. αH1.4 (rabbit UI100 crude serum) 
1:1k, 8. sheep αH1 1:1k 
(B) CHO cell line carrying integrated lacO repeats was transient transfected with dlacI-
EGFP control vector or dlacI-EGFP-VP16 plasmid and subjected to    
immunofluorescence staining of pS173-H1.2 and GFP. 
(C) Profile of partial colocalization of pS173-H1.4 in the open chromatin of lacO repeat 
over the arbitrarily drawn line. (red: pS73-H1.2, green: EGFP-VP16) 
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Figure B.3 
 
 
Evidence That H1 Kinase Activity is Not Associated With Liganded ER In Vivo  
(A) MCF-7 cells received no estradiol treatment (E2 0 m) or 10 nM E2 treatment for 20 
min (E2 20 m) were lysed in lysis buffer (50 mM HEPES pH 7.6, 150 mM NaCl. 5 mM 
EDTA, 10% glycerol, 10 mM NaF, 1 mM Na3VO4, 1% NP-40, 0.2 mM AEBSF, 50 nM 
microcystein).  ERα was immunoprecipitated from cell lysate with or without rabbit 
polyclonal antibody against ERα (HC-20).  The immunoprecipitate was added to 50 μl of 
substrate in the kinase reaction buffer (20 mM HEPES pH 7.6, 1 mM EGTA, 1 mM DTT, 
5 mM MgCl2, 10 mM ATP, 0.1 μCi/μl 
32
P-γATP).  The reactions were incubated at 30 C 
for 30 min.  10 μl of reaction mixture was spot onto phosphocellulose P81 paper.  The air 
dried P81 paper was washed 5 x with 0.75 % phosphoric acid, transferred to 4 ml 
scintillation tube with 2 ml scintillation cocktail.  
32
P in different reactions was measured 
by scintillation counter. 
(B) The immunoprecipitate with or without antibody before and after E2 stimulation were 
eluted with SDS sample buffer and were subjected to western blot to confirm the 
successful immunoprecipitation of ERα.  Whole cell lysate from MCF-7 expressing ERα 
and HeLa cells lacking ERα were served as positive and negative control, respectively.  
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Figure B.4 
 
 
Analysis of the Colocalization of H1 Phosphorylation with Newly Synthesized DNA 
(A, B) HeLa cells were labeled with 10 μM BrdU for 30 min then fixed by 4% PFA in 
PBS for 10 min and permeabilized in 0.2% Trion-X 100 in PBS for 3 min.  Cells were 
incubated with DNAse I with diluted antibody in digestion solution (30 mM Tris pH 8.0, 
0.3 mM MgCl2, 0.5 mM β-Me, 0.2 U/μl DNAse I) at 37 C for 1 h.  After incubation with 
secondary antibody at room temperature for 1 h, images were collected by Zeiss LSM 
510 using 63 x objective. (Scale bar = 5 μm) 
(C) Upper panel: enlarged portion from merged image in B was shown; lower panel: the 
green channel (pS187-H1.4 staining) was rotated counterclockwise 90
o
 before merging 
with red channel.  The profiles over the arbitrarily drawn line were shown.  
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Figure B.5 
 
Interphase Phosphorylation Diminishes Chromatin Binding by H1 
Isolated nuclei from HeLa S3 were resuspended in Buffer B (15 mM HEPES pH 
7.9, 60 mM KCl, 15 mM NaCl, 0.34 mM sucrose, 10% glycerol) and incubated with 
different (NH4)2SO4 concentrations (100–1000 mM) at 4ºC for 30 min.  Both 
supernatants and 0.4 N H2SO4 acid extraction of pellet from salt extraction were 
precipitated with 20% TCA and separated in 15% SDS-PAGE.  Amount of H1.4 was 
quantified from Coomassie blue staining of gel and amount of pS187-H1.4 was 
quantified from western blot.  All values were normalized as the percentage to intensity 
from no salt extracted pellet. 
 
